<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d754002dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BY AND AMONG </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SENTREHEART, INC., </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ATRICURE, INC., </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STETSON MERGER SUB, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECOND STETSON MERGER SUB, LLC </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SHAREHOLDER
REPRESENTATIVE SERVICES LLC, AS SECURITYHOLDER REPRESENTATIVE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of August&nbsp;11, 2019 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS DOCUMENT IS INTENDED SOLELY TO FACILITATE DISCUSSIONS AMONG THE PARTIES IDENTIFIED HEREIN. IT IS NOT INTENDED TO CREATE, AND WILL NOT BE DEEMED TO
CREATE, A LEGALLY BINDING OR ENFORCEABLE OFFER OR AGREEMENT OF ANY TYPE OR NATURE PRIOR TO THE DULY AUTHORIZED AND APPROVED EXECUTION OF THIS DOCUMENT BY ALL SUCH PARTIES AND THE DELIVERY OF AN EXECUTED COPY HEREOF BY ALL SUCH PARTIES TO ALL OTHER
PARTIES. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TABLE OF CONTENTS </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 1 DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Certain Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 2 THE MERGERS; CLOSING; EFFECTIVE TIME</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">The Mergers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Closing of the Mergers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Effects of the Mergers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Certificate of Formation and Operating Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Managers and Officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Deliveries at Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Treatment of Company Common Stock, Company Preferred Stock, Options, Restricted Stock, RSUs and Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Surrender and Payment of Closing Merger Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Lost Certificates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Purchase Price Adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Milestone Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Registration Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Dissenting Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Withholding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.16.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Representative Reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF THE COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Due Organization, Good Standing and Power</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">No Subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Authority and Enforceability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">No Contravention</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Financial Statements; No Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Accounts Receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Indebtedness</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Environmental Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Material Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Compliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Compliance with Privacy Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Medical Device Regulatory and Related Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Health Care Regulatory and Related Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Trade Compliance Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Anti-Money Laundering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR></TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Ethical Practices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Customers and Suppliers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Inventory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Product Liability; Product Warranty</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Labor and Employment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Employee Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.26.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Broker</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.27.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.28.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Absence of Certain Changes or Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.29.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.30.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.31.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Takeover Statutes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.32.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Corporate Records</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.33.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Government Grants and Incentives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.34.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Health Care Professionals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.35.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Affiliated Transactions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.36.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Exclusivity of Representations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF PARENT, MERGER SUB 1 AND MERGER SUB
2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Due Organization; Good Standing; Corporate Power</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Authority and Enforceability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">No Contravention</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">No Legal Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Brokers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Issuance of Parent Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Merger Sub 1 and Merger Sub 2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Financial Statements; No Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">SEC Filings; Securities Law and Other Matters; Absence of Certain Changes or Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Absence of Certain Changes or Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Compliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Takeover Statutes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Intended Tax Treatment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Independent Investigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 5 COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Conduct of Business of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Access to Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Notification of Certain Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Additional Agreements; Reasonable Best Efforts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Bridge Note Conversion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Parachute Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Indemnification; Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Preservation of Books and Records</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Public Announcement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Financial Statement Preparation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Representations as to Tax Treatment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 6 CONDITIONS TO CONSUMMATION OF THE TRANSACTION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Conditions to Each Party&#146;s Obligation to Effect the Transactions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Conditions to the Obligation of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Conditions to the Obligations of Parent, Merger Sub 1 and Merger Sub 2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 7 TERMINATION; WAIVER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Effect of Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 8 SECURITYHOLDER REPRESENTATIVE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Appointment; Duties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Resignation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 9 MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Non-Survival; Recourse</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement; Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Validity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Extension; Waiver</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Governing Law; Jurisdiction; Service of Process</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Waiver of Jury Trial</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Parties in Interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Specific Performance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Waiver of Conflicts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Counterparts; Effectiveness</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>EXHIBITS</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Merger Certificates</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Exchange Agent Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Escrow Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit D</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Net Working Capital Illustration</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit E</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Letter of Transmittal</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Milestone Diligence Report</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit G</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> and Liquidity Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>SCHEDULES</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule 1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Interim Success Milestone</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule 2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Closing Management Bonus Allocation</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">THIS AGREEMENT AND PLAN OF MERGER (including any amendment hereto, this &#147;<U>Agreement</U>&#148;), dated as of August&nbsp;11, 2019, is
entered into by and among SentreHEART, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), AtriCure, Inc., a Delaware corporation (&#147;<U>Parent</U>&#148;), Stetson Merger Sub, Inc., a Delaware corporation and wholly owned direct
subsidiary of Parent (&#147;<U>Merger Sub 1</U>&#148;), Second Stetson Merger Sub, LLC, a Delaware limited liability company and wholly owned direct subsidiary of Parent (&#147;<U>Merger Sub 2</U>&#148;), and Shareholder Representative Services LLC,
a Colorado limited liability company, solely in its capacity as representative, agent and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> of the Company Securityholders (the &#147;<U>Securityholder
Representative</U>,&#148; with Parent, the Company, Merger Sub 1 and Merger Sub 2 sometimes being hereinafter referred to individually as a &#147;<U>Party</U>&#148; and collectively referred to as the &#147;<U>Parties</U>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>,
the Parties intend that, on the terms and subject to the conditions set forth in this Agreement, pursuant to the provisions of the Delaware General Corporation Law (the &#147;<U>DGCL</U>&#148;), (i) Merger Sub 1 will merge with and into the Company
(the &#147;<U>Reverse Merger</U>&#148;) with the Company as the surviving corporation, and (ii)&nbsp;immediately thereafter, pursuant to the provisions of the DGCL and the Delaware Limited Liability Company Act (the &#147;<U>DLLCA</U>&#148;) the
First-Step Surviving Corporation (as defined below) will merge with and into Merger Sub 2 (the &#147;<U>Second-Step Merger</U>&#148;), with Merger Sub 2 continuing as the surviving company, with both the Reverse Merger and the Second-Step Merger
occurring as part of a single integrated plan. As used in this Agreement &#147;<U>Mergers</U>&#148; shall mean the Reverse Merger and the Second-Step Merger, collectively or sequentially, as appropriate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, for U.S. federal income Tax purposes, it is intended that (a)&nbsp;the Mergers are part of a single integrated plan undertaken
by the parties to this Agreement, (b)&nbsp;the Mergers qualify as a reorganization under the provisions of Section&nbsp;368(a) of the Internal Revenue Code of 1986, as amended, and (c)&nbsp;this Agreement is intended to be and is adopted as a
&#147;plan of reorganization&#148; within the meaning of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-2(g)</FONT> (the &#147;<U>Intended Tax Treatment</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Board of Directors of the Company (the &#147;<U>Company Board</U>&#148;) has (a)&nbsp;determined that this Agreement and
the transactions contemplated hereby, including the Mergers (the &#147;<U>Transactions</U>&#148;), are in the best interests of the Company and its stockholders, (b)&nbsp;approved and declared advisable this Agreement and the Transactions and
(c)&nbsp;resolved to recommend adoption of this Agreement by the stockholders of the Company in accordance with the DGCL; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>,
the respective boards of directors of each of Parent and Merger Sub 1, and Parent, as the sole stockholder of Merger Sub 1 and the sole member of Merger Sub 2, have (a)&nbsp;determined that this Agreement and the Transactions, including the Mergers,
are in the best interests of Parent, Merger Sub 1, Merger Sub 2 and their respective stockholders and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
members, and (b)&nbsp;approved this Agreement and the Transactions on the terms and subject to the conditions set forth in this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, concurrently with the execution of this Agreement, the Company shall deliver, in accordance with Section&nbsp;228 of the DGCL,
a written consent of its stockholders approving the Agreement and the Transactions, including the Mergers, in accordance with Section&nbsp;251 of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the respective covenants and promises contained herein and for other good and valuable
consideration, the receipt and adequacy of which are hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 1 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain Definitions</U>. As used herein, the terms below shall have the following
meanings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, with respect to any Person, any other Person which directly or indirectly Controls, is
Controlled by<B> </B>or is under common Control with such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Aggregate Exercise Price</U>&#148; means the sum of the
aggregate exercise prices of all In the Money Vested Options and In the Money Vested Warrants, in each case, that are outstanding and unexercised as of immediately prior to the Effective Time (after giving effect to any acceleration occurring prior
to the Effective Time) (<I>it being understood, however, that</I>, upon achievement of the applicable Milestones, the calculation of the Aggregate Exercise Price shall include the exercise prices of the In the Money Vested Options and In the Money
Vested Warrants, as calculated as of such date after the Effective Time, that would have been outstanding at the time of achievement of the applicable Milestones if the Effective Time occurred as of such post-Effective Time date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Aggregate Merger Consideration</U>&#148; means, as of any applicable date, collectively, the rights of the Company Securityholders to
receive (a)&nbsp;the Closing Merger Consideration, (b)&nbsp;distribution from the Representative Reserve, if any, (c)&nbsp;the Milestone Consideration (less the amount of any Milestone Management Bonus, the amount of any Guggenheim Payment, the
amount of any Additional Reserve and any <FONT STYLE="white-space:nowrap">Set-off</FONT> Amounts), if any, and (d)&nbsp;any amounts payable under <U>Section</U><U></U><U>&nbsp;2.11</U> (including amounts released from the Purchase Price Adjustment
Escrow Fund). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Additional Reserve</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.16</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agreement</U>&#148; has the meaning assigned to such term in the introductory paragraph. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>aMAZE IDE Clinical Trial</U>&#148; means the pivotal trial aMAZE Study: LAA
Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation (aMAZE) sponsored by the Company (clinicaltrials.gov ID NCT02513797). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Anti-Boycott Regulations</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.18(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable Privacy Laws</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.15(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Assets</U>&#148; means all of the Company&#146;s right and title to and interest in the properties and assets of any kind, whether
tangible or intangible, real or personal or mixed, and wherever located, which are used or held for use in connection with the operation of the Business, as currently conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Base Purchase Price</U>&#148; means Forty Million Dollars ($40,000,000). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Blackout Notice</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.13(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Books and Records</U>&#148; means all Records of the Business, including all sales order files, distributor files, engineering and
product files, purchase order files, manufacturing records, test specifications and validation procedures, client and customer lists, supplier lists, pricing information, sales and promotional literature and business files of the Business, and all
Records of the Business pertaining to current and former employees, books of account, accounting, financial statements, receivables, payables, inventory, results of operations, customers, suppliers, employees, employees benefit plans, Taxes, Tax
Returns, Trade Secrets and other Intellectual Property, Permits, other tangible or intangible Assets, Contracts, Liabilities or otherwise relating to the Business (but excluding any materials protected by the attorney-client privilege or any other
applicable privilege or protection against disclosure and materials which cannot be disclosed without violation of any applicable Law or binding confidentiality obligation). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bridge Notes</U>&#148; means all convertible promissory notes issued by the Company in connection with that Note Purchase Agreement,
dated August&nbsp;21, 2018, by and among the Company and the lenders party thereto, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business</U>&#148; means the
Company&#146;s business, as conducted on the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day that is not a Saturday, Sunday or
other day on which banks are required or authorized by law to be closed in the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cash on Hand</U>&#148; means,
with respect to the Company, all cash, cash equivalents and freely marketable securities (including all cash posted to support letters of credit, performance bonds or other similar obligations or deposits with third parties, including landlords), in
each case determined in accordance with GAAP and expressed in United States dollars. For the avoidance of doubt, Cash on Hand shall be calculated net of issued but uncleared checks and drafts and shall include checks, other wire transfers and drafts
deposited or available for deposit for the account of Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Claim</U>&#148; means any claim, suit, action, arbitration, mediation, petition,
cause of action, complaint, charge, allegation, criminal prosecution, investigation, demand letter, hearing or proceeding, whether civil, criminal, administrative or investigative, at law or at equity, before or by any Governmental Authority,
arbitrator, other tribunal, and any formal information request from a Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; has the meaning
assigned to such term in <U>Section</U><U></U><U>&nbsp;2.3</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Cash on Hand</U>&#148; means, without duplication, as of
12:01 am Pacific Time on the Closing Date, an amount equal to the Cash on Hand (before taking into account the consummation of the Transactions or payment of any Indebtedness, Company Transaction Fees or the Closing Management Bonus included in the
calculation of Closing Merger Consideration). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Company Transaction Fees</U>&#148; means, without duplication, as of 12:01
am Pacific Time on the Closing Date, an amount equal to the unpaid Company Transaction Fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Consideration
Adjustment</U>&#148; means an amount initially equal to zero, subject to the following adjustments pursuant to the provisions set forth in <U>Section</U><U></U><U>&nbsp;2.11</U>: (a) if the Closing Cash on Hand (as so finally determined) is less
than the Estimated Cash on Hand, then the Closing Consideration Adjustment will be decreased by the amount of such difference; if the Closing Cash on Hand (as so finally determined) is greater than the Estimated Cash on Hand, then the Closing
Consideration Adjustment will be increased by the amount of such difference; if the Closing Cash on Hand (as so finally determined) is equal to the Estimated Cash on Hand, there will be no adjustment to the Closing Consideration Adjustment;
(b)&nbsp;if the Closing Company Transaction Fees (as so finally determined) are greater than the Estimated Company Transaction Fees, then the Closing Consideration Adjustment will be decreased by the amount of such difference; if the Closing Company
Transaction Fees (as so finally determined) are less than the Estimated Company Transaction Fees, then the Closing Consideration Adjustment will be increased by the amount of such difference; if the Closing Company Transaction Fees (as so finally
determined) are equal to the Estimated Company Transaction Fees, there will be no adjustment to the Closing Consideration Adjustment; (c)&nbsp;if the Closing Indebtedness (as so finally determined) is greater than the Estimated Indebtedness, then
the Closing Consideration Adjustment will be decreased by the amount of such difference; if the Closing Indebtedness (as so finally determined) is less than the Estimated Indebtedness, then the Closing Consideration Adjustment will be increased by
the amount of such difference; if the Closing Indebtedness (as so finally determined) is equal to the Estimated Indebtedness, there will be no adjustment to the Closing Consideration Adjustment; and (d)&nbsp;if the Closing Working Capital Amount (as
so finally determined) is greater than the Estimated Net Working Capital, the Closing Consideration Adjustment will be increased by the amount of such difference; if the Closing Working Capital Amount (as so finally determined) is less than the
Estimated Net Working Capital, the Closing Consideration Adjustment will be decreased by the amount of such difference; if the Closing Working Capital Amount (as so finally determined) is equal to the Estimated Net Working Capital, there will be no
adjustment to the Closing Consideration Adjustment. By way of example, if the Closing Working Capital is a deficit equal to ($2,956,294.82), then the Closing Consideration Adjustment will be decreased by $1,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.3</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Indebtedness</U>&#148; means, without duplication, as of 12:01 am Pacific
Time on the Closing Date, an amount equal to the outstanding Indebtedness of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Management Bonus</U>&#148;
means an amount equal to $3,500,000 in the aggregate, payable to the individuals set forth on Schedule 2 in accordance with such schedule pursuant to the Company&#146;s Amended and Restated Management Incentive Plan in effect as of the date of this
Agreement, plus the related employer portion of any payroll, employment or similar Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Merger Consideration</U>&#148;
means (a)&nbsp;the Base Purchase Price, <U>plus</U> (b)&nbsp;the amount by which the Estimated Net Working Capital exceeds the Target Net Working Capital, if any, <U>minus</U> (c)&nbsp;the amount by which the Target Net Working Capital exceeds the
Estimated Net Working Capital, if any, <U>plus</U> (d)&nbsp;the Estimated Cash on Hand, <U>minus</U> (e)&nbsp;the Estimated Indebtedness, <U>minus</U> (f)&nbsp;the Estimated Company Transaction Fees, <U>minus</U> (g)&nbsp;the Purchase Price
Adjustment Escrow Amount, <U>minus</U> (h)&nbsp;the Representative Reserve, <U>minus</U> (i)&nbsp;the Closing Management Bonus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Statement</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.11(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Working Capital Amount</U>&#148; means, without duplication, as of 12:01 am Pacific Time on the Closing Date, an amount equal
to: (a)&nbsp;the aggregate dollar amount of the consolidated current assets of the Company as of immediately after the Effective Time (other than any deferred Tax assets and any such assets that are included in Cash on Hand), <U>minus</U><I>
</I>(b)&nbsp;the aggregate dollar amount of the consolidated current liabilities of the Company as of immediately after the Effective Time (other than any such liabilities that are included in Closing Indebtedness, Closing Company Transaction Fees,
the Closing Management Bonus, any deferred Tax liabilities and any deferred revenue), in the case of each of clauses &#147;(a)&#148; and &#147;(b),&#148; determined in accordance with GAAP and otherwise in accordance with Company accounting
principles. Any Tax liabilities included in clause &#147;(b)&#148; shall (i)&nbsp;be calculated as of the end of the day on the Closing Date, (ii)&nbsp;only include liabilities for Taxes with respect to any Tax period (or portion thereof) ending on
(and including) the Closing Date or any Tax period ending prior to the Closing Date for which Tax Returns are not yet due and (iii)&nbsp;take into account any estimated payments or prepayments of Tax (not to reduce such Tax liability below zero) and
any Tax deductions arising from the Transactions (that are reasonably determined to be more likely than not to be deductible if challenged). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Commercially Reasonable Efforts</U>&#148; means, the expenditure of efforts and resources consistent with the usual practice of
Parent and its Subsidiaries with respect to development, regulatory approval, commercialization and reimbursement of products of similar commercial potential at a similar stage in product lifecycle, taking into account: (a)&nbsp;issues of efficacy,
safety and expected and actual approved labeling, (b)&nbsp;the expected and actual competitiveness of alternative products sold by third parties in the marketplace, (c)&nbsp;the expected and actual patent and other proprietary position of the
product, (d)&nbsp;the likelihood of obtaining FDA and other regulatory approval given the regulatory structure involved, (e)&nbsp;the regulatory approval of the product and scope of any marketing approval, (f)&nbsp;pending or actual legal
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
proceedings with respect to products liability, invalidity proceedings with respect to Intellectual Property or infringement of a third party&#146;s Intellectual Property involving the product
and (g)&nbsp;pricing, reimbursement and profitability relating to the product(s), but in each case not including payments made or to be made pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Per Share Merger Consideration</U>&#148; means, as of any applicable date, an amount equal to: (a) (i)&nbsp;the sum of the
Aggregate Merger Consideration <U>plus</U> (ii)&nbsp;the Aggregate Exercise Price <U>minus</U> (iii)&nbsp;the Preference Amount, if any, <U>divided by</U> (b)&nbsp;the Fully Diluted Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common </U><U>Stockholder</U>&#148; means a holder of Company Common Stock immediately prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company</U>&#148; has the meaning assigned to such term in the introductory paragraph. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Associate</U>&#148; means any current or former officer or other employee of the Company or current or former independent
contractor, consultant, agent or director of the Company or any of the Company&#146;s former subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Benefit
Plans</U>&#148; means each Employee Benefit Plan that the Company maintains, to which the Company contributes or with respect to which the Company is a participating employer and in which any Company Associate participates or is owed benefits or for
which an obligation or other Liability of the Company exists. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Board</U>&#148; has the meaning assigned to such term in
the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Capital Stock</U>&#148; means the Company Common Stock and Company Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Charter</U>&#148; means the Certificate of Incorporation of the Company, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Common Stock</U>&#148; means the common stock, par value $0.0001 per share, of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Disclosure Letter</U>&#148; has the meaning assigned to such term in the introductory paragraph to <U>Article 3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Material Adverse Effect</U>&#148; means any fact, event, change, development, condition, circumstance or effect that,
individually or in the aggregate, is, or would reasonably be expected to be, materially adverse to the business, operations, financial condition, assets (whether tangible or intangible), liabilities, capitalization or results of operations of the
Company or its Subsidiaries, taken as a whole; provided that, &#147;<U>Company Material Adverse Effect</U>&#148; shall not include any such fact, event, change, development, condition, circumstance or effect to the extent it results or arises from
(a)&nbsp;any acts of terrorism, sabotage, military action or war (whether or not declared) or any escalation or worsening thereof, (b)&nbsp;changes generally affecting (i)&nbsp;the industry in which the Company operates, (ii)&nbsp;the United States
or worldwide economy, (iii)&nbsp;financial markets in the United States or worldwide, or political conditions in the United States or worldwide, (c)&nbsp;changes in applicable Law or GAAP (or authoritative interpretation thereof), (d)
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any action required to be taken by the Company pursuant to the terms of this Agreement, (e)&nbsp;any action taken by the Company that is permitted or requested to be taken by Parent in writing,
(f)&nbsp;the announcement or pendency of the Transactions, including the impact thereof on the relationships with customers, suppliers, partners or employees of the Company or (g)&nbsp;any failure to meet any internal or published budgets,
projections, forecasts or predictions in respect of financial performance for any period, except, in each case of the foregoing clauses (a), (b) and (c), if such event, change, development, condition, circumstance or effect disproportionately, to a
material degree, affects (relative to other participants in the Company&#146;s industry) the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Preferred
Stock</U>&#148; means the Series A Preferred Stock, the Series B Preferred Stock, the Series C Preferred Stock and the Series D Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Securityholders</U>&#148; means collectively, Common Stockholders, Preferred Stockholders, Option Holders, Warrant Holders
and holders of any other securities or rights convertible into shares of Company Capital Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Transaction
Fees</U>&#148; means (without duplication of any other amount payable in connection with this Agreement or the Transactions) the following fees, expenses and other similar amounts that have been or are expected to be incurred on or prior to the
Effective Time on behalf of the Company in connection with this Agreement and the consummation of the Transactions: (a)&nbsp;the fees and expenses of, or other similar amounts charged by, counsel to the Company, including those of Goodwin Procter
LLP, (b)&nbsp;the fees and expenses of, or other similar amounts charged by, any brokers, agents, auditors or financial advisors engaged by the Company, (c)&nbsp;the fees and expenses of, or other similar amounts charged by, any accountants engaged
by the Company, (d)&nbsp;the fees and expenses of, or other similar amounts charged by, any other consultants, advisors or experts engaged by the Company and (e)&nbsp;fifty percent (50%) of the costs of the representations and warranties insurance
policy bound by Parent on the date hereof. For the avoidance of doubt, &#147;Company Transaction Fees&#148; shall exclude (i)&nbsp;all stay bonus, retention bonus, incentive bonus, completion bonus, change of control bonus or any other transaction
related bonuses, including all liabilities for the employer portion of any payroll, employment or similar Taxes, as a result of or otherwise related to the consummation of the Transactions and (ii)&nbsp;the Closing Management Bonus and any Milestone
Management Bonus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Transaction Fees Schedule</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(f)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contract</U>&#148; means any written agreement, contract, lease, license, promise,
commitment or undertaking. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Control</U>&#148; means, as to any Person, the power to direct or cause the direction of the
management and policies of such Person, whether through the ownership of voting securities, the power to cause the direction of the management and policies of that Person, by Contract or otherwise (the terms &#147;Controlled by&#148; and &#147;under
common Control with&#148; shall have correlative meanings). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Covered Person</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;5.7(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>CPT</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.12(a)(iii)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>CPT Milestone</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.12(a)(iii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>CPT Milestone Consideration</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.12(a)(iii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>CPT Milestone Initial Period</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.12(a)(iii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>CPT Milestone Period</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.12(a)(iii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>D&amp;O Tail Policy</U>&#148; means a directors&#146; and officers&#146;
liability insurance and fiduciary liability insurance &#147;tail&#148; or <FONT STYLE="white-space:nowrap">&#147;run-off&#148;</FONT> policy for the benefit of the Covered Persons which covers a period of six (6)&nbsp;years from and after the
Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Damages</U>&#148; includes any loss, damage, injury, Liability, claim, demand, settlement, judgment, award,
fine, penalty, Tax, fee (including reasonable attorneys&#146; fees), charge, cost (including costs of investigation) or expense of any nature, but excludes any consequential damages, indirect damages, diminution in value or punitive damages (unless
actually recovered by a third party in connection with a third party claim). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Data Subject Consents</U>&#148; has the meaning
assigned to such term in <U>Section</U><U></U><U>&nbsp;3.15(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>DGCL</U>&#148; has the meaning assigned to such term in the
Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disputed Item</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.11(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dissenting Shares</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.14(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>DLLCA</U>&#148; has the meaning assigned to such term in the Recitals.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>EAR</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.18(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effective Time</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Employee Benefit Plan</U>&#148;<B> </B>means any of the following, whether written or oral (and regardless of whether mandatorily
sponsored pursuant to any applicable Law or voluntarily sponsored): (a) any nonqualified deferred compensation plan or supplemental executive retirement plan or arrangement that is an Employee Pension Benefit Plan, (b)&nbsp;any qualified defined
contribution retirement plan or arrangement that is an Employee Pension Benefit Plan, (c)&nbsp;any qualified defined benefit retirement plan or arrangement that is an Employee Pension Benefit Plan, (d)&nbsp;any Employee Welfare Benefit Plan or
material fringe benefit plan or program, (e)&nbsp;any vacation, paid time off, relocation, profit sharing, bonus, stock option, restricted stock, restricted stock unit, stock purchase, other equity-related, change in control, transaction, retention,
Tax <FONT STYLE="white-space:nowrap">gross-up,</FONT> perquisite, consulting, employment, severance, redundancy, termination indemnity, bonus, commission or other incentive plan, agreement or arrangement and (f)&nbsp;any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
plan, agreement or arrangement providing benefits related to clubs, childcare, parenting, sabbatical or sick leave. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Employee Pension Benefit Plan</U>&#148; has the meaning set forth in Section&nbsp;3(2) of ERISA and specifically includes any plan
operated pursuant to the Laws of any Governmental Authority other than the United States or any plan operated with respect to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Employees whether or not such plan is subject to ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Employee Welfare Benefit Plan</U>&#148; has the meaning set forth in Section&nbsp;3(1) of ERISA and specifically includes any plan
operated pursuant to the Laws of any Governmental Authority other than the United States and any plan operated with respect to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Employees, whether or not such plan is subject to ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environment</U>&#148; means soil, surface or subsurface strata, surface waters (including navigable waters and ocean waters),
groundwaters, drinking water supply, stream sediments, ambient air (including indoor air), plant and animal life and any other environmental medium or natural resource. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Laws</U>&#148; means any and all applicable Laws: (a)&nbsp;relating to pollution (or the investigation, cleanup, or
other analysis thereof) or the protection of the Environment, or (b)&nbsp;concerning exposure to, or the management, manufacture, use, containment, storage, recycling, reclamation, reuse, treatment, generation, discharge, Release, transportation,
processing, production, disposal or remediation of any Hazardous Substances, or the handling of Hazardous Substances. The term &#147;<U>Environmental Laws</U>&#148; includes the following (including their implementing Laws and any applicable state
analogs): the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended by the Superfund Amendments and Reauthorization Act of 1986, 42 U.S.C. &#167;&#167; 9601 et seq., the Solid Waste Disposal Act, as amended by the
Resource Conservation and Recovery Act of 1976, as amended by the Hazardous and Solid Waste Amendments of 1984, 42 U.S.C. &#167;&#167; 6901 et seq., the Federal Water Pollution Control Act of 1972, as amended by the Clean Water Act of 1977, 33
U.S.C. &#167;&#167; 1251 et seq., the Toxic Substances Control Act of 1976, as amended, 15 U.S.C. &#167;&#167; 2601 et seq., the Emergency Planning and Community
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-to-Know</FONT></FONT> Act of 1986, 42 U.S.C. &#167;&#167; 7401 et seq., and the Occupation Safety and Health Act of 1970, as amended, 29 U.S.C. &#167;&#167; 651 et seq. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Permit</U>&#148; means any and all Permits issued to the Company in connection with the operation of the Business in
accordance with Environmental Laws applicable to the Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act
of 1974, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA Affiliate</U>&#148; means any trade or business (whether or not incorporated)&nbsp;(i) under common
control within the meaning of Section&nbsp;4001(b)(1) of ERISA with the Company or (ii)&nbsp;which together with the Company is treated as a single employer under Section&nbsp;414(t) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Account</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.9(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Agent</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Agreement</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Cash on Hand</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Company Transaction Fees</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Indebtedness</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Net Working Capital</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Account</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities and Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Agent</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Agent Agreement</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Expense</U>&#148; means any fee, cost, expense, payment, expenditure or Liability.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>FCPA</U>&#148; means the U.S. Foreign Corrupt Practices Act and all rules, regulations and guidance promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>FD&amp;C Act</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.16(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>FDA</U>&#148; means the U.S. Food&nbsp;&amp; Drug Administration or any successor entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>FDA Law and Regulation</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.16(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Financial Statements</U>&#148; means the audited balance sheets of the Company as of December&nbsp;31, 2018 and December&nbsp;31,
2017, and the related audited statements of operations and comprehensive loss, statements of stockholders&#146; equity and statements of cash flows for each of the years then ended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>First-Step Surviving Corporation</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fraud</U>&#148; means a misrepresentation or omission of a material fact (a)&nbsp;by the Company with respect to the making of the
representations and warranties set forth in <U>Article 3</U> of this Agreement, or (b)&nbsp;by Parent, Merger Sub 1 or Merger Sub 2 with respect to the making of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the representations and warranties set forth in <U>Article 4</U> of this Agreement, in either case, which the Person making such misrepresentation or omission knew to be false and with the intent
to deceive and to induce reliance by another Person and upon which such other Person reasonably relied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fully Diluted
Shares</U>&#148; means the aggregate number of shares of Company Common Stock then held by each holder of Company Preferred Stock, Company Common Stock, RSUs, In the Money Vested Options and In the Money Vested Warrants (assuming each such Option
and Warrant were exercised) on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, where each holder of Company Preferred Stock is to be treated for such purpose as holding in lieu of such shares of Company Preferred Stock the greatest
whole number of shares of Company Common Stock then issuable upon conversion in full of such Company Preferred Stock pursuant to the terms of the Company Charter (<I>it being understood, however, that</I>, upon achievement of the applicable
Milestones, the calculation of the Fully Diluted Shares shall include the number of such shares of Company Common Stock, shares of Company Preferred Stock, In the Money Vested Options and In the Money Vested Warrants, as calculated as of such date
after the Effective Time, that would have been outstanding at the time of achievement of the applicable Milestones if the Effective Time occurred as of such date after the Effective Time). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; means accounting principles generally accepted in the United States as consistently applied and maintained by the
Company throughout the applicable periods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>General Enforceability Exceptions</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.3(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Goodwin</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;9.12</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Government Grants</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.33</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Authority</U>&#148; means any (a)&nbsp;nation or government (whether
foreign or domestic), including any federal, state, provincial or local municipality, principality, commonwealth, province, territory, county, district or other jurisdiction of any nature or other political subdivision, instrumentality or authority
thereof, or (b)&nbsp;department, commission, bureau, agency, authority, board, court, arbitrator, arbitration tribunal, official, officer, self-regulatory authority or organization, or other entity or body, domestic or foreign (including any
multinational, supra-national or quasi-governmental entity, body or authority), exercising executive, judicial, regulatory, administrative, enforcement, police, military or taxing governmental functions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Damages</U>&#148; means (a)&nbsp;any civil, administrative or criminal penalties, assessments or fines paid or payable
to a Governmental Authority, (b)&nbsp;any restitution, penalties or damages paid to a third party, in each case, resulting from the (i)&nbsp;conviction (including as a result of the entry of a guilty plea, a consent judgment or a plea of nolo
contendere) of the Company of a crime or (ii)&nbsp;settlement or resolution with a Governmental Authority for the purpose of closing a Governmental Investigation or (c)&nbsp;any administrative sanctions, injunctive relief, deferred prosecution
agreement, <FONT STYLE="white-space:nowrap">non-prosecution</FONT> agreement, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
corporate integrity agreement or requirement to alter business practices imposed by or entered into with any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Investigation</U>&#148; means an investigation or issuance of a subpoena, civil investigative demand or other formal or
informal request for information or documents by a Governmental Authority for the purpose of investigating violations of any applicable Laws (including any Health Care Laws) or imposing criminal sanctions or civil or administrative penalties, fines,
damages, sanctions or injunctions on the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Group Health Plan</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.15(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guggenheim Payment</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.12(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hazardous Substance</U>&#148; means any substance, material or waste which is
regulated by any Environmental Law, including any material, substance or waste which is defined as a &#147;hazardous waste,&#148; &#147;hazardous material,&#148; &#147;hazardous substance,&#148; &#147;extremely hazardous substance,&#148;
&#147;extremely hazardous waste,&#148; &#147;restricted hazardous waste,&#148; &#147;contaminant,&#148; &#147;pollutant,&#148; &#147;toxic waste&#148; or &#147;toxic substance&#148; under any provision of Environmental Law, and including petroleum,
petroleum products or any derivative or <FONT STYLE="white-space:nowrap">by-products</FONT> thereof, nuclear fuel, asbestos or asbestos-containing material, radioactive materials, urea formaldehyde and polychlorinated biphenyls. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Health Care Laws</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.17(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Health Care Professional</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.34</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Highest In the Money Exercise Price</U>&#148; means the highest per share exercise price at which the Common Per Share Merger
Consideration or the Preferred Per Share Merger Consideration with respect to a share of Series D Preferred Stock, as applicable, would exceed such highest per share exercise price assuming that (a)&nbsp;all vested Options and all vested Warrants
(i)&nbsp;with a per share exercise price equal to or less than such highest per share exercise price are included in the Fully Diluted Shares and (ii)&nbsp;with a per share exercise price greater than such highest per share exercise price are
excluded from the Fully Diluted Shares and (b)&nbsp;the sum of the exercise prices of all vested Options and Warrants (i)&nbsp;with a per share exercise price equal to or less than such highest per share exercise price were included in the Aggregate
Exercise Price and (ii)&nbsp;with a per share exercise price greater than such highest per share exercise price were excluded from the Aggregate Exercise Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Holder of Registrable Securities</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.13(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Improper Payment Law</U>&#148; means the FCPA and any other applicable Laws regarding corruption, bribery, money laundering or
illegal payments or gratuities, including the U.K. Bribery Act 2010, &#167;&#167; 299, 299a/b and 331 et seq. of the German Criminal Code (Strafgesetzbuch), and anti-bribery laws of all other jurisdictions in which the Company directly or indirectly
does business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>In the Money Vested Option</U>&#148; means any vested Option that has an exercise
price in respect of a share of Common Stock subject to such vested Option that is less than the Highest In the Money Exercise Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>In the Money Vested Warrant</U>&#148; means any vested Warrant that has an exercise price in respect of a share of Series D Preferred
Stock subject to such vested Warrant that is less than the Highest In the Money Exercise Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means,
without duplication: (a)&nbsp;any obligations of the Company for borrowed money (including all obligations for principal, interest premiums, penalties, fees, expenses and breakage costs), (b) any obligations of the Company evidenced by any note,
bond, debenture or other debt security, (c)&nbsp;any leases for personal property required by GAAP to be capitalized prior to the adoption of Accounting Standards Update <FONT STYLE="white-space:nowrap">No.&nbsp;2016-02</FONT> and related guidance,
(d)&nbsp;any obligations of a Person, other than the Company, secured by a Lien against any of the Company&#146;s Assets, (e)&nbsp;all obligations of the Company for the reimbursement of letters of credit, bankers&#146; acceptance or similar credit
transactions, but only to the extent actually drawn and (f)&nbsp;any of the foregoing to the extent guaranteed by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness Payoff Schedule</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.9(f)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent Accountant</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.11(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indication</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.12(a)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property</U>&#148; means any and all intellectual property, including (a)&nbsp;patents and provisional and <FONT
STYLE="white-space:nowrap">non-provisional</FONT> patent applications, and all continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> extensions, reissues, divisions or invention
disclosures relating thereto, (b)&nbsp;trademarks, trade names, service marks, logos, trade dress, domain names and social media accounts and handles, together with all goodwill in any of the foregoing and all applications and registrations of the
same, (c)&nbsp;copyrights (including software in source code or object code form) and all applications and registrations of the same, (d)&nbsp;moral rights, including the right to the integrity of the work, the right to be associated with the work
as its author by name or under a pseudonym and the right to remain anonymous, (e)&nbsp;rights of publicity and privacy, (f)&nbsp;mask works, schematics, technology, <FONT STYLE="white-space:nowrap">know-how,</FONT> Trade Secrets, customer lists,
technical information, technical data, process technology, specifications, plans, drawings and blue prints, inventions, improvements thereto, ideas, algorithms, devices, systems, processes, and any and all other tangible or intangible proprietary
information, (g)&nbsp;rights analogous to those set forth above and (h)&nbsp;rights to sue for past, present, and future infringement, misappropriation or other unauthorized use of the rights set forth above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property Assignment Agreement</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.7(a)(iii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intended Tax Treatment</U>&#148; has the meaning assigned to such term in the
Recitals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interim Balance Sheet Date</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.6(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interim Financial Statements</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.6(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interim Success Milestone</U>&#148; has the meaning assigned to such term on
<U>Schedule 1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interim Success Milestone Consideration</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.12(a)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>IT Assets</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.15(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Knowledge</U>&#148; or any similar phrase, when used with respect to the Company,
means the actual knowledge of Russell Seiber or Chris Lowe, in each case after reasonable inquiry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>LARIAT System</U>&#148; means
the following components sold together as one system: LARIAT device, FINDRWIRZ guide wire system, ENDOCATH balloon, SOFTIP guide cannula, TENSURE tightener and SureCUT suture cutter. For the avoidance of doubt, the LARIAT System must include all of
the components listed above to be a complete system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Laws</U>&#148; means any laws, statutes, ordinances, rules and agency
guidelines having the force of law enacted, issued or adopted by any Governmental Authority but, for the avoidance of doubt, excludes any Orders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Leased Real Property</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.30(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Legal Proceeding</U>&#148; means any action, suit, litigation, arbitration, claim, proceeding (including any civil, criminal,
administrative, investigative or appellate proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise involving, any court or other Governmental Authority or any arbitrator or
arbitration panel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Letter of Transmittal</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(h)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liability</U>&#148; means any liability, obligation, commitment, expense, deficiency,
guaranty or endorsement of or by any Person, whether known or unknown, and whether accrued, absolute, contingent, matured or unmatured. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lien</U>&#148; means any charge, community or other marital property interest, lien, pledge, option, charge, easement, security
interest, deed of trust, mortgage, conditional sales agreement, encumbrance, right of way, encroachment, servitude, right of first option, right of first refusal, call option, drag along, voting trust or agreement, proxy or similar restriction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Made Available</U>&#148;, with respect to any document or other information, means such document or other item of information was
included in the virtual data room established by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company in connection with the Transactions at least one (1)&nbsp;day prior to the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Majority Holders</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;8.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Breach</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;7.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Company Trade Secrets</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.11(k)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Compliance Violation</U>&#148; means any violation that by its nature could reasonably require voluntary disclosure to a
Governmental Authority occurring as a result of any action or omission by any officer, director, manager, managing director, employee, agent or contract worker of the Company or any of its Affiliates in respect of any applicable Law (including
Improper Payment Laws, the International Emergency Economic Powers Act, the Arms Export Control Act, the United Nations Participation Act, the Comprehensive Iran Sanctions, Accountability and Divestment Act, the Iran and Syria Nonproliferation Act,
EAR, OFAC Regulations, other Trade Control Laws, Anti-Boycott Regulations or Money Laundering Laws, including the criminal money laundering provisions set forth in Title 18 of the Code). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Contracts</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.13(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Certificates</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Consideration Schedule</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.9(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Mergers</U>&#148; has the meaning assigned to such term in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Sub 1</U>&#148; has the meaning assigned to such term in the introductory paragraph. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Sub 2</U>&#148; has the meaning assigned to such term in the introductory paragraph. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Milestone Consideration</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.12(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Milestone Management Bonus</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.12(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Milestone Notice</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.12(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Milestone Periods</U>&#148; means the PMA Milestone Period and the CPT Milestone Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Milestones</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.12(a)(iii)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Money Laundering Laws</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.19</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Accredited</FONT> Securityholder</U>&#148; means
any Company Securityholder that is not an &#147;accredited investor&#148; as such term is defined in Rule 501(a) of the Securities Act, as determined by Parent in its sole discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> Agreement</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;5.2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Objection</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.11(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Objection Period</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.11(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>OFAC Regulations</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.18(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Open Source Software</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.11(n)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Option Holder</U>&#148; means any holder of Options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Options</U>&#148; means options to subscribe for and purchase Company Common Stock, whether vested or not. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Order</U>&#148; means any judgment, decision, consent decree, injunction, ruling, assessment or order of any Governmental Authority
that is expressly by its terms binding on any Person or its property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Ordinary Course of Business</U>&#148; or &#147;<U>Ordinary
Course</U>&#148; or any similar phrase means the ordinary course of the Business, consistent with the past customs and practices of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Organizational Documents</U>&#148; means, with respect to a particular Person, the certificate of formation, the operating agreement,
partnership agreement, the certificate (or articles) of incorporation or bylaws (or similar charter documents) of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>other thing of value</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.20(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Outside Date</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;7.1(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent</U>&#148; has the meaning assigned to such term in the introductory paragraph. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Common Stock</U>&#148; means the common stock, $0.001 par value per share, of Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Diligence Obligations</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.12(d)(i)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Financial Statements</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;4.10(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Market Price</U>&#148; means the average of the volume-weighted average prices
for the Parent Common Stock as reported on NASDAQ for each of the twenty (20)&nbsp;consecutive complete trading days ending with the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) complete trading day prior to the applicable date
of measurement, rounded to the nearest whole cent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Material Adverse Effect</U>&#148; means, with respect to Parent,
Merger Sub 1 or Merger Sub 2, (a) any event or condition which has resulted in or would reasonably expected to result in a material adverse change in the business, financial condition or results of operations of Parent, Merger Sub 1 and Merger Sub
2, taken as a whole or (b)&nbsp;would materially impair or delay the ability of Parent, Merger Sub 1 or Merger Sub 2 to perform their respective obligations hereunder, including the consummation of the Mergers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Related Person</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;4.14(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Reports</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;4.9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Party</U>&#148; and &#147;<U>Parties</U>&#148; have the meanings assigned to such terms in the introductory paragraph. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Payoff Letters</U>&#148; means a payoff letter from each creditor with respect to the Indebtedness identified on
<U>Section</U><U></U><U>&nbsp;3.8</U> of the Company Disclosure Letter setting forth: (a)&nbsp;the amount required to pay off in full on the Closing Date the Indebtedness owing to such creditor (including the outstanding principal, accrued and
unpaid interest and prepayment and other penalties) and wire transfer information for such payment and (b)&nbsp;if applicable,&nbsp;the commitment of such creditor to release all Liens that it may hold on any of the Assets of the Company within a
designated time period after the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permits</U>&#148; means each license, permit, franchise, approval, authorization,
variance, consent, waiver or order of, or filing or registration with, or issued or granted by, any Governmental Authority for the conduct of the Business or relating to the operation of the Company as currently conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means (a)&nbsp;Liens for Taxes, assessments and other charges of Governmental Authorities not yet due and
payable or being contested in good faith through appropriate proceedings and as to which adequate reserves are included in the Financial Statements if and to the extent required by GAAP, (b)&nbsp;statutory and contractual mechanics&#146;,
laborers&#146;, materialmen&#146;s, warehouseman&#146;s, carrier&#146;s and other similar Liens arising in the Ordinary Course of Business for sums not yet due or being contested in good faith through appropriate proceedings and as to which adequate
reserves are included in the Financial Statements if and to the extent required by GAAP, (c)&nbsp;with regard to Real Property, (i)&nbsp;any and all matters of record, including zoning restrictions, easements, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> building or use restrictions, prescriptive rights, encroachments, and other reservations, entitlements, covenants, conditions, oil and gas leases, mineral severances and Liens that are not
violated by the current use or occupancy by the Company of such Real Property, (ii)&nbsp;any easements, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
building, use or environmental restrictions and Laws, prescriptive rights, encroachments and party-walls that are not violated by the current use or occupancy by the Company of such Real Property
and (iii)&nbsp;statutory, common law and contractual landlord&#146;s Liens, rights of distress or Liens under any Real Property Lease other leases, subleases or license agreements pursuant to which the Company is a lessee and not in default,
(d)&nbsp;such other imperfections of title as do not materially detract from the value or otherwise materially interfere with the current use of any of the Company&#146;s properties or otherwise impair the Company&#146;s operation of the Business as
currently conducted and (e)&nbsp;any Liens arising from or related to any equipment financing or leasing arrangements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any person or entity, including an individual, trustee, corporation, partnership, limited partnership, limited
liability company, trust, unincorporated organization, business association, firm, joint venture and Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Personal Data</U>&#148; shall mean, in reference to a natural Person, such individual&#146;s name, location, street address,
telephone number, email address, photograph, social security number, driver&#146;s license number, passport number, or customer or account number, or any other information used to identify, contact or precisely locate such natural Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>PMA</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.12(a)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>PMA Milestone</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.12(a)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>PMA Milestone Consideration</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.12(a)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>PMA Milestone Initial Period</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.12(a)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>PMA Milestone Period</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.12(a)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preference Amount</U>&#148; means the sum of the aggregate Series A Preference Amount, the aggregate Series B Preference Amount, the
aggregate Series C Preference Amount and the aggregate Series D Preference Amount, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preferred Per Share Merger
Consideration</U>&#148; means, as of any applicable date, (a)&nbsp;with respect to each share of Series A Preferred Stock, the Series A Preference Amount <U>plus</U> the Common Per Share Merger Consideration, (b)&nbsp;with respect to each share of
Series B Preferred Stock, the Series B Preference Amount <U>plus</U> the Common Per Share Merger Consideration, (c)&nbsp;with respect to each share of Series C Preferred Stock, the Series C Preference Amount <U>plus</U> the Common Per Share Merger
Consideration and (d)&nbsp;with respect to each share of Series D Preferred Stock, the Series D Preference Amount <U>plus</U> the Common Per Share Merger Consideration, <I>provided, however</I>, in each case, that if, after taking into account the
applicable Participation Cap (as defined in the Company Charter), the foregoing calculations would result in a holder of the applicable class of Company Preferred Stock being entitled to receive greater consideration if such shares of Company
Preferred Stock were converted into Company Common Stock, then the holders of the applicable class of Company Preferred Stock will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-21- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
deemed to have converted into shares of Company Common Stock as of immediately prior to the Effective Time and shall be entitled to receive Common Per Share Merger Consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preferred Stockholders</U>&#148; means collectively, the holders of Company Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Product</U>&#148; means any product (including any component thereof) manufactured, shipped, sold, marketed, distributed, or
otherwise introduced into the stream of commerce (including through use in a clinical study) by or on behalf of the Company, and any other product sold within or outside of the United States by the Company through any distributor or agent or
pursuant to any other contractual relationship with any other Person, in each case, as of the date of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Pro Rata
Share</U>&#148; means, with respect to a Company Securityholder, a fraction, the numerator of which equals the Aggregate Merger Consideration then payable in respect of the Company Common Stock, Company Preferred Stock, RSUs, In the Money Vested
Options and In the Money Vested Warrants held by such Company Securityholder in accordance with this Agreement and the Company Charter and the denominator of which equals the Aggregate Merger Consideration then payable respect of all holders of
Company Common Stock, Company Preferred Stock, In the Money Vested Options and In the Money Vested Warrants entitled to receive a portion of the Aggregate Merger Consideration pursuant to the terms of this Agreement and the Company Charter. For the
avoidance of doubt, the applicable Pro Rata Share shall be calculated (or <FONT STYLE="white-space:nowrap">re-calculated,</FONT> as the case may be) at the applicable time of release of Aggregate Merger Consideration, including the Closing Merger
Consideration, the Purchase Price Adjustment Escrow Amount, the Representative Reserve and the Milestone Consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prospectus</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.13(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Price Adjustment Escrow Amount</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.9(b)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Price Adjustment Escrow Fund</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.9(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Qualified Repurchase</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;4.14(b)(v)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Real Property</U>&#148; means all real property owned or leased by an applicable
Person, together with all buildings, improvements, fixtures and easements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Real Property Leases</U>&#148; means all leases or
subleases pursuant to which the Company currently lease or occupy any Real Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Record</U>&#148; means any information that
is inscribed on a tangible medium or that is stored in an electronic or other medium and is retrievable in perceivable form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Recourse Theory</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;9.1</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-22- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registrable Securities</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.13(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registration Statement</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.13(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Regulatory Permits</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.16(g)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Release</U>&#148; means any release, spill, emission, discharge, leaking, pumping,
injection, deposit, disposal, dumping, emptying or leaching of Hazardous Substances into the Environment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representative
Losses</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;8.3</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representative
Reserve</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.9(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representatives</U>&#148;
means officers, directors, employees, agents, attorneys, accountants, advisors and representatives. The term &#147;Representatives&#148; shall be deemed to include current and future &#147;Representatives.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Response Date</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.11(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Parties</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.18(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Shares</U>&#148; means unvested restricted shares of Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reverse Merger</U>&#148; has the meaning assigned to such term in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>RSU Holder</U>&#148; means any holder of RSUs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>RSUs</U>&#148; means restricted stock units settleable or payable in shares of Company Common Stock, whether vested or not. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule 144</U>&#148; means Rule 144 promulgated by the SEC under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sarbanes-Oxley Act</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;4.9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Scheduled Company Intellectual Property</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.11(b)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;4.9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Second Effective Time</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Second-Step Merger</U>&#148; has the meaning assigned to such term in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Section</U><U></U><U>&nbsp;280G</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;5.6</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-23- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Section</U><U></U><U>&nbsp;280G Payments</U>&#148; has the meaning assigned to such
term in <U>Section</U><U></U><U>&nbsp;5.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securityholder Representative</U>&#148; has the meaning assigned to such term in
the introductory paragraph. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series A Preference Amount</U>&#148; has the meaning assigned to such term in the Company Charter.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series A Preferred Stock</U>&#148; means Company&#146;s Series A Preferred Stock, par value $0.0001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series B Preference Amount</U>&#148; has the meaning assigned to such term in the Company Charter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series B Preferred Stock</U>&#148; means Company&#146;s Series B Preferred Stock, par value $0.0001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series C Preference Amount</U>&#148; has the meaning assigned to such term in the Company Charter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series C Preferred Stock</U>&#148; means Company&#146;s Series C Preferred Stock, par value $0.0001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series D Preference Amount</U>&#148; has the meaning assigned to such term in the Company Charter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series D Preferred Stock</U>&#148; means Company&#146;s Series D Preferred Stock, par value $0.0001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Set-off</FONT> Amount</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.12(g)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Share Cap</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.12(e)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Significant Customers</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.21(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Significant Holders</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;2.16</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Significant Suppliers</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.21(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standard Inbound Licenses</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.11(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standard Outbound Licenses</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.11(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-24- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stockholder Approval</U>&#148; has the meaning assigned to such term in
<U>Section</U><U></U><U>&nbsp;3.3(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; means any Person of which fifty percent (50%) or more of the
voting power or value of the equity securities is owned, directly or indirectly, by the Company or Parent, as the context requires. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Surviving Company</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;2.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Takeover Statute</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.31</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Target Net Working Capital</U>&#148; means ($1,956,294.82). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax</U>&#148; and &#147;<U>Taxes</U>&#148; means (a)&nbsp;any and all taxes, and any and all similar charges, fees, levies, duties,
deficiencies, customs or assessments, in each case in the nature of a tax, including any income, gross receipts, ad valorem, net worth, premium, value-added, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum, excise, severance,
stamp, occupation, windfall profits, real property, personal property, commercial activity, tangible property, sales, use, escheat, abandoned property, capital gains, transfer, transfer gains, estimated, withholding,
<FONT STYLE="white-space:nowrap">back-up</FONT> withholding, employment, unemployment, insurance, social security, FICA, FUTA, business license, business organization, environmental, workers compensation, payroll, profits, license, lease, service,
service use, and franchise taxes or similar fines or levies, imposed by any federal, state, local, or foreign Governmental Authority, and (b)&nbsp;any interest, fines, penalties, assessments, or additions resulting from, attributable to, or incurred
in connection with any items described in this paragraph or any contest or dispute thereof or any Tax Returns or failure to file any Tax Return. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Items</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.29(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Returns</U>&#148; means any and all returns, reports, information statements and amendments thereto, with respect to Taxes
required to be filed with the Internal Revenue Service or other Taxing Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Taxing Authority</U>&#148; means the Internal
Revenue Service or any other Governmental Authority having jurisdiction over the determination, assessment and collection of Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Third Party Intellectual Property</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.11(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trade Control Laws</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.18(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trade Secret</U>&#148; means information, including <FONT STYLE="white-space:nowrap">know-how,</FONT> customer lists, software
(source code and object code), technical information, data, process technology, plans, drawings and blueprints, anywhere in the world that derives independent economic value, actual or potential, from not generally being known to, and not being
readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use and that is the subject of efforts that are reasonable under the circumstances to maintain its secrecy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-25- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Documents</U>&#148; means, collectively, this Agreement, the Letter of
Transmittal, the Escrow Agreement and the Exchange Agent Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transactions</U>&#148; has the meaning assigned to such term
in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Treasury Laws</U>&#148; means the regulations promulgated pursuant to the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>WARN</U>&#148; has the meaning assigned to such term in <U>Section</U><U></U><U>&nbsp;3.24(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Warrant Holder</U>&#148; means a holder of one or more Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Warrants</U>&#148; means warrants issued by the Company to purchase shares of Company Capital Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Interpretation</U>. In this Agreement, unless otherwise specified or where the context otherwise
requires: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;the headings of particular provisions of this Agreement are inserted for convenience only and will
not be construed as a part of this Agreement or serve as a limitation or expansion on the scope of any term or provision of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;words importing any gender shall include other genders; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;words defined in the singular form only shall have correlative meanings when used in the plural form, and vice
versa; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; shall be deemed to be
followed by the words &#147;without limitation&#148; or &#147;but not limited to;&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;the words
&#147;hereof,&#148; &#147;herein&#148; and &#147;herewith&#148; and words of similar import shall be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;references to &#147;Articles,&#148; &#147;Exhibits,&#148; or &#147;Sections&#148; shall be to Articles, Exhibits or
Sections of or to this Agreement and references to &#147;Schedules&#148; shall be to the indicated schedule or section of the Company Disclosure Letter; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;references to any Person include the successors and permitted assigns of such Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;any reference in this Agreement to &#147;reflected on&#148; or &#147;set forth in&#148; means an item (i)&nbsp;that
is specifically disclosed in the document to which such disclosure relates or (ii)&nbsp;whose disclosure in such document is reasonably apparent on its face; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;the parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the event an
ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto and no presumption or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-26- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;&#147;shall,&#148; &#147;will,&#148; or &#147;agrees&#148; are mandatory, and &#147;may&#148; is permissive; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;all accounting terms not specifically defined herein shall, to the extent not inconsistent with the express terms
of this Agreement, be construed in conformity with GAAP; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;references to any United States legal term for any
action, remedy, method of judicial proceeding, legal document, legal status, court, official, Law or any legal concept or thing shall, in respect of any jurisdiction other than the United States, be deemed to include what most nearly approximates in
that jurisdiction the United States legal term; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;references to &#147;Dollars&#148; or &#147;$&#148; shall
be to U.S. Dollars, and all payments to be made pursuant to this Agreement shall be made in U.S. Dollars. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE MERGERS; CLOSING; EFFECTIVE TIME </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>The Mergers</U>. At the Effective Time, upon the terms and subject to the conditions of this
Agreement and in accordance with the DGCL and the DLLCA, as part of a single integrated plan, Merger Sub 1 will be merged with and into the Company, with the Company surviving and continuing its corporate existence (the &#147;<U>First-Step Surviving
Corporation</U>&#148;). Immediately thereafter, at the Second Effective Time, the First-Step Surviving Corporation will merge with and into Merger Sub 2, with Merger Sub 2 surviving and continuing its limited liability company existence (the
&#147;<U>Surviving Company</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2. <U>Effective Time</U>. Subject to the terms and conditions set forth in this
Agreement, Certificates of Merger substantially in the forms attached hereto as <U>Exhibit A</U> (the &#147;<U>Merger Certificates</U>&#148;) for each of the Reverse Merger and the Second-Step Merger shall be duly executed by the Company and Merger
Sub 1, pursuant to Section&nbsp;251 of the DGCL, in the case of the Reverse Merger, and duly executed by the First-Step Surviving Corporation and Merger Sub 2, pursuant to Section&nbsp;264 of the DGCL and
<FONT STYLE="white-space:nowrap">Section&nbsp;18-209</FONT> of the DLLCA, in the case of the Second-Step Merger, and thereafter filed with the Secretary of State of the State of Delaware on the Closing Date. The Reverse Merger shall become effective
at such time as the properly executed and certified copy of the applicable Merger Certificate is duly filed with the Secretary of State of the State of Delaware in accordance with the DGCL or at such later time as Parent and the Company may agree
upon and set forth in the applicable Merger Certificate (such time as the Reverse Merger becomes effective, the &#147;<U>Effective Time</U>&#148;). The Second-Step Merger shall become effective at such time as the properly executed and certified
copy of the applicable Merger Certificate is duly filed and in accordance with the DGCL and the DLLCA, or at such later time as Parent and the Company may agree upon and set forth in the applicable Merger Certificate (such time as the Second-Step
Merger becomes effective, the &#147;<U>Second Effective Time</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section 2.3. <U>Closing of the Mergers</U>. Subject to the terms
and conditions of this Agreement, the closing of the Mergers (the &#147;<U>Closing</U>&#148;) will take place on the date that is three (3) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-27- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Business Days following satisfaction of the conditions to Closing set forth in Article 5 (the &#147;<U>Closing Date</U>&#148;) by means of a virtual closing through electronic exchange of
signatures, unless another time, date or place is agreed to in writing by the Parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effects of the Mergers</U>. The Mergers shall have the effects set forth in the applicable
provisions of the DGCL and the DLLCA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Certificate of Formation and Operating Agreement</U>.
Unless otherwise determined by Parent prior to the Effective Time, the certificate of formation of the Surviving Company shall be amended and restated as of the Second Effective Time to conform to the certificate of formation of Merger Sub 2 in
effect immediately prior to the Second Effective Time, until thereafter amended in accordance with applicable Laws, except that the name of the Surviving Company shall be SentreHEART LLC. The operating agreement of the Surviving Company shall be
amended and restated as of the Second Effective Time to conform to the operating agreement of Merger Sub 2 as in effect immediately prior to the Second Effective Time, until thereafter amended in accordance with applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Managers and Officers</U>. Unless otherwise determined by Parent prior to the Effective Time, the
managers and officers of the Surviving Company immediately after the Effective Time shall be those individuals designated by Parent in its sole discretion, each to hold office in accordance with the Organizational Documents of the Surviving Company
until such director or officer&#146;s successor is duly elected or appointed and qualified. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Deliveries at Closing</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the delivery of the items set forth <U>Section</U><U></U><U>&nbsp;2.7(b)</U>, at the Closing, Parent
shall execute and/or deliver to the Company (or such other Person as indicated below) all of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;the Escrow Agreement, duly executed by Parent and the Escrow Agent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Exchange Agent Agreement duly executed by Parent and the Exchange Agent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;an intellectual property assignment agreement assigning all of the Company&#146;s Intellectual Property first to
the First-Step Surviving Corporation upon the effectiveness of the Reverse Merger, and immediately thereafter assigning all of the Company&#146;s Intellectual Property to the Surviving Company upon the effectiveness of the Second-Step Merger, duly
executed by Parent (the &#147;<U>Intellectual Property Assignment Agreement</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;a certificate of a
duly authorized officer of Parent certifying that (A)&nbsp;attached thereto are true and complete copies of Parent&#146;s certificate of incorporation and bylaws as in effect on the Closing Date; (B)&nbsp;attached thereto are true and complete
copies of all resolutions adopted by the board of directors of Parent authorizing the execution, delivery and performance of this Agreement and the Transaction Documents and the consummation of the transactions contemplated hereby and thereby; and
(C)&nbsp;all such resolutions are in full force and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-28- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effect and are all the resolutions adopted in connection with the transactions contemplated hereby and thereby; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;a certificate of a duly authorized officer of Merger Sub 1 certifying that (A)&nbsp;attached thereto are true and
complete copies of Merger Sub 1&#146;s certificate of incorporation and bylaws as in effect on the Closing Date; (B)&nbsp;attached thereto are (1)&nbsp;true and complete copies of all resolutions adopted by the board of directors of Merger Sub 1
authorizing the execution, delivery and performance of this Agreement and the Transaction Documents to which it is a party and the consummation of the transactions contemplated hereby and thereby and (2)&nbsp;resolutions of the sole stockholder of
Merger Sub 1 adopting this Agreement and approving the consummation of the transactions contemplated by this Agreement and the Transaction Documents; and (C)&nbsp;all such resolutions are in full force and effect and are all the resolutions adopted
in connection with the transactions contemplated hereby and thereby; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;a certificate of the sole member of
Merger Sub 2 certifying that (A)&nbsp;attached thereto are true and complete copies of Merger Sub 2&#146;s certificate of formation and operating agreement as in effect on the Closing Date; (B)&nbsp;attached thereto are true and complete copies of
all resolutions adopted by the sole member of Merger Sub 2 authorizing the execution, delivery and performance of this Agreement and the Transaction Documents to which it is a party and the consummation of the transactions contemplated hereby and
thereby; and (C)&nbsp;all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions contemplated hereby and thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the delivery of the items set forth in <U>Section</U><U></U><U>&nbsp;2.7(a)</U>, at the Closing, the
Company shall execute and/or deliver, as applicable, to Parent (or such other Person as indicated below) all of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;a certificate of a duly authorized officer of the Company certifying that (A)&nbsp;attached thereto are true and
complete copies of the Company Charter and the Company&#146;s bylaws as in effect on the Closing Date: (B)&nbsp;attached thereto are (1)&nbsp;all resolutions adopted by the Company Board authorizing the execution, delivery and performance of this
Agreement and the Transaction Documents and the consummation of the transactions contemplated hereby and thereby and (2)&nbsp;resolutions of the stockholders of the Company adopting this Agreement and approving the consummation of the transactions
contemplated by this Agreement and the Transaction Documents; and (C)&nbsp;all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions contemplated hereby and thereby; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Escrow Agreement, duly executed by the Securityholder Representative; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the Exchange Agent Agreement, duly executed by the Securityholder Representative; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the Intellectual Property Assignment Agreement, duly executed by the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-29- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;a good standing certificate (or its equivalent) from the
secretary of state or similar Governmental Authority of the jurisdiction under the Laws in which the Company is organized; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;FIRPTA documentation, consisting of (A)&nbsp;a certificate in accordance with the requirements of Sections <FONT
STYLE="white-space:nowrap">1.897-2(h)(1)(i)</FONT> and <FONT STYLE="white-space:nowrap">1.1445-2(c)(3)(i)</FONT> of the Treasury Laws, and (B)&nbsp;a FIRPTA notification letter to the IRS in accordance with
<FONT STYLE="white-space:nowrap">Section&nbsp;1.897-2(h)(2)</FONT> of the Treasury Laws, duly executed by an authorized executive officer of the Company, dated the Closing Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;the Payoff Letters, in form and substance reasonably acceptable to Parent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;the consents listed on <U>Section</U><U></U><U>&nbsp;2.7(b)(viii)</U> of the Company Disclosure Letter in form
and substance reasonably satisfactory to Parent; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;a certificate signed by the Chief Executive Officer of the
Company stating that the Merger Consideration Schedule is true, correct and complete in all respects and complies with the Organizational Documents of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;the invoices and other documentation required by <U>Section</U><U></U><U>&nbsp;2.9(f)</U> for the unpaid Company
Transaction Fees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;letters of resignation and release, effective as of the Effective Time, in form and
substance reasonably satisfactory to Parent, from each of the directors and officers of the Company and each person holding a comparable position with any of the Company&#146;s Subsidiaries, in each case other than those officers, if any, designated
in writing by Parent prior to the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;evidence of termination of each outstanding Warrant, whether
vested or unvested; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;evidence of termination of the Company&#146;s Amended and Restated Investors&#146;
Rights Agreement, dated September&nbsp;22, 2016; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;resolutions of the Company Board to terminate the
Company&#146;s defined contribution 401(k) plan; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xv)&nbsp;&nbsp;&nbsp;&nbsp;evidence that the Company has bound the D&amp;O Tail
Policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Treatment of Company Common Stock, Company Preferred Stock, Options, Restricted
Stock, RSUs and Warrants</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;At the Effective Time, as a result of the Reverse Merger and without any action
on the part of Parent, Merger Sub 1, Merger Sub 2, the Company or any Company Securityholder, each share of Company Preferred Stock issued and outstanding at the Effective Time other than shares of Company Preferred Stock held by Parent, Merger Sub
1, Merger Sub 2 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-30- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or any other Affiliate of Parent shall, by virtue of the Reverse Merger and without any action on the part of Merger Sub 1, Merger Sub 2, the Company or the holder thereof, be canceled,
extinguished and converted into the right to receive applicable Preferred Per Share Merger Consideration, as determined in accordance with the Company Charter and as set forth on the Merger Consideration Schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;At the Effective Time, as a result of the Reverse Merger and without any action on the part of Parent, Merger Sub
1, Merger Sub 2, the Company or any Company Securityholder, each share of Company Common Stock issued and outstanding at the Effective Time other than shares of Company Common Stock held by Parent, Merger Sub 1, Merger Sub 2 or any other Affiliate
of Parent shall, by virtue of the Reverse Merger and without any action on the part of Merger Sub 1, Merger Sub 2, the Company or the holder thereof, be canceled, extinguished and converted into the right to receive the Common Per Share Merger
Consideration, as determined in accordance with the Company Charter and as set forth on the Merger Consideration Schedule.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Immediately prior to the Effective Time, the Company shall take all actions necessary to cause each outstanding
Option, whether vested or unvested, to be cancelled and extinguished effective as of the Effective Time, and the holder of each such Option shall have the right to receive, following the Effective Time, an amount for each vested share of Company
Common Stock subject to an Option equal to (A)&nbsp;the Common Per Share Merger Consideration, <U>minus</U> (B)&nbsp;the per share exercise price for such Option. Thereafter, without impairing the rights of the Option Holders to receive payments to
the extent set forth herein, including without limitation payments of the Milestone Consideration, if any, the Option Holders shall, as of the Effective Time, cease to have any further right or entitlement to acquire any Company Common Stock or any
shares of capital stock or membership interests of Parent or the Surviving Company under the cancelled Options, and without respect to whether or not any such Option was vested or unvested as of the Effective Time. For the avoidance of doubt, the
holders of each outstanding Option for which the per share exercise price exceeds the Common Per Share Merger Consideration, shall have the right to future payments of the Common Per Share Merger Consideration to the extent that the Common Per Share
Merger Consideration exceeds the per share exercise price of such Option (including with respect to payments of the Milestone Consideration, if any). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Immediately prior to the Effective Time, the Company shall take all actions necessary to cause each outstanding
(i)&nbsp;Restricted Share and (ii)&nbsp;RSU, whether vested or unvested, to be cancelled and extinguished effective as of the Effective Time. Each RSU Holder shall have the right to receive, following the effective Time, an amount for each RSU equal
to the Common Per Share Merger Consideration. Thereafter, without impairing the rights of RSU Holders to receive payments to the extent set forth herein, the RSU Holders and the holders of Restricted Shares shall, as of the Effective Time, cease to
have any further rights or entitlements to acquire any Company Common Stock or any shares of capital stock or membership interests of Parent or the Surviving Company under the cancelled RSUs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Immediately prior to the Effective Time, the Company shall take all actions necessary to cause each outstanding
Warrant, whether vested or unvested, to be cancelled and extinguished effective as of the Effective Time, and the holder of each such Warrant, shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-31- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
have the right to receive, following the Effective Time, an amount for each vested share of Series D Preferred Stock subject to a Warrant equal to (A)&nbsp;the Preferred Per Share Merger
Consideration applicable to shares of Series D Preferred Stock <U>minus</U> (B)&nbsp;the per share exercise price for such Warrant. Thereafter, without impairing the rights of the Warrant Holders to receive payments to the extent set forth herein,
the Warrant Holders shall, as of the Effective Time, cease to have any further right or entitlement to acquire any shares of Series D Preferred Stock under the cancelled Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;At the Effective Time, as a result of the Reverse Merger, each Share held in the Company&#146;s treasury or by
Parent, Merger Sub 1, Merger Sub 2 or the Company immediately prior to the Effective Time, if any, shall, by virtue of the Reverse Merger and without any action on the part of Merger Sub 1, Merger Sub 2, the Company or the holder thereof, be
canceled and retired and cease to exist and no payment shall be made with respect thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;At the Effective
Time, upon the consummation of the Reverse Merger, each share of the common stock, par value $0.001 per share, of Merger Sub 1 issued and outstanding immediately prior to the Effective Time shall be converted automatically into one fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> share of common stock of the First-Step Surviving Corporation. From and after the Effective Time, all certificates representing shares of common stock of Merger Sub 1 shall be deemed for all purposes
to represent the number of shares of common stock of the First-Step Surviving Corporation into which the shares of common stock of Merger Sub 1 were converted in accordance with the immediately preceding sentence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;At the Second Effective Time, upon the consummation of the Second-Step Merger, each share of the common stock, par
value $0.0001 per share, of the First-Step Surviving Corporation issued and outstanding immediately prior to the Effective Time shall be converted automatically into one membership interest of the Surviving Company. From and after the Effective
Time, all certificates representing shares of common stock of the First-Step Surviving Corporation shall be deemed for all purposes to represent the number of membership interests of the Surviving Company into which the shares of common stock of the
First-Step Surviving Corporation were converted in accordance with the immediately preceding sentence. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Surrender and Payment of Closing Merger Consideration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exchange Agent; Exchange Account</U>. Acquiom Financial LLC, in its capacity as payments administrator (the
&#147;<U>Exchange Agent</U>&#148;), shall act as the agent for the purpose of paying the Closing Merger Consideration, pursuant to a payments administration agreement among Parent, the Securityholder Representative and the Exchange Agent (the
&#147;<U>Exchange Agent Agreement</U>&#148;) in the form attached hereto as <U>Exhibit B</U>. The Exchange Agent&#146;s fees and expenses shall be borne equally by Parent and the Company Securityholders. Subject to
<U>Section</U><U></U><U>&nbsp;2.12(e)(i)</U>, the Closing Merger Consideration shall be paid in shares of Parent Common Stock, as determined based on the Parent Market Price as of the date of this Agreement. At or promptly following the Effective
Time, Parent shall deposit, or cause the Surviving Company to deposit, with the Exchange Agent certificates representing the shares of Parent Common Stock to be issued as Closing Merger Consideration (or make appropriate alternative arrangements if
uncertificated shares of Parent Common Stock represented by book-entry shares will be issued) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-32- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and an amount in cash representing cash to be issued as Closing Merger Consideration to <FONT STYLE="white-space:nowrap">Non-Accredited</FONT> Securityholders (the &#147;<U>Exchange
Account</U>&#148;). Notwithstanding the foregoing, with respect to any holder of Company Capital Stock, Options, RSUs or Warrants representing at least five percent (5%) of the Fully Diluted Shares of the Company at the Closing, such holder&#146;s
portion of the Closing Merger Consideration shall be payable directly to such holder at the Closing (and shall not be deposited in the Exchange Account) if such holder delivered a Letter of Transmittal and the documents reasonably requested by the
Exchange Agent at least two (2)&nbsp;Business Days prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Escrow</U>. At the Closing,
Parent shall deposit or shall cause the Surviving Company to deposit with SunTrust Bank, N.A. (the &#147;<U>Escrow Agent</U>&#148;) the Purchase Price Adjustment Escrow Amount into an escrow account (the &#147;<U>Escrow Account</U>&#148;) pursuant
to the terms of an Escrow Agreement in the form attached hereto as <U>Exhibit C</U> (the &#147;<U>Escrow Agreement</U>&#148;). &#147;<U>Purchase Price Adjustment Escrow Amount</U>&#148; means an amount of cash equal to $500,000 (together with all
distributions, dividends and payments thereon, the &#147;<U>Purchase Price Adjustment </U><U>Escrow Fund</U>&#148;). The Purchase Price Adjustment Escrow Fund shall be held as a trust fund and shall not be subject to any lien, attachment, trustee
process or any other judicial process of any creditor of any party, and shall be held and disbursed solely for the purposes of and in accordance with the terms of this Agreement and the Escrow Agreement. The adoption of this Agreement and the
approval of the Mergers by the Company Securityholders shall constitute approval of the Escrow Agreement and of all of the arrangements relating thereto, including the indemnification obligations, placement of Purchase Price Adjustment Escrow Amount
in escrow and the appointment of the Securityholder Representative and establishment of the Representative Reserve. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Securityholder Representative Reserve</U>. At the Closing, Parent shall deposit or shall cause the Surviving
Company to deposit with the Securityholder Representative an amount equal to $250,000 (the &#147;<U>Representative Reserve</U>&#148;), which amount shall be used to reimburse or to fund potential expenses of the Securityholder Representative in
carrying out its authorized duties in accordance with <U>Article 8</U> hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Estimated Net Working
Capital, Cash on Hand, Company Transaction Fees and Indebtedness</U>. The Company has delivered to Parent its good faith estimate of (i)&nbsp;the Closing Working Capital Amount (the &#147;<U>Estimated Net Working Capital</U>&#148;), (ii) the Closing
Cash on Hand (the &#147;<U>Estimated Cash on Hand</U>&#148;), (iii) the Closing Company Transaction Fees (the &#147;<U>Estimated Company Transaction Fees</U>&#148;) and (iv)&nbsp;the Closing Indebtedness (the &#147;<U>Estimated
Indebtedness</U>&#148;), including, in each case, reasonable support for its calculation of each such item and line item detail of the components thereof. A pro forma calculation of Net Working Capital prepared to reflect the Company&#146;s
anticipated Net Working Capital as of June&nbsp;30, 2019 is attached hereto as <U>Exhibit D</U>, and the Estimated Net Working Capital shall be calculated in accordance with the accounting principles and components set forth on <U>Exhibit D</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Merger Consideration Schedule</U>. At least two (2)&nbsp;Business Days prior to the Closing Date, the
Company shall deliver to Parent a Merger Consideration Schedule (the &#147;<U>Merger Consideration Schedule</U>&#148;), setting forth Company&#146;s calculation of the allocation of the Closing Merger Consideration among the Company Securityholders,
in addition to an electronic copy thereof in Microsoft Excel format. Parent shall be able to rely on, and shall have no </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-33- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
liability to any party to this Agreement or to any Company Securityholder for any payment reflected on, the Merger Consideration Schedule. Notwithstanding the foregoing and notwithstanding
anything set forth to the contrary in the Merger Consideration Schedule, Parent shall make all payments to Non-Accredited Securityholders in cash rather than Parent Common Stock. The Merger Consideration Schedule shall include: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;the name, address (as listed in the corporate record books of the Company), email address (if available) and the
social security number or tax identification number of each Company Securityholder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the number of shares
(separated by class and series) of Company Capital Stock, or the number of Warrants, RSUs, Restricted Shares or shares of Company Common Stock underlying Options held by each Company Securityholder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;certificate number(s) for all Company Capital Stock; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the allocation of the Closing Merger Consideration among the Company Securityholders, determined in accordance
with the terms of this Agreement and the Company&#146;s Organizational Documents as in effect as of immediately prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Indebtedness and Company Transaction Fees</U>. At the Closing, Parent shall deliver or pay, or shall cause the
Surviving Company to deliver or pay, in cash by wire transfer of immediately available funds, the balance of amounts of the Indebtedness identified on an &#147;<U>Indebtedness Payoff Schedule</U>&#148; (which shall exclude the Bridge Notes) and
outstanding Company Transaction Fees identified on a &#147;<U>Company Transaction Fees Schedule</U>&#148;, each delivered to Parent by the Company prior to the Closing Date, as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;all amounts necessary to fully discharge the then-outstanding balances of the Indebtedness identified on the
Indebtedness Payoff Schedule shall be paid on behalf of the Company to the applicable creditors&#146; accounts set forth in the Payoff Letters or as otherwise advised by such creditors in writing; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;all amounts necessary to fully discharge the then-outstanding balances of Transaction Fees identified on the
Company Transaction Fees Schedule shall be paid on behalf of the Company to the accounts designated by the Persons owed such amounts as set forth on the Company Transaction Fees Schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing Management Bonus</U>. At the Closing, Parent shall deliver or pay to the Surviving Company an amount
equal to the Closing Management Bonus for distribution to the individuals set forth on <U>Schedule 2</U> through the Surviving Company&#146;s payroll payment system (in each case, subject to applicable withholding Taxes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;<U>Procedures for Surrender</U>. Promptly after the Effective Time, Parent shall send, or shall cause the Exchange
Agent to send, to each record holder of Company Capital Stock, Options, RSUs or Warrants at the Effective Time, whose Company Capital Stock, Options, RSUs or Warrants were converted pursuant to <U>Section</U><U></U><U>&nbsp;2.8</U> into the right to
receive the Aggregate Merger Consideration, a letter of transmittal (in the form attached hereto as <U>Exhibit E</U>) (a &#147;<U>Letter of Transmittal</U>&#148;) and instructions (which shall specify that the delivery shall be effected, and risk of
loss and title shall pass, only upon proper delivery of the certificates </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-34- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
representing the Company Capital Stock, Options, RSUs or Warrants, or transfer of the Company Capital Stock, Options, RSUs or Warrants in book-entry form to the Exchange Agent, and which Letter
of Transmittal will be in customary form and have such other provisions as Parent and the Surviving Company may reasonably specify) for use in such exchange. Each holder of Company Capital Stock, Options, RSUs or Warrants that have been converted
into the right to receive the Aggregate Merger Consideration shall be entitled to receive the Aggregate Merger Consideration into which such Company Capital Stock, Options, RSUs or Warrants have been converted pursuant to
<U>Section</U><U></U><U>&nbsp;2.8</U> in respect of the Company Capital Stock, Options, RSUs or Warrants represented by a certificate or in book-entry form following (i)&nbsp;surrender to the Exchange Agent of a certificate or certificates
representing Company Capital Stock or Warrants or (ii)&nbsp;receipt of such other evidence, if any, of transfer as the Exchange Agent may reasonably request in the case of book-entry Company Capital Stock; in each case, together with a duly
completed and validly executed Letter of Transmittal and such other documents as may reasonably be requested by the Exchange Agent. No interest shall be paid or accrued upon the surrender or transfer of any Company Capital Stock, Options, RSUs or
Warrants. Upon payment of the Closing Merger Consideration pursuant to the provisions of this <U>Article 2</U>, each share of Company Capital Stock, Option, RSU or Warrant so surrendered or transferred shall immediately be cancelled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Payments to <FONT STYLE="white-space:nowrap">Non-Registered</FONT> Holders</U>. If any portion of the Aggregate
Merger Consideration is to be paid to a Person other than the Person in whose name the surrendered shares of Company Capital Stock, Options, RSUs or Warrants is registered, it shall be a condition to such payment that: (i)&nbsp;such certificate
representing such shares of Company Capital Stock, Options, RSUs or Warrants shall be properly endorsed or shall otherwise be in proper form for transfer or such book-entry share of Company Capital Stock, Option, RSU or Warrant shall be properly
transferred and (ii)&nbsp;the Person requesting such payment shall pay to the Exchange Agent any transfer or other Tax required as a result of such payment to a Person other than the registered holder of such share of Company Capital Stock, Option,
RSU or Warrant, or establish to the reasonable satisfaction of the Exchange Agent that such Tax has been paid or is not payable. For the avoidance of doubt, a Company Securityholder may transfer or assign its right to its portion of the Aggregate
Merger Consideration, subject to satisfaction of the conditions set forth in the previous sentence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;<U>Full
Satisfaction</U>. The Aggregate Merger Consideration paid upon the surrender of Company Capital Stock, Options, RSUs or Warrants in accordance with the terms hereof shall be deemed to have been paid in full satisfaction of all rights pertaining to
the Company Capital Stock, Options, RSUs or Warrants formerly represented by such certificate or in book-entry form, and from and after the Effective Time, there shall be no further registration of transfers of Company Capital Stock, Options, RSUs
or Warrants on the stock transfer books of the Surviving Company. If, after the Effective Time, certificates representing Company Capital Stock, Options, RSUs or Warrants or book-entry Company Capital Stock, Options, RSUs or Warrants are presented
to the Surviving Company, they shall be cancelled and exchanged as provided in this <U>Article 2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Exchange Account</U>. Any portion of the Exchange Account that remains unclaimed by the holders
of Company Capital Stock, Options, RSUs or Warrants six (6)&nbsp;months after the date that the last payment is made by Parent with respect to any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-35- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Milestone Consideration, shall be returned to Parent, and any such holder who has not exchanged Company Capital Stock, Options, RSUs or Warrants for the Aggregate Merger Consideration in
accordance with this <U>Section</U><U></U><U>&nbsp;2.9</U> prior to that time shall thereafter look only to Parent (subject to abandoned property, escheat or other similar Laws), as general creditors thereof, for payment of the Closing Merger
Consideration without any interest. Notwithstanding the foregoing, Parent shall not be liable to any holder of Company Capital Stock, Options, RSUs or Warrants for any amounts paid to a public official pursuant to applicable abandoned property,
escheat, or similar laws. Any amounts remaining unclaimed by holders of Company Capital Stock, Options, RSUs or Warrants two (2)&nbsp;years after the date that the last payment is made by Parent with respect to any Milestone Consideration (or such
earlier date, immediately prior to such time when the amounts would otherwise escheat to or become property of any Governmental Authority) shall become, to the extent permitted by applicable Law, the property of Parent free and clear of any claims
or interest of any Person previously entitled thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions</U>. All shares of Parent Common Stock,
if any, issued pursuant to the terms of this Agreement will be issued in a transaction exempt from registration under the Securities Act by reason of Section&nbsp;4(2) thereof and/or Regulation D promulgated under the Securities Act and may not be <FONT
STYLE="white-space:nowrap">re-offered</FONT> or resold other than in conformity with the registration requirements of the Securities Act and such other applicable rules and Laws or pursuant to an exemption therefrom. Until the resale by the Company
Securityholders of their Parent Common Stock has become registered (including pursuant to the Registration Statement) under the Securities Act, or otherwise transferable pursuant to an exemption from such registration otherwise required thereunder,
the Parent Common Stock issued to the Company Securityholders shall be characterized as &#147;<U>restricted securities</U>&#148; under the Securities Act and, if certificated, shall bear the following legend (or if held in book-entry form, will be
noted with a similar restriction): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;THE SHARES OF STOCK REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT PURPOSES
ONLY, AND THE RESALE OF SUCH SHARES HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. SUCH SHARES MAY NOT BE RESOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION WITHOUT AN EXEMPTION UNDER THE SECURITIES ACT.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Parent agrees to cooperate in a timely manner with the Company Securityholders holding Registrable Securities to remove any restrictive legends or similar
transfer instructions from the Registrable Securities upon the registration of the Registrable Securities or in the event that the Registrable Securities are otherwise transferable pursuant to an exemption from registration otherwise required
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section 2.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Lost Certificates</U>. If any certificate representing Company Capital Stock shall
have been lost, stolen, or destroyed, upon the making of an affidavit of that fact by the Person claiming such certificate to be lost, stolen, or destroyed and, if required by Parent, the posting by such Person of a bond, in such reasonable amount
as Parent may direct, as indemnity against any claim that may be made against it with respect to such certificate, the Exchange Agent will issue, in exchange for such lost, stolen, or destroyed certificate, the Closing Merger </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-36- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Consideration to be paid in respect of the shares of Company Capital Stock formerly represented by such certificate as contemplated under this&nbsp;<U>Article&nbsp;2</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase Price Adjustment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing Balance Sheet</U>. Within sixty (60)&nbsp;days following the Closing Date, Parent shall prepare and
deliver to the Securityholder Representative a statement setting forth Parent&#146;s good faith determination of the Closing Working Capital Amount, the Closing Cash on Hand, the Closing Company Transaction Fees and the Closing Indebtedness and any
Closing Consideration Adjustment resulting therefrom (the &#147;<U>Closing Statement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Objection
Period</U>. The Securityholder Representative shall have thirty (30)&nbsp;Business Days from its receipt of the Closing Statement (the &#147;<U>Objection Period</U>&#148;) to review the Closing Statement. Parent shall grant the Securityholder
Representative access, at reasonable times and places and upon reasonable advance notice, to all books, records and employees of the Surviving Company as reasonably requested by the Securityholder Representative in connection with its review of the
Closing Statement. Upon the expiration of the Objection Period, the Securityholder Representative shall be deemed to have accepted, and shall be bound by, the Closing Statement and the calculation of the Closing Working Capital Amount, the Closing
Cash on Hand, the Closing Company Transaction Fees and the Closing Indebtedness unless the Securityholder Representative shall have informed Parent in writing of its disagreement with the Closing Statement prior to the expiration of the Objection
Period (the &#147;<U>Objection</U>&#148;), specifying each disputed item and setting forth in reasonable detail the basis for each such dispute (each, a &#147;<U>Disputed Item</U>&#148;). Parent shall have thirty (30)&nbsp;Business Days from the
date on which it receives the Objection (the date on which such thirty (30)-Business Day period ends, the &#147;<U>Response Date</U>&#148;) to review and respond to the Objection. Parent shall be deemed to have accepted the Securityholder
Representative&#146;s calculations of the Disputed Items unless Parent informs the Securityholder Representative in writing of its disagreement with such Disputed Items. If Parent and the Securityholder Representative are able to negotiate a
mutually agreeable resolution of each Disputed Item, and each signs a certificate to that effect, the Closing Statement and the calculation of the Closing Working Capital Amount set forth therein, as adjusted to reflect such resolution, shall be
deemed final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> and binding for all purposes under this Agreement. If any Disputed Item has not been resolved by the Response Date or any mutually agreed extension thereof, either Parent or the
Securityholder Representative may refer such Disputed Item to an independent, mutually agreeable, nationally recognized public accounting firm (the &#147;<U>Independent Accountant</U>&#148;) who shall accept its appointment within seven
(7)&nbsp;days after such referral, to make a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> and binding determination as to any such remaining Disputed Item pursuant to the terms of this Agreement. The Independent Accountant shall be
directed to make a determination of each Disputed Item in accordance with <U>Section</U><U></U><U>&nbsp;2.11(c)</U> promptly, but no later than thirty (30)&nbsp;days, after acceptance of its appointment. Parent and the Securityholder Representative
agree to use commercially reasonable efforts to effect the selection and appointment of the Independent Accountant pursuant to this <U>Section</U><U></U><U>&nbsp;2.11(b)</U>, including executing an engagement agreement with the Independent
Accountant providing for reasonable and customary compensation and other terms of such engagement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Dispute
Resolution</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-37- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;If any Disputed Item is referred to the Independent Accountant
for resolution pursuant to <U>Section</U><U></U><U>&nbsp;2.11(b)</U>, the Independent Accountant shall determine only with respect to such Disputed Item submitted whether such Disputed Item as set forth in the Closing Statement requires adjustment
and the amount of any such required adjustment. Parent and the Securityholder Representative shall be entitled to submit presentations and other documentation to support their respective calculations of each such Disputed Item to the Independent
Accountant and shall instruct the Independent Accountant to, and the Independent Accountant shall, make its determination based solely on such documentation and presentations submitted by the Securityholder Representative and Parent in accordance
with the guidelines and procedures set forth in this Agreement and in the engagement agreement referred to in <U>Section</U><U></U><U>&nbsp;2.11(b)</U> and not on the basis of an independent review. With respect to each submitted Disputed Item, the
Independent Accountant&#146;s determination shall be within the range of values assigned to such Disputed Item by Parent and the Securityholder Representative. Any finding by the Independent Accountant shall be: (A)&nbsp;a reasoned award stating in
reasonable detail the findings of fact on which it is based, (B)&nbsp;final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> and binding upon the parties hereto and (C)&nbsp;accompanied by a certificate from the Independent Accountant
certifying that it reached such findings in accordance with the provisions of this <U>Section</U><U></U><U>&nbsp;2.11</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;The expenses of any dispute resolution pursuant to this <U>Section</U><U></U><U>&nbsp;2.11(c)</U> including those
charged by the Independent Accountant or incurred by any party hereto in enforcing a final determination of any Disputed Item on the part of the Independent Accountant shall be allocated between Parent, on the one hand, and the Securityholder
Representative (on behalf of the Company Securityholders in accordance with their respective Pro Rata Shares of the Aggregate Merger Consideration), on the other hand, based upon the percentage which the portion of the aggregate dollar value of the
Disputed Items not awarded to Parent and the Securityholder Representative bears to the amount actually contested by such Party. For example, should the spread between the Disputed Items total $1,000 and the Independent Accountant awards $600 in
favor of the Securityholder Representative&#146;s position, Parent would bear 60% (i.e., $600 &divide; $1000) of the costs of dispute resolution and the Securityholder Representative (on behalf of the Company Securityholders) would bear 40% (i.e.,
$400 &divide; $1000) of the costs of dispute resolution. Notwithstanding the foregoing, each of Parent and the Securityholder Representative (on behalf of the Company Securityholders) shall bear the expenses of its own Representatives incurred by it
in connection with the preparation or review of the Closing Statement or any Objection thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment</U>. If, upon the final determination of the Closing Working Capital Amount, the Closing Cash on
Hand, the Closing Company Transaction Fees and the Closing Indebtedness as provided in <U>Section</U><U></U><U>&nbsp;2.11(b)</U> or <U>2.11(c)</U>, as applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;the result would be that the Closing Consideration Adjustment is a negative number, then: (A)&nbsp;the
Securityholder Representative and Parent shall instruct the Escrow Agent to pay the amount of such Closing Consideration Adjustment to Parent from the Purchase Price Adjustment Escrow Fund, (B)&nbsp;if the aggregate amount in the Purchase Price
Adjustment Escrow Fund is insufficient to cover the full amount of such Closing Consideration Adjustment, then each Company Securityholder entitled to a portion of the Closing Merger Consideration pursuant to this Agreement shall, within ten
(10)&nbsp;Business Days </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-38- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
following such final determination of the Closing Working Capital Amount, Closing Cash on Hand, Closing Company Transaction Fees and Closing Indebtedness, pay such Company Securityholders&#146;
portion of the amount of such deficiency to Parent, in accordance with such Company Securityholder&#146;s Pro Rata Share and (C)&nbsp;if the aggregate amount in the Purchase Price Adjustment Escrow Fund is greater than the amount needed to cover the
full amount of the Closing Consideration Adjustment, then the Securityholder Representative and Parent shall instruct the Escrow Agent to release the balance of the Purchase Price Adjustment Escrow Fund to the Exchange Agent following payment of the
Closing Consideration Adjustment for distribution to the Company Securityholders in accordance with their respective Pro Rata Shares; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the result would be that the Closing Consideration Adjustment is a positive number, then the Securityholder
Representative and Parent shall instruct the Escrow Agent to release the balance of the Purchase Price Adjustment Escrow Fund to the Exchange Agent for distribution to the Company Securityholders in accordance with their respective Pro Rata Shares;
or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;if the result would be that the Closing Consideration Adjustment is zero, then the Securityholder
Representative and Parent shall instruct the Escrow Agent to release the balance of the Purchase Price Adjustment Escrow Fund to the Exchange Agent for distribution to the Company Securityholders in accordance with their respective Pro Rata Shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Any instruction to the Escrow Agent required to be delivered pursuant to
<U>Section</U><U></U><U>&nbsp;2.11(d)(i)</U> shall be delivered, and any payment required to be made by Parent pursuant to <U>Section</U><U></U><U>&nbsp;2.11(d)(ii)</U> shall be made: (x)&nbsp;if no Objection is made by the Securityholder
Representative during the Objection Period, within ten (10)&nbsp;days following the expiration of the Objection Period or (y)&nbsp;if the Securityholder Representative submits an Objection within the Objection Period, within ten (10)&nbsp;days
following the final determination of the Closing Working Capital Amount, Closing Cash on Hand, Closing Indebtedness and Closing Company Transaction Fees as provided in <U>Section</U><U></U><U>&nbsp;2.11(b)</U> or <U>2.11(c)</U>, as applicable. To
the extent permitted by applicable Laws, any payment made pursuant to this <U>Section</U><U></U><U>&nbsp;2.11</U> shall be treated by all parties as an adjustment to the aggregate Closing Merger Consideration. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Milestone Consideration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Milestones and Milestone Consideration</U>. As additional consideration for the Mergers, and subject to the
deductions set forth in <U>Section</U><U></U><U>&nbsp;2.12(b)</U> and <U>Section</U><U></U><U>&nbsp;2.12(g)</U>, after the Effective Time, the Company Securityholders will be entitled to receive the Milestone Consideration set forth below, when and
if required to be paid in accordance with the provisions of this <U>Section</U><U></U><U>&nbsp;2.12</U>. For the avoidance of doubt, the maximum amount payable to the Company Securityholders pursuant to this <U>Section</U><U></U><U>&nbsp;2.12</U> is
$260,000,000. For clarity, the Milestone Consideration under this <U>Section</U><U></U><U>&nbsp;2.12</U> will be owed to the Company Securityholders whether the milestone event triggering such Milestone Consideration being owed was achieved by
Parent or any of its Affiliates or any of its or their (sub)licensees, or any (sub)licensees&#146; sublicensees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<I>Interim Success Milestone</I>. In the event that the Interim Success Milestone (as defined on <U>Schedule 1</U>
hereto) is achieved, Parent shall pay to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-39- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Exchange Agent, for distribution to the Company Securityholders pursuant to their respective Pro Rata Shares, $25,000,000 (the &#147;<U>Interim Success Milestone Consideration</U>&#148;), payable
in shares of Parent Common Stock (determined based on the Parent Market Price as of the date of achievement of such Interim Success Milestone) or cash, in its sole discretion, subject to <U>Section</U><U></U><U>&nbsp;2.12(e)</U>. If the Interim
Success Milestone is achieved and paid in accordance with this <U>Section</U><U></U><U>&nbsp;2.12(a)(i)</U>, the PMA Milestone Consideration, if the PMA Milestone is later achieved, will be reduced by&nbsp;$25,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<I>PMA Milestone</I>. In the event that, on or before December&nbsp;31, 2022 (the &#147;<U>PMA Milestone Initial
Period</U>&#148;), the FDA issues premarket approval (&#147;<U>PMA</U>&#148;) of the LARIAT System with an approved indication allowing commercial distribution in the United States for the closure of the left atrial appendage (LAA) for treatment of
atrial fibrillation (the &#147;<U>Indication</U>&#148;) (the &#147;<U>PMA Milestone</U>&#148;), Parent shall pay to the Exchange Agent, for distribution to the Company Securityholders pursuant to their respective Pro Rata Shares, $140,000,000
payable in shares of Parent Common Stock (determined based on the Parent Market Price as of the date of achievement of such PMA Milestone) or cash, in its sole discretion, subject to <U>Section</U><U></U><U>&nbsp;2.12(e) </U>and subject to reduction
pursuant to <U>Section</U><U></U><U>&nbsp;2.12(a)(i)</U> if the Interim Success Milestone has been achieved and paid in accordance with <U>Section</U><U></U><U>&nbsp;2.12(a)(i)</U>. If such PMA is issued after December&nbsp;31, 2022, but on or
before December&nbsp;31, 2023, Parent shall pay to the Exchange Agent, for distribution to the Company Securityholders pursuant to their respective Pro Rata Shares, an amount equal to $140,000,000 (reduced to $115,000,000 pursuant to
<U>Section</U><U></U><U>&nbsp;2.12(a)(i)</U> if the Interim Success Milestone has been achieved and paid in accordance with <U>Section</U><U></U><U>&nbsp;2.12(a)(i)</U>) <I>minus</I> the amount equal to <I>the product of</I> $140,000,000 (reduced to
$115,000,000 pursuant to <U>Section</U><U></U><U>&nbsp;2.12(a)(i)</U> if the Interim Success Milestone has been achieved and paid in accordance with <U>Section</U><U></U><U>&nbsp;2.12(a)(i)</U>) and one-twenty fourth (1/24) times the number of full
calendar months elapsed between the expiration of the PMA Milestone Initial Period and the date on which such PMA is issued (the amount paid under this <U>Section</U><U></U><U>&nbsp;2.12(a)(ii)</U> the &#147;<U>PMA Milestone Consideration</U>&#148;,
and the time period commencing on the Closing Date and expiring on the date on which the PMA Milestone Consideration is paid to the Exchange Agent, the &#147;<U>PMA Milestone Period</U>&#148;). For the avoidance of doubt, if the FDA requires a
post-approval or post-market study following issuance of such PMA approval, such study would not disqualify achievement of the PMA Milestone pursuant to this <U>Section</U><U></U><U>&nbsp;2.12(a)(ii)</U> and Parent&#146;s obligation to pay to the
Exchange Agent, for distribution to the Company Securityholders pursuant to their respective Pro Rata Shares, the PMA Milestone Consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<I>CPT Milestone</I>. In the event that, on or before December&nbsp;31, 2025 (the &#147;<U>CPT Milestone Initial
Period</U>&#148;), the American Medical Association approves a Medicare Category 1 Current Procedural Terminology Code (&#147;<U>CPT</U>&#148;) (the &#147;<U>CPT Milestone</U>,&#148; and together with the Interim Success Milestone and the PMA
Milestone, the &#147;<U>Milestones</U>&#148;) for the LARIAT System for the Indication, Parent shall pay to the Exchange Agent, for distribution to the Company Securityholders, pursuant to their respective Pro Rata Shares, $120,000,000, payable in
shares of Parent Common Stock (determined based on the Parent Market Price as of the date of achievement of such CPT Milestone) or cash, in its sole discretion, subject to <U>Section</U><U></U><U>&nbsp;2.12(e)</U>. If such CPT is issued after
December&nbsp;31, 2025, but on or before December&nbsp;31, 2026, Parent shall pay to the Exchange Agent, for distribution to the Company Securityholders pursuant to their respective Pro Rata Shares, an amount equal to $120,000,000 <I>minus</I> the
amount equal to <I>the product of</I> $120,000,000 and one-twenty fourth (1/24) times the number of full </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-40- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
calendar months elapsed between the expiration of the CPT Milestone Initial Period and the date on which such CPT is issued (the amount paid under this
<U>Section</U><U></U><U>&nbsp;2.12(a)(iii)</U> the &#147;<U>CPT Milestone Consideration</U>&#148;, and, collectively with the Interim Success Milestone Consideration and the PMA Milestone Consideration, the &#147;<U>Milestone
Consideration</U>,&#148; and the time period commencing on the Closing Date and expiring on the date on which the CPT Milestone Consideration is paid to the Exchange Agent, the &#147;<U>CPT Milestone Period</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;<I>Late Payment</I>. If the Exchange Agent does not receive payment of any Milestone Consideration due to the
Company Securityholders on or before the specified due date therefor in this <U>Section</U><U></U><U>&nbsp;2.12</U>, simple interest shall thereafter accrue on the sum due to the Company Securityholders until the date of payment to the Exchange
Agent at the per annum rate of fifteen percent (15%) or the maximum rate allowable by Law, whichever is lower. All such accrued interest shall be payable in cash. Without limiting the foregoing, in the event that any Milestone Consideration is due
and payable to the Company Securityholders, but not received by the Exchange Agent on or before the specified due date therefor in this <U>Section</U><U></U><U>&nbsp;2.12</U>, the applicable Parent Market Price used for purposes of calculating such
Milestone Consideration shall be equal to the lower of (A)&nbsp;the Parent Market Price at the time of achievement of the applicable Milestone and (B)&nbsp;the Parent Market Price at the time of Parent&#146;s actual payment of the Milestone
Consideration. In the event that the Securityholder Representative incurs any costs (including attorneys&#146; fees) in connection with enforcement of the Company Securityholders&#146; rights hereunder, Parent shall reimburse the Securityholder
Representative for all such expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;<I>Reductions</I>. For the avoidance of doubt and consistent with the
provisions set forth in Section 2.12(b), the amount of any Milestone Consideration payable to the Exchange Agent for distribution to the Company Securityholders as set forth in <U>Section</U><U></U><U>&nbsp;2.12(a)</U> shall be reduced by
(i)&nbsp;the amount of any Milestone Management Bonus related to such Milestone Consideration payment, (ii)&nbsp;the amount of any Guggenheim Payment related to such Milestone Consideration payment, (iii)&nbsp;the amount of any Additional Reserve
funded and not yet repaid prior to such Milestone Consideration payment and (iv)&nbsp;the amount of any <FONT STYLE="white-space:nowrap">Set-off</FONT> Amount pursuant to <U>Section</U><U></U><U>&nbsp;2.12(g)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Milestone Notice</U>. Within ten (10)&nbsp;Business Days after the achievement of any Milestone, Parent shall
deliver to the Securityholder Representative notice of the achievement of the Milestone (each, a &#147;<U>Milestone Notice</U>&#148;), which shall include a breakdown of the percentage of the associated Milestone Consideration payment that will be
made in Parent Common Stock and the percentage of the associated Milestone Consideration payment that will be made in cash. As promptly as practicable (but in any event within twenty (20)&nbsp;Business Days following Parent&#146;s delivery to the
Securityholder Representative of a Milestone Notice, the Company Securityholders shall deliver an updated Merger Consideration Schedule to the Securityholder Representative and Parent, which shall include, in addition to the information set forth in
<U>Section</U><U></U><U>&nbsp;2.9(e)</U>, (i) the amount of the Milestone Consideration payable to the individuals set forth on <U>Schedule 2</U> pursuant to the Company&#146;s Amended and Restated Management Incentive Plan in effect as of the date
of this Agreement (the &#147;<U>Milestone Management Bonus</U>&#148;), (ii) any amounts due to Guggenheim Partners in respect of services rendered to the Company in connection with the Transactions that become due as a result of the achievement of
such Milestone (a &#147;<U>Guggenheim Payment</U>&#148;), (iii) any amounts funded as Additional Reserve and (iv)&nbsp;an allocation of the applicable Milestone Consideration Payment (less the Milestone Management Bonus, any Guggenheim Payment and
any Additional Reserve) among the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-41- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company Securityholders, determined in accordance with the terms of this Agreement and the Company&#146;s Organizational Documents as in effect as of immediately prior to the Effective Time. All
payments under this <U>Section</U><U></U><U>&nbsp;2.12</U><U>(b)</U> shall be made in accordance with any such updated Merger Consideration Schedule delivered by the Company Securityholders to the Securityholder Representative and Parent with
respect to the Milestone that has been achieved. Within ten (10)&nbsp;days following the delivery of an updated Merger Consideration Schedule by the Company Securityholders to the Securityholder Representative and Parent, Parent shall pay the
respective Milestone Consideration by (i)&nbsp;in the case of the Milestone Management Bonus, by delivering or paying to the Surviving Company an amount equal to the Closing Management Bonus for distribution to the individuals set forth on
<U>Schedule 2</U> through the Surviving Company&#146;s payroll payment system (in each case subject to applicable withholding Taxes), (ii) in the case of any Guggenheim Payment, by delivering to the Exchange Agent, for distribution to Guggenheim
Partners in accordance with the Merger Consideration Schedule, and into the Exchange Account, cash in the amount of such Guggenheim Payment, (iii)&nbsp;in the case of repayment of any Additional Reserve, by delivering to the Exchange Agent, for
distribution to the applicable Significant Holders in accordance with the Merger Consideration Schedule, and into the Exchange Account, cash in the amount of such Additional Reserve, and (iv)&nbsp;in the case of the other payments, by delivering to
the Exchange Agent, for distribution to the Company Securityholders in accordance with the Merger Consideration Schedule, either stock certificates (or evidence of book-entry positions) representing the number of shares of Parent Common Stock
issuable pursuant to <U>Section</U><U></U><U>&nbsp;2.12(a)</U> hereof or depositing with the Exchange Agent, and into the Exchange Account, cash to make all cash payments set forth in <U>Section</U><U></U><U>&nbsp;2.12(a)</U> hereof. Parent shall be
able to rely on, and shall have no liability to any party to this Agreement or to any Company Securityholder for any payment reflected on, any updated Merger Consideration Schedule. Notwithstanding the foregoing and notwithstanding anything set
forth to the contrary in the Merger Consideration Schedule, Parent shall make all payments to Non-Accredited Securityholders in cash rather than Parent Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitations</U>. For the avoidance of doubt, the Interim Success Milestone, the PMA Milestone Consideration and
the CPT Milestone Consideration shall each be payable only once upon the first achievement of the corresponding Interim Success Milestone, PMA Milestone or CPT Milestone, and no amounts shall be due or payable for subsequent or repeated achievement
of the Interim Success Milestone, PMA Milestone or CPT Milestone. Each of Parent, the Company and the Securityholder Representative hereby acknowledges that the achievement of each Milestone is uncertain and therefore Parent does not guarantee to
Company, the Company Securityholders and the Securityholder Representative that Parent will be required to pay any Milestone Consideration. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Parent Obligations</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Parent Diligence Obligations</U></I>. Subject to the other terms of this
<U>Section</U><U></U><U>&nbsp;2.12(d)</U>, Parent, as the sole member of the Surviving Company, and the board of managers of the Surviving Company, shall have sole discretion over all matters relating to the Surviving Company and the LARIAT System
after the Effective Time, including any research, development, regulatory, marketing, manufacturing, distribution and sales decisions. Although Parent has a present intention to continue the operations of the Surviving Company (including the
development, marketing, manufacturing, distribution and sale of the LARIAT System and efforts to seek PMA and achieve the CPT Milestone), the Parties acknowledge that Parent has no obligation to operate the Surviving Company (or to operate its own
business, or cause its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-42- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Affiliates to operate their respective businesses) in order to cause the achievement of any of the Milestones; <I>provided</I>,<I> however</I>, that Parent hereby agrees that during the
applicable Milestone Periods (i)&nbsp;it will use Commercially Reasonable Efforts, and will cause its Affiliates and (sub)licensees and any (sub)licensees&#146; sublicensees to use similar efforts, to achieve the Milestones, (ii)&nbsp;it shall not
take any actions in bad faith concerning the operations of the Surviving Company with the intention of avoiding Parent&#146;s obligations to make payment of any Milestone Consideration hereunder, and (iii)&nbsp;it shall not discontinue the
development (including the regulatory activities associated therewith) marketing, manufacturing, distribution or sales of the LARIAT System, or withdraw the PMA for the LARIAT System, during the applicable Milestone Periods if it does not possess a
valid commercial, developmental, regulatory or legal reason for doing so (which reason may not be solely to avoid payment of the Milestone Consideration) (collectively, the &#147;<U>Parent Diligence Obligations</U>&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<I>Diligence Reports</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;Until the expiration of the PMA Milestone Period without payment of the PMA Milestone Consideration, beginning at
the start of calendar year 2020 Parent shall provide to the Securityholder Representative reasonably detailed semi-annual written reports in the form attached hereto as <U>Exhibit </U><U>F</U> (on or about each August 15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> and on or about each February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) detailing the commercialization and development activities with respect to the LARIAT System completed during
the past six (6)&nbsp;month reporting period and anticipated to be undertaken during the next six (6)&nbsp;month period, in each case, by, as applicable, Parent, its Affiliates, its (sub)licensees or any (sub)licensees&#146; sublicensees. Parent
shall cause its senior officers from its development operations to be reasonably available to the Securityholder Representative to answer questions related to the matters required to be discussed in each report required pursuant to this
<U>Section</U><U></U><U>&nbsp;2.12(d)(ii)(A)</U>.<U> </U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;Following achievement of the PMA Milestone, until
the expiration of the CPT Milestone Period without payment of the CPT Milestone Consideration, Parent shall provide to the Securityholder Representative reasonably detailed semi-annual written reports in the form attached hereto as <U>Exhibit
</U><U>F</U> (on or about each August 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and on or about each February 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) detailing the commercialization and development activities with
respect to the LARIAT System completed during the past six (6)&nbsp;month reporting period and anticipated to be undertaken during the next six (6)&nbsp;month period, in each case, by, as applicable, Parent, its Affiliates, its (sub)licensees or any
(sub)licensees&#146; sublicensees. Parent shall cause its senior officers from its development operations to be reasonably available to the Securityholder Representative to answer questions related to the matters required to be discussed in each
report required pursuant to this <U>Section</U><U></U><U>&nbsp;2.12(d)(ii)(B)</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Payments in Stock or
Cash</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Each Milestone Consideration payment required to be made by Parent to the Company Securityholders
pursuant to <U>Section</U><U></U><U>&nbsp;2.12(a)</U> will be made in Parent Common Stock to the extent necessary so that the Company Securityholders receive no less than forty-five percent (45%) of the value of each Milestone Consideration payment
in the form of Parent Common Stock, <I>provided</I>, <I>however</I>, that in no event shall the total number of shares of Parent Common Stock issued as Milestone Consideration exceed 19.9% of the total
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-43- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares of Parent Common Stock outstanding as of the date hereof, which is equal to 7,719,907 shares (the &#147;<U>Share Cap</U>&#148;), which limitation shall control in the event that issuance
of forty-five percent (45%) of a Milestone Consideration payment in Parent Common Stock would result in issuance of shares of Parent Common Stock under this Agreement in excess of the Share Cap and, in such event, the balance of such Milestone
Consideration payment will be made in cash; and provided further, that all payments to <FONT STYLE="white-space:nowrap">Non-Accredited</FONT> Securityholders will be made in cash. In the event that payment in cash to Non-Accredited Securityholders
in accordance with the foregoing sentence would result in a failure to meet the forty-five percent (45%) threshold, payment of the Milestone Consideration to the Company Securityholders other than the Non-Accredited Securityholders shall be adjusted
to ensure that the forty-five percent (45%) threshold will be met in the aggregate. Notwithstanding the foregoing, each Milestone Consideration payment required to be made by Parent to the Company Securityholders pursuant to
<U>Section</U><U></U><U>&nbsp;2.12(a)</U> will be made in cash to the extent necessary so that the Company Securityholders receive an amount of cash at least equal to the amount of interest imputed to such Milestone Consideration payment pursuant to
section 483 of the Code. For this purpose, payment of Parent Common Stock that is characterized as interest pursuant to section 483 of the Code shall not count towards the forty-five percent (45%) threshold, and the assumed value of any rights of
Dissenting Shares shall be counted as <FONT STYLE="white-space:nowrap">non-stock</FONT> consideration. In determining the forty-five percent (45%) threshold pursuant to this <U>Section</U><U></U><U>&nbsp;2.12(e)</U>, the opening value of Parent
Common Stock shall be used if the Parent Common Stock issued pursuant to this <U>Section</U><U></U><U>&nbsp;2.12</U> is issued during the trading day and the closing value of Parent Common Stock shall be used if the Parent Common Stock issued
pursuant to this <U>Section</U><U></U><U>&nbsp;2.12</U> is issued after the close of the trading day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, the Company Securityholders shall have the right to elect to receive all or any
portion of each Milestone Consideration in cash rather than Parent Common Stock in the event of the occurrence of the following events (as determined by the Company Securityholders in their reasonable discretion): (A) Parent shall have (1)&nbsp;been
adjudicated as bankrupt or insolvent, (2)&nbsp;been the subject of an order for relief under Title 11 of the United States Code or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution or liquidation law or statute of any
other jurisdiction or foreign country, (3)&nbsp;made a general assignment for the benefit of creditors or (4)&nbsp;had a receiver appointed on account of the insolvency of Parent, (B)&nbsp;shares of Parent Common Stock shall have been delisted from
NASDAQ or (C)&nbsp;there shall have occurred a Parent Material Adverse Effect that is continuing at the time when such Milestone Consideration becomes due. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer Restriction</U>. From the Effective Time until the earlier to occur of the end of all Milestone
Periods or the date on which all Milestone Consideration has become due and payable (subject to any reduction thereof as a result of the exercise of any right of <FONT STYLE="white-space:nowrap">set-off</FONT> pursuant to
<U>Section</U><U></U><U>&nbsp;2.12(g)</U>), neither Parent nor the Surviving Company shall sell, assign, transfer divest or otherwise dispose of all of its rights to develop or commercialize the LARIAT System, including by way of merger or
consolidation, unless, as a condition to such sale, assignment, transfer, merger or consolidation, the purchaser, assignee or transferee (as applicable) assumes in writing all obligations of Parent set forth in this
<U>Section</U><U></U><U>&nbsp;2.12</U> with respect to the LARIAT System (subject to all limitations and qualifications included in this Agreement with respect to such obligations), including the obligation to pay, upon the achievement of any
Milestone that has not, prior to the date of such sale, assignment or transfer, been achieved in accordance with this <U>Section</U><U></U><U>&nbsp;2.12</U>, the applicable Milestone Consideration payable with respect to such Milestone in accordance
with the terms hereof. Notwithstanding the foregoing, Parent may not transfer or otherwise assign the rights to develop or commercialize the LARIAT System pursuant to the previous sentence unless: (1)&nbsp;such transferee or assignee is at least as
creditworthy as Parent on the date of such transfer, (2)&nbsp;such transferee or assignee shall have </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-44- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
affirmatively assumed all obligations of Parent pursuant to this Agreement, (3)&nbsp;such transferee or assignee is able to fully satisfy and perform the obligations hereunder, and
(4)&nbsp;Parent shall have delivered evidence reasonably satisfactory to the Securityholder Representative that such transferee shall be able to fully satisfy and perform all of the obligations under this Agreement. Notwithstanding the foregoing,
Parent shall be permitted to transfer the rights to develop or commercialize the LARIAT System to an Affiliate so long as Parent remains obligated under this Agreement, including with respect to the Parent Diligence Obligations and all payment
obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U><FONT STYLE="white-space:nowrap">Set-off</FONT></U>. The obligation of Parent to pay any
Milestone Consideration shall be qualified by the right of Parent and the Surviving Company to reduce or hold back the amount of any one or more of the Interim Success Milestone Consideration, PMA Milestone Consideration and CPT Milestone
Consideration by (i)&nbsp;the amount of any Damages actually incurred or suffered by Parent or the Surviving Company as a result of the matters set forth on <U>Section</U><U></U><U>&nbsp;2.12(g)</U> of the Company Disclosure Letter (as finally
determined by a court of competent jurisdiction), and (ii)&nbsp;the amount that would be necessary to satisfy in full any then pending and unsatisfied or unresolved matters set forth on <U>Section</U><U></U><U>&nbsp;2.12(g)</U> as if such matters
were resolved in favor of Parent, provided, that any amounts described in clause (ii)&nbsp;are deposited by Parent into an escrow account and released upon the joint written instruction of Parent and the Securityholder Representative following final
determination of such matters (either by mutual agreement by Parent and the Securityholder Representative or final determination by a court of competent jurisdiction) (any such reduction of Milestone Consideration pursuant to this
<U>Section</U><U></U><U>&nbsp;2.12(g)</U>, a &#147;<U><FONT STYLE="white-space:nowrap">Set-off</FONT> Amount</U>&#148;). Any <FONT STYLE="white-space:nowrap">set-off</FONT> pursuant to this <U>Section</U><U></U><U>&nbsp;2.12(g)</U> shall be net of
any insurance or other third party proceeds received by Parent with respect to such matter (net of costs, expenses and Taxes incurred by Parent). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration Statement</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall either (i)&nbsp;file a shelf registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT>
(except if Parent is not then eligible to register for resale the&nbsp;Registrable Securities&nbsp;on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3,&nbsp;in</FONT> which case such registration shall be on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-1&nbsp;or</FONT> another appropriate form as determined by the Parent in its sole discretion in accordance with the Securities Act and the rules promulgated thereunder and the Parent shall undertake to
register such&nbsp;Registrable Securities&nbsp;on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3&nbsp;as</FONT> soon as practicable following the availability of such form) (including any amendments or supplements, a &#147;<U>Registration
Statement</U>&#148;) and the prospectus forming part of such registration statement in compliance with Rule 415 under the Securities Act (including any amendments or supplements, a &#147;<U>Prospectus</U>&#148;) or (ii)&nbsp;if Parent already has an
effective Registration Statement, file a Prospectus under such effective registration statement, in either case, covering the resale on a continuous basis of all of the Registrable Securities (as defined below) held by recipients of Closing Merger
Consideration that have adequately and timely provided Parent, upon its written request, with all stockholder information required under the Securities Act and the rules and Laws promulgated thereunder to be included in the Registration Statement
and, in each case, as soon as reasonably practicable after the later of (i)&nbsp;the Closing Date or (ii)&nbsp;the date of completion by the Company&#146;s auditor of its review of the Company&#146;s financial statements required to be filed by
Parent pursuant to Article 3 or Article 11 of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> (but in no event later than ninety (90)&nbsp;days following such date). After the Closing, Parent and the Company shall mutually cooperate in good
faith with respect to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-45- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
completion of the financial statements referenced in the immediately preceding sentence. The Parent Common Stock issued as Closing Merger Consideration as well as any Parent Common Stock that may
be issued in connection with any adjustment pursuant to this Agreement, including with respect to Milestone Consideration and any post-Closing adjustments are referred to herein as the &#147;<U>Registrable Securities</U>.&#148; In connection with
clauses (i)&nbsp;and (ii) of this subsection (a), Parent shall use commercially reasonable efforts to cause such Registration Statement to become effective as soon as reasonably practicable and to remain effective as provided herein. The number of
Registrable Securities issued shall be reserved for the benefit of the holders of Registrable Securities and covered by the Registration Statement for the benefit of the holders of Registrable Securities for the time periods set forth in this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall use its commercially reasonable efforts to prepare and file with the SEC such
amendments and supplements to the Registration Statement as may be necessary to keep the Registration Statement effective until the earliest of (i)&nbsp;such time that all Registrable Securities covered by the Registration Statement have been sold
and (ii)&nbsp;such time that all Registrable Securities covered by such Registration Statement may be sold without restriction, including volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT>
restrictions pursuant to Rule 144. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall furnish to each Holder of Registrable Securities such number
of copies, without charge, of such Registration Statement, each amendment and supplement thereto, and Prospectus included therein, all exhibits and other documents filed therewith and such other documents as such Holder of Registrable Securities may
reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Holder of Registrable Securities. Parent will keep the Securityholder Representative advised in writing as to the initiation of the registration
and as to the effectiveness thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Parent may require each Holder of Registrable Securities as to which any
registration is being effected to furnish Parent with such information regarding such Person that is necessary to satisfy the disclosure requirements relating to the registration and the distribution of such securities under the Securities Act and
the rules and Laws promulgated thereunder as Parent may from time to time reasonably request in writing. Each such Holder of Registrable Securities shall promptly notify Parent in writing of any changes in the information set forth in the
Registration Statement after it is prepared regarding the Holder of Registrable Securities. None of the information supplied (or to be supplied) by or on behalf of any of the Company Securityholders for inclusion or incorporation by reference in the
Registration Statement or Prospectus will, at the time the Registration Statement is declared effective under the Securities Act (or with respect to any post-effective amendments or supplements thereto, at the time such post-effective amendments or
supplements become effective under the Securities Act), contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the
circumstances under which they are made, not misleading.<B> </B>For the purposes of this <U>Section</U><U></U><U>&nbsp;2.13</U>, a &#147;<U>Holder of Registrable Securities</U>&#148; refers solely to a holder of Registrable Securities as of the
Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Parent may, by two (2)&nbsp;days prior written notice to all the Holders of Registrable
Securities (each, a &#147;<U>Blackout Notice</U>&#148;), (i) delay the filing of the Registration Statement or a request for acceleration of the effective date or (ii)&nbsp;suspend the Registration Statement after effectiveness and require that the
Holders of Registrable Securities immediately </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-46- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cease sales of shares pursuant to the Registration Statement, in each case for a reasonable period of time that is no longer than fourteen (14)&nbsp;calendar days, in the event that
(A)&nbsp;Parent is engaged in any activity or transaction or preparations or negotiations for any activity or transaction that Parent desires to keep confidential for business reasons or has other material nonpublic information, if Parent determines
in good faith that the public disclosure requirements imposed on Parent under the Securities Act in connection with the Registration Statement would require at that time disclosure of such activity, transaction, preparations, negotiations or
information and such disclosure could result in imminent and material harm to Parent or (B)&nbsp;any other event occurs that makes any statement of a material fact made in the Registration Statement, including any document incorporated by reference
therein, untrue or that requires the making of any additions or changes in the Registration Statement in order to make the statements therein not misleading; <I>provided, however</I>, that at the time such Blackout Notice is sent and during the
entire delay or suspension period Parent shall be in compliance with the current public information requirement under Rule 144 of the Securities Act. Parent shall not deliver a Blackout Notice more than two (2)&nbsp;times in any twelve
(12)&nbsp;month period. If Parent suspends the Registration Statement and requires the Holders of Registrable Securities to cease sales of shares pursuant to this <U>Section</U><U></U><U>&nbsp;2.13(e)</U> Parent shall, as promptly as reasonably
practicable following the termination of the circumstance which entitled Parent to do so, take such actions as may be necessary to file or reinstate the effectiveness of the Registration Statement and give written notice to all Holders of
Registrable Securities authorizing them to resume sales pursuant to the Registration Statement. If as a result thereof the Prospectus included in the Registration Statement has been amended to comply with the requirements of the Securities Act,
Parent shall enclose such revised Prospectus with the notice to Holders of Registrable Securities given pursuant to this <U>Section</U><U></U><U>&nbsp;2.13(e)</U>, and the Holders of Registrable Securities shall make no offers or sales of shares
pursuant to the Registration Statement other than by means of such revised Prospectus. Parent need not specify the nature of the event giving rise to any delay or suspension in any notice to Holders of Registrable Securities and such Holders of
Registrable Securities agree to treat and keep the existence of such delay or suspension, as the case may be, confidential. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall cause all shares of Parent Common Stock received by Company Securityholders to be listed on NASDAQ
within one (1)&nbsp;Business Day after (i)&nbsp;the Closing with respect to shares of Parent Common Stock issued at the Closing, and (ii)&nbsp;the date of issuance with respect to shares of Parent Common Stock issued in connection with any
adjustment pursuant to <U>Section</U><U></U><U>&nbsp;2.11</U> or <U>Section</U><U></U><U>&nbsp;2.12</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall pay all fees and expenses in connection with compliance with its obligations under this
<U>Section</U><U></U><U>&nbsp;2.13</U>, including all fees and expenses in connection with the filing of the Registration Statement, the registering of the Registrable Securities, fees and expenses of compliance with securities or &#147;blue
sky&#148; Laws, transfer agent fees, the maintenance of the effectiveness of the Registration Statement, and the continued listing of the shares of Parent Common Stock on NASDAQ, including all registration, filing, qualification, printing,
accounting and other fees and expenses except that Parent shall not be responsible for the fees of the Representatives of and counsel to, the Company Securityholders, including those with respect to any review and preparation of the Registration
Statement (all of which shall be included in the Company Transaction Fees or payable by the Securityholder Representative (on behalf of the Company Securityholders) out of the Representative Reserve). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-47- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall, and the Company shall, use commercially reasonable
efforts to cause each Company Securityholder that will receive shares of Parent Common Stock in connection with the transactions contemplated hereby to enter into a <FONT STYLE="white-space:nowrap">Lock-Up</FONT> and Liquidity Agreement in
substantially the form attached hereto as <U>Exhibit G</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Dissenting Shares</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any provisions of this Agreement to the contrary, shares of Company Capital Stock held by a holder
of Company Capital Stock who has demanded and perfected a demand for appraisal of such holder&#146;s shares of Company Capital Stock in accordance with Section&nbsp;262 of the DGCL and as of the Closing Date has neither effectively withdrawn nor
lost such holder&#146;s right to such appraisal (&#147;<U>Dissenting Shares</U>&#148;) shall not be converted into the applicable portion of the Aggregate Merger Consideration, but shall be entitled to only such rights as are granted by the DGCL.
Parent shall be entitled to retain any amount that otherwise would have constituted Aggregate Merger Consideration to be paid on account of such Dissenting Shares pending resolution of the claims of holders of Dissenting Shares, and the <FONT
STYLE="white-space:nowrap">non-dissenting</FONT> Company Securityholders shall not be entitled to any portion of such retained amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the provisions of <U>Section</U><U></U><U>&nbsp;2.14(a)</U>, if any holder of Dissenting Shares
shall lose such holder&#146;s status as such (through the failure to perfect or otherwise), then as of the Effective Time or the occurrence of such event, whichever occurs later, such Dissenting Shares shall automatically be deemed to have been
converted only into the right to receive the applicable portion of the Aggregate Merger Consideration, without interest thereon, promptly following the surrender of the certificate or certificates representing such shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding</U>. Parent and the Exchange Agent shall be entitled to deduct and withhold from any
consideration payable pursuant to this Agreement such amounts as are required to be deducted or withheld therefrom under the Code, or under any provision of state, local or foreign Tax Laws. To the extent such amounts are so deducted or withheld and
remitted to the proper Taxing Authority, the amount of such consideration shall be treated for all purposes under this Agreement as having been paid to the Person to whom such consideration would otherwise have been paid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representative Reserve</U>. The Company Securityholders that are party to that certain engagement
letter with the Securityholder Representative, dated as of the date hereof (the &#147;<U>Significant Holders</U>&#148;) shall be permitted to fund, at their reasonable discretion, additional amounts (the &#147;<U>Additional Reserve</U>&#148;) to the
Securityholder Representative, which Additional Reserve shall be used to increase the Representative Reserve. Any such Additional Reserve shall be repaid to the applicable Significant Holders out of any Milestone Consideration payable pursuant to
this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-48- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 3 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as set forth on the Disclosure Letter delivered by the Company to Parent in connection with this Agreement (the &#147;<U>Company
Disclosure Letter</U>&#148;), the Company hereby represents and warrants to each of Parent, Merger Sub 1 and Merger Sub 2 as of the date hereof: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Due Organization, Good Standing and Power</U>. The Company is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware, with the requisite power and authority to conduct the Business as it is currently being conducted and to own, lease or license, as applicable, its Assets.
<U>Section</U><U></U><U>&nbsp;3.1</U><U>(i)</U> of the Company Disclosure Letter sets forth each jurisdiction in which the Company is licensed or qualified to do business, and the Company is duly licensed or qualified to do business and is in good
standing in each jurisdiction in which the properties owned or leased by it or the operation of its Business as currently conducted makes such licensing or qualification necessary, except for such failures to be licensed or qualified that would not
have a Company Material Adverse Effect. True, correct and complete copies of the Organizational Documents of the Company as amended to date and currently in effect have been Made Available to Parent, Merger Sub 1 and Merger Sub 2.
<U>Section</U><U></U><U>&nbsp;3.1</U><U>(ii)</U> of the Company Disclosure Letter lists the directors and officers of the Company as of the date of this Agreement. <U>Section</U><U></U><U>&nbsp;3.1</U><U>(iii)</U> of the Company Disclosure Letter
lists every state or foreign jurisdiction in which the Company has employees or owns or leases facilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Subsidiaries</U>. The Company does not have any Subsidiaries and does not, directly or
indirectly, own any interest in any other corporation, partnership, limited liability company, limited partnership, joint venture or other business association or entity. The Company is not obligated to make any future investment in or capital
contribution to any entity. The Company has not guaranteed or made itself responsible or liable for any obligation of any other entity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Authority and Enforceability</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has full corporate power and authority to execute and deliver this Agreement and each of the Transaction Documents to which it
is or will be a party, and to perform its obligations hereunder and thereunder and to consummate the Transactions contemplated hereby. The execution, delivery and performance by the Company of this Agreement and the Transaction Documents to which it
is a party, have been, or will be when executed and delivered on the Closing Date, duly authorized by all necessary corporate action by the Company and no other corporate proceedings on the part of the Company (other than the Stockholder Approval)
will be necessary to authorize the execution, delivery and performance of this Agreement or to consummate the Mergers and the other transactions contemplated hereby and thereby. This Agreement and the Transaction Documents to which the Company is a
party have been, or will be when executed and delivered on the Closing Date, duly executed and delivered by the Company and, assuming the due execution and delivery by the other parties thereto, constitute (or will constitute) a valid and legally
binding obligation of the Company, enforceable against the Company in accordance with the terms hereof, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or similar
Laws affecting creditors&#146; rights generally and by general </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-49- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equitable principles (whether considered in a proceeding at law or in equity) (the &#147;<U>General Enforceability Exceptions</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The affirmative vote or affirmative action by written consent of holders of (i)&nbsp;at least a majority of all
shares of Company Capital Stock, voting together as a single class, (ii)&nbsp;at least a majority of the holders of Company Preferred Stock (voting together as a single class and not as separate series, on an
<FONT STYLE="white-space:nowrap">as-converted</FONT> basis) and (iii)&nbsp;at least a majority of the holders of the Series D Preferred Stock (collectively, the &#147;<U>Stockholder Approval</U>&#148;), are the only votes, approvals, consents or
other actions of the Company or the holders of any class or series of capital stock of the Company (including any class or series of Company Preferred Stock or Company Common Stock) necessary to authorize, approve and adopt this Agreement, the
Mergers and the other transactions contemplated hereby and to consummate the Mergers and the other transactions contemplated hereby. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;(i) The Company is authorized to issue 75,000,000 shares of Company Common Stock and 58,797,402 shares of Company
Preferred Stock, of which 2,025,000 shares are designated as Series A Preferred Stock, 7,680,501 shares are designated as Series B Preferred Stock, 17,114,794 shares are as designated as Series C Preferred Stock and 31,977,107 shares are designated
as Series D Preferred Stock. As of the date of this Agreement: (i)&nbsp;there are 3,694,266 shares of Company Common Stock issued and outstanding, (ii)&nbsp;there are 49,126,220 shares of Company Preferred Stock issued and outstanding, consisting of
2,025,000 shares of Series A Preferred Stock, 7,650,907 shares of Series B Preferred Stock, 16,933,526 shares of Series C Preferred Stock and 22,516,787 shares of Series D Preferred Stock and (iii)&nbsp;the Company has no other issued or outstanding
shares of Company Capital Stock. All of the outstanding shares of Company Capital Stock have been duly authorized and validly issued, and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> The respective rights, restrictions,
privileges and preferences of Company Preferred Stock are as stated in the Company Charter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;No shares of
Company Capital Stock are subject to any right of repurchase, option or forfeiture provision or any restriction on transfer (other than restrictions on transfer imposed by virtue of applicable Laws).<I> </I><U>Section</U><U></U><U>&nbsp;3.4(b)</U>
of the Company Disclosure Letter sets forth, as of the date of this Agreement, a correct and complete list of each holder of Company Preferred Stock, Company Common Stock, Options, RSUs, Restricted Shares and Warrants or other equity interests in
the Company, including (i)&nbsp;the name and address of such holder, (ii)&nbsp;the number, class and series of all equity interests held by such holder, (iii)&nbsp;the certificate number(s) representing such equity interests (if applicable), (iv)
the number of shares of Company Common Stock into which such shares of Company Preferred Stock, Options or Warrants are convertible or exercisable, (v)&nbsp;any accrued but unpaid dividends and liquidation preference with respect to the shares held
by such holder, (vi)&nbsp;the exercise price of any Options or Warrants held by such holder, and (vii)&nbsp;whether such Option is subject to Section&nbsp;422 of the Code or subject to Section&nbsp;409A of the Code. Except as set forth in
<U>Section</U><U></U><U>&nbsp;3.4(b)</U> of the Company Disclosure Letter, there are no outstanding or authorized Options, Warrants, convertible securities or other similar rights or agreements relating to the equity securities of the Company or
obligating the Company to issue or sell any equity securities of the Company. All of the shares of Company Capital Stock are not subject to any preemptive rights created by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-50- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statute, the Organizational Documents of the Company or any agreement to which the Company is a party, and free of any Liens created by the Company in respect thereof. All issued and outstanding
shares of Company Capital Stock (i)&nbsp;were issued in compliance with applicable Laws concerning the issuances securities and (ii)&nbsp;were not issued in violation of or subject to any purchase option, call option, right of first refusal or
offer, voting trust or similar arrangement, shareholders agreement, preemptive right, subscription right or similar right. No shares of Company Capital Stock are held as treasury stock or are owned by the Company. The Company has never declared or
paid any dividends on any shares of Company Capital Stock, and there are no accrued dividends remaining unpaid with respect to any shares of Company Capital Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Contravention</U>. The execution, delivery and performance by the Company of this Agreement and
the Transaction Documents to which it is a party, and the consummation of the transactions contemplated hereby and thereby, including the Mergers, do not and will not: (i)&nbsp;conflict with or result in a violation or breach of, or default under,
any provision of the Organizational Documents of the Company, (ii)&nbsp;conflict with or result in a violation or breach of any provision of any Law or Order applicable to the Company in any material respect, (iii)&nbsp;except as set forth in
<U>Section</U><U></U><U>&nbsp;3.5</U> of the Company Disclosure Letter, require the consent, notice or other action by any Person under, conflict with, result in a violation or breach of, constitute a default or an event that, with or without notice
or lapse of time or both, would constitute a default under, result in the acceleration of or create in any party the right to accelerate, terminate, materially modify or cancel any Contract to which the Company is a party or by which the Company is
bound or to which any of their respective properties and Assets are subject (including any Material Contract) or any Permit affecting the properties, Assets or Business of the Company or (iv)&nbsp;result in the creation or imposition of any Lien
other than Permitted Liens on any material properties or material Assets of the Company, except, in the cases of clauses (iii)&nbsp;and (iv) as would not result in a Company Material Adverse Effect. No consent, approval, Permit, Order, declaration
or filing with, or notice to, any Governmental Authority is required by or with respect to the Company in connection with the execution, delivery and performance of this Agreement and the Transaction Documents and the consummation of the
transactions contemplated hereby and thereby, except for the Stockholder Approval and the filing of the Certificates of Merger with the Secretary of State of Delaware. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial Statements</U><U>; No Liabilities.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Attached to <U>Section</U><U></U><U>&nbsp;3.6</U> of the Company Disclosure Letter are true and correct copies of
the Financial Statements and the unaudited balance sheet of the Company as of March&nbsp;31, 2019 (the &#147;<U>Interim Balance Sheet Date</U>&#148;), and the related unaudited statements of operations and comprehensive loss, statements of
stockholders&#146; equity and statements of cash flows for the periods then ended (the &#147;<U>Interim Financial Statements</U>&#148;). The Financial Statements and the Interim Financial Statements (a)&nbsp;have been prepared from the Books and
Records of the Company, (b)&nbsp;have been prepared in accordance with GAAP (except that the Interim Financial Statements do not contain footnotes and are subject to <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments) and (c)&nbsp;present
fairly in all material respects the consolidated financial condition, results of operations and cash flows of the Company for the periods covered and as of the respective dates thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except for the Liabilities: (i)&nbsp;reflected or reserved against on the Interim Financial Statements,
(ii)&nbsp;incurred since the date of the Interim Financial Statements in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-51- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Ordinary Course, (iii)&nbsp;incurred in connection with the execution of this Agreement or (iv)&nbsp;set forth on <U>Section</U><U></U><U>&nbsp;3.6(b)</U> of the Company Disclosure Letter, the
Company does not have any Liabilities of any nature that would be required to be set forth on a balance sheet prepared in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that, in
all material respects: (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation of Financial Statements in conformity with GAAP
and to maintain asset accountability, (iii)&nbsp;access to Assets is permitted only in accordance with management&#146;s general or specific authorization and (iv)&nbsp;the recorded accountability for Assets is compared with the existing Assets at
reasonable intervals and appropriate action is taken with respect to any differences. The Company&#146;s internal control over financial reporting is effective in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Accounts Receivable</U>(a) . Subject to any reserves set forth in the Financial Statements, the
accounts receivable shown on the Financial Statements represent bona fide claims against debtors for sales and other charges from <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> transactions between unrelated parties in the Ordinary Course
of Business, consistent with GAAP and the Company&#146;s past practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Indebtedness</U>.
<U>Section</U><U></U><U>&nbsp;3.8</U> of the Company Disclosure Letter sets forth an accurate and complete list of each item of Indebtedness of the Company as of the date of this Agreement and the amount of such Indebtedness as of the close of
business on the date of this Agreement. No Indebtedness of the Company contains any restriction upon: (i)&nbsp;the prepayment of any of such Indebtedness, (ii)&nbsp;the incurrence of any other Indebtedness by the Company or (iii)&nbsp;the ability of
the Company to grant any Lien on any of its assets. With respect to each item of Indebtedness, the Company is not in material default and no payments are past due. The Company has not received any written notice of a default, alleged failure to
perform or any offset or counterclaim with respect to any item of Indebtedness. Neither the consummation of the Transactions nor the execution, delivery or performance of any Transaction Document will cause a default, breach or an acceleration,
automatic or otherwise, of any conditions, covenants or other terms of the Company&#146;s Indebtedness. The Company has not guaranteed, is not responsible for and does not have any Liability for any Indebtedness of any other Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>. Except as disclosed on <U>Section</U><U></U><U>&nbsp;3.9</U> of the Company
Disclosure Letter, there is no Legal Proceeding pending, or, to the Knowledge of the Company, that has been threatened: (i)&nbsp;that involves the Company or any of the material Assets owned or used by the Company, (ii)&nbsp;that, to the Knowledge
of the Company, involves any Liability (of any director, officer or other employee in their capacity as such) that has been retained or assumed, indemnified against or guaranteed (either contractually or by operation of any Law) by the Company,
(iii)&nbsp;that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the Mergers or any other transaction contemplated by this Agreement, (iv)&nbsp;that relates to the ownership or alleged
ownership of any capital stock or other securities of the Company, or any option, warrant or other right to acquire capital stock or other securities of any of the Company or (v)&nbsp;that relates to any right or alleged right to receive any
consideration as a result of or in connection with this Agreement, any other Transaction </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-52- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Document, the Mergers or any other transaction contemplated by this Agreement. Except as set forth on <U>Section</U><U></U><U>&nbsp;3.9</U> of the Company Disclosure Letter, the Company has not
commenced or threatened any Legal Proceeding against any other Person and there have been no Legal Proceedings commenced against the Company in the past three (3)&nbsp;years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Assets</U>. Except as disclosed on <U>Section</U><U></U><U>&nbsp;3.10</U> of the Company
Disclosure Letter, the Company has good and valid and title to, or valid leasehold interests in, all of its material Assets. The Company&#146;s Assets constitute all personal property necessary to conduct the Business of the Company as it is
currently conducted. None of the Company&#146;s material Assets are owned by any other Person without a valid and enforceable right of the Company to use and possess such Asset, which right will remain valid and enforceable following the Effective
Time. None of the Company&#146;s material Assets is subject to any Lien, other than Permitted Liens. All material Assets of the Company: are in reasonably good operating condition and repair (ordinary wear and tear excepted) and are reasonably
adequate for the conduct of the Company&#146;s Business as it is currently conducted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual Property</U><B>.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company owns all right, title and interest in the Scheduled Company Intellectual Property and Material Company
Trade Secrets. To the Company&#146;s Knowledge, the Company either owns all right, title and interest in, or is validly licensed to use in the manner used and contemplated to be used by the Company, all Intellectual Property used in or necessary for
the operation of its business, Products or services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 3.11(b)</U> of the Company Disclosure Letter
lists all: (i)&nbsp;patents, provisional and <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications, registered trademarks, registered trade names, registered service marks and registered copyrights, applications to register
trademarks, trade names, service marks and copyrights, domain names and other registrations or pending applications to register Intellectual Property owned by the Company (&#147;<U>Scheduled</U><U> Company Intellectual Property</U>&#148;), including
where applicable the registration, issuance and application numbers, and the jurisdictions, both domestic and foreign, in which each such item of Intellectual Property has been issued or registered or in which any application for such issuance and
registration has been filed (and, with respect to domain names, the domain name registrar), (ii) Contracts to which the Company is a party and pursuant to which any Person is authorized to use any Scheduled Company Intellectual Property or any other
Intellectual Property owned by the Company (other than, with respect to such Intellectual Property, nonexclusive licenses pursuant to terms entered into by end users of the Company&#146;s Products in the Ordinary Course (forms of which have been
Made Available to Parent), or for any use that is authorized solely for the purpose of conducting work for the Company) (collectively, &#147;<U>Standard Outbound Licenses</U>&#148;), (iii) Contracts to which the Company is a party and pursuant to
which the Company is authorized to use any Intellectual Property of any third party (&#147;<U>Third Party Intellectual Property</U>&#148;), including patents, trademarks, and copyrights, and applications therefor, and software (other than
(1)&nbsp;standard employee, contractor, or consulting agreements entered into in the Ordinary Course (forms of which have been Made Available to Parent) and (2)&nbsp;licenses for Open Source Software and
<FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> commercial or shrinkwrap software for which the license fee is less than Seventy-Five
Thousand Dollars ($75,000) annually, collectively, &#147;<U>Standard Inbound Licenses</U>&#148;), and (iv)&nbsp;all Contracts to which the Company is a party that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-53- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provide for an optional or contingent licenses, sublicense, or other agreement as described in clauses (ii)&nbsp;or (iii) above in this paragraph (subject to the exclusions contained in such
clauses). All issued patents and registered trademarks included in the Scheduled Company Intellectual Property are validly applied for, have been duly maintained, are in full force and effect, have not been cancelled, expired, withdrawn, lapsed,
invalidated or abandoned, and, to the Company&#146;s Knowledge, are enforceable. The Company is not obligated to pay any royalties to any third party under any patent, trademark, copyright or other license for Third Party Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company has taken all action necessary in its reasonable discretion to obtain or maintain the enforceability
and registration of all Scheduled Company Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in
<U>Section</U><U></U><U>&nbsp;3.11(d)</U> of the Company Disclosure Letter, the Company has not sent to any third party or otherwise communicated to another Person in the six (6)&nbsp;years preceding the date of this Agreement, any charge,
complaint, Claim, demand or notice asserting that such Person has infringed, misappropriated or acted in conflict with any of the Scheduled Company Intellectual Property or any other Intellectual Property owned by the Company or that any Claim,
demand, or notice asserting any such other Person has conducted any acts of unfair competition against the Company, nor, to the Knowledge of the Company, is any such infringement, misappropriation, conflict or act of unfair competition occurring or
threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Section</U><U></U><U>&nbsp;3.11(e)</U> of the Company Disclosure Letter,
the Company has not received any Claim, demand or notice that the Company has infringed, misappropriated, copied in an unauthorized manner or otherwise acted in conflict with any Third Party Intellectual Property, that the Company has conducted any
acts of unfair competition or other legal wrong against any third party or that the Scheduled Company Intellectual Property or the Material Company Trade Secrets are invalid, unenforceable, not owned by the Company or are otherwise defective,
inoperable, unregisterable or unpatentable, except for communications from patent and trademark offices received in the normal course of patent and trademark prosecution, and the Company has not received in the three (3)&nbsp;years preceding the
date of this Agreement any offer to take a license for any patents, trademarks, copyrights or other Intellectual Property of any third party. Without limiting the foregoing, the Company has not received notice of any inventorship challenge,
opposition, cancellation, <FONT STYLE="white-space:nowrap">re-examination,</FONT> interference, invalidity, unenforceability or other action or proceeding (other than in the ordinary course of patent prosecution) relating to any Scheduled Company
Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Section</U><U></U><U>&nbsp;3.11(f)</U> of the Company
Disclosure Letter, (i)&nbsp;to the Knowledge of the Company, there is no unauthorized use, disclosure, infringement or misappropriation of any rights of the Company in the Scheduled Company Intellectual Property or any Third Party Intellectual
Property licensed to the Company, by any third party, including any employee or former employee of the Company, and (ii)&nbsp;other than employee and consulting agreements, there are no royalties, fees or other payments or compensation payable by
any third party to, or to any third party by, the Company by reason of the Company&#146;s ownership, use, sale or disposition of any Intellectual Property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-54- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Section</U><U></U><U>&nbsp;3.11(g)</U>
of the Company Disclosure Letter, the Company is not, nor will the Company be, as a result of the execution and delivery of this Agreement, or the performance of its obligations hereunder, in breach of any Contract involving Intellectual Property to
which the Company is currently a party, or in violation of any Third Party Intellectual Property thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;To
the Company&#146;s Knowledge, the business of the Company (including its Products and services) as previously and presently conducted in the United States and in any jurisdiction foreign to the United States, have not and do not interfere with,
conflict with, infringe upon, misappropriate or otherwise violate any Third Party Intellectual Property, and no action or Claim is pending or, to the Knowledge of the Company, threatened alleging that the Products or services of the Company or the
operation of their respective businesses interfere with, conflict with, infringe upon, misappropriate, or otherwise violate any Third Party Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Section</U><U></U><U>&nbsp;3.11(i)</U> of the Company Disclosure Letter, each current and
former officer, employee, consultant and contract worker involved in the development of Intellectual Property of the Company has executed and provided to the Company a written, enforceable and valid agreement providing that the Company is the owner
(including through assignment) of any Intellectual Property such current or former officer, employee or contract worker of the Company created or creates within the scope of his or her employment, or, in the case of a
<FONT STYLE="white-space:nowrap">non-employee,</FONT> from the services such <FONT STYLE="white-space:nowrap">non-employee</FONT> of the Company performed or performs for the Company, in each case, to the fullest extent permitted under applicable
law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;No Company Securityholder or former securityholder, and no current or former partner, director, manager,
managing director, officer or employee of the Company (or any of their respective predecessors in interest) has or will have, after giving effect to the transactions contemplated by this Agreement, any legal or equitable right, title or interest in
or to, or any right to use, directly or indirectly, in whole or in part, any Scheduled Company Intellectual Property or any other Intellectual Property owned by the Company, except in connection with performing services for the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Company has entered into written, enforceable and valid confidentiality agreements with all employees and third
parties to whom the Company has disclosed material Company-owned confidential Intellectual Property, including Trade Secrets owned by the Company that are used in and material to the business or Products of the Company (&#147;<U>Material Company
Trade Secrets</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;The Company has taken commercially reasonable measures designed to protect the
confidentiality of its Material Company Trade Secrets, including requiring their former and current officers, employees, contract workers and all other Persons having access thereto to execute written, enforceable and valid <FONT
STYLE="white-space:nowrap">non-disclosure</FONT> agreements. To the Company&#146;s Knowledge, no Material Company Trade Secret has been disclosed or authorized to be disclosed by the Company to any third party other than pursuant to a written,
enforceable and valid <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement that adequately protects the Company&#146;s proprietary interests in and to such Material Company Trade Secret. To the Knowledge of the Company, no party to any
non-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-55- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
disclosure agreement with the Company is in breach or default thereof or has threatened breach or default thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not misrepresented, or failed to disclose, any facts or information in any application for any of
the Company&#146;s patents or patent applications in a manner that constitutes fraud, misrepresentation or other inequitable conduct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 3.11(n)</U> of the Company Disclosure Letter sets forth a complete and accurate list of each item of
open source, free, shared or public library software (&#147;<U>Open Source Software</U>&#148;), in each case that is contained in or distributed with any Products of the Company. The Company does not use, develop or maintain, and has not used,
developed or maintained, any proprietary software for use in or with, or contemplated to be used in or with, its respective Products, (i)&nbsp;which uses any Open Source Software or is subject to any open source licensing agreement and
(ii)&nbsp;which thereby requires the Company to disclose the source code of such proprietary software. The use of any Open Source Software in conjunction with any of the Company&#146;s Products does not impose a requirement or condition that any
such Product or part thereof (other than such Open Source Software itself)&nbsp;(A) be disclosed or distributed in source code form, (B)&nbsp;be licensed for the purpose of making modifications or derivative works, (C)&nbsp;be licensed under the
same license as third-party software or (D)&nbsp;be redistributable at no charge. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Environmental Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in <U>Section</U><U></U><U>&nbsp;3.12</U> of the Company Disclosure Letter, the Company is, and
for the past three (3)&nbsp;years has been, in compliance in all material respects with all Environmental Laws and, in the past three (3)&nbsp;years, no written complaint, demand or notice has been made, given or filed (or, to the Knowledge of the
Company, has been threatened) by any Person against the Company alleging any failure to comply with any Environmental Law or seeking contribution towards, or participation in, any remediation of any contamination of any property. The Company holds,
and is and for the past three (3)&nbsp;years has been in compliance in all material respects with all of the terms and conditions of, all Environmental Permits that are required under any Environmental Law, and for the past three (3)&nbsp;years has
complied in all material respects with all other applicable limitations, restrictions, conditions, standards, prohibitions, requirements, obligations, schedules and timetables that are contained in any Environmental Law. To the Knowledge of the
Company, no Release of Hazardous Substances has occurred as a result of the Company&#146;s operations in an amount or manner that would reasonably be expected to result in any material liability to the Company or its operations under Environmental
Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has Made Available accurate and complete copies of: (i)&nbsp;all material internal and
external environmental audits and studies in its possession, if any, relating to the Company or its operations and (ii)&nbsp;all material correspondence with any Governmental Authority on substantial environmental matters relating to the Company or
its operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-56- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Material Contracts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section</U><U></U><U>&nbsp;3.13(a)</U> of the Company Disclosure Letter sets forth a list of all Contracts
described in clauses&nbsp;(i) through (xxvii)&nbsp;below to which the Company is a party or by which it or its Assets is bound excluding purchase orders delivered or accepted in the Ordinary Course (&#147;<U>Material Contracts</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;any Contract involving the issuance or repurchase of any capital stock or other equity interest of the Company,
other than Contracts in connection with Company Benefit Plans; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;each Contract that requires the rendering of
supply of products, subsequent to the date of this Agreement, of more than $75,000 in any calendar year; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;each Contract entered into involving the acquisition or disposition by the Company, whether by sale of
securities, sale of assets, merger, consolidation, amalgamation or similar transaction; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;any Contract under
which (A)&nbsp;the Company has granted exclusive rights with respect to the Products or related services or (B)&nbsp;another party processes, produces or manufactures, or will process, produce or manufacture, any Products or has the right to do so
in the future; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;any Contract through which the Company receives a license to Third Party Intellectual Property
(other than Standard Inbound Licenses) or grants a license to Intellectual Property of the Company (other than Standard Outbound Licenses); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;any litigation or dispute settlement agreement entered into within the last three (3)&nbsp;years; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;any Contract containing contingent consideration or other similar earnout payment obligations as to which the
Company has any ongoing or future Liability or obligations of any nature (contingent or otherwise); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;any
Contract (A)&nbsp;pursuant to which any third party developed or is developing any Products or (B)&nbsp;for <FONT STYLE="white-space:nowrap">pre-clinical</FONT> or other testing or clinical or marketing trials relating to the Products, in each case,
other than any agreements substantially on the same form as the Company&#146;s applicable standard form contract; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;each Contract with any Company Securityholder, or with any director or officer of the Company, other than
Contracts relating to the employment of any employee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;any Contract with any physician, hospital, clinic or
other health care provider or any medical advisor, in each case, other than any agreements substantially on the same form as the Company&#146;s applicable standard form contract; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-57- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;any Contract with any group purchasing organization or
integrated delivery network; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;any (A)&nbsp;sales agent, sales representative, resale, remarketing,
distribution or consignment Contract relating to the Company&#146;s Products or (B)&nbsp;other Contract for the marketing, resale (or other sale by or through any third party) or distribution of Products (excluding, for the avoidance of doubt,
employment agreements between the Company, on the one hand, and any employee thereof, on the other hand), in each case, other than any agreements substantially on the same form as the Company&#146;s applicable standard form contract; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;any Contract with any Governmental Authority; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;any Contract with any Significant Customer or Significant Supplier; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xv)&nbsp;&nbsp;&nbsp;&nbsp;any Contract relating to any capital expenditure or leasehold improvement that has commenced but is not yet
completed or that obligates the Company to incur expenditures with respect to a project that has not yet commenced, in each case, involving remaining payments by the Company in excess of $50,000 in the aggregate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;all broker, distributor, dealer, manufacturer&#146;s representative, franchise, agency, sales promotion, market
research, marketing consulting and advertising Contracts to which the Company is a party; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;any
(A)&nbsp;interest rate swap, cap, floor or option Contract or any other interest rate risk management arrangement or foreign exchange Contract or (B)&nbsp;other hedging, swap, derivative or similar Contract; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;any performance or payment guarantee (other than ordinary course contractual warranties), keep well
arrangement and other similar credit support obligation or arrangement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xix)&nbsp;&nbsp;&nbsp;&nbsp;any employment, consulting,
contractor or agency Contract with any current (or, to the extent obligations remain outstanding thereunder, former) employee, contract worker, independent contractor, consultant or agent of the Company (other than (A)&nbsp;offer letters with
employees providing for &#147;at will&#148; employment with the Company with no obligation to pay severance or (B)&nbsp;standard confidentiality agreements entered into with employees in the ordinary course of business and on the Company&#146;s
standard form of confidentiality agreement, which standard form has been made available to Parent); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xx)&nbsp;&nbsp;&nbsp;&nbsp;any
severance, change in control, retention or similar Contract, including any Contract providing for a &#147;stay&#148; or &#147;sale&#148; bonus, with any current or former Company Securityholder, director, manager, managing director, officer,
employee, contract worker, or other agent, or any Affiliate of the Company that would result in any obligation (absolute or contingent) of the Company to make any payment to any Person following either the consummation of the transactions
contemplated hereby, termination of employment (or the relevant relationship), or both; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-58- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xxi)&nbsp;&nbsp;&nbsp;&nbsp;any Real Property Lease or other Contract relating to any
lease, lease guarantee, sublease, license, easement or other use of Leased Real Property; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xxii)&nbsp;&nbsp;&nbsp;&nbsp;any operating
lease pursuant to which the Company has remaining payment obligations in excess of $50,000 in the aggregate and that is not terminable by the Company upon thirty (30)&nbsp;days or less for a cost of less than $10,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xxiii)&nbsp;&nbsp;&nbsp;&nbsp;any Contract containing any provision limiting in any respect the freedom of the Company or its employees or
Affiliates (or which after the Effective Time purport to limit or would limit the freedom of Parent, the Surviving Company, any of their respective subsidiaries or any employees or Affiliates of any of the foregoing) to engage in any line of
business, to develop, market, distribute, sell or license any products or services, to compete with any Person, to own any assets, properties or rights, to operate at any location in the world or to change sales quotas or targets under any Contracts
with distributors, sales agents, sales representatives, or other agents, including any Contract that contains exclusivity, <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> <FONT
STYLE="white-space:nowrap">non-consolidation,</FONT> standstill or similar restrictions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xxiv)&nbsp;&nbsp;&nbsp;&nbsp; any Contract
containing &#147;<U>most favored nation</U>&#148; provisions or any similar provision requiring that a third party be offered terms or concessions at least as favorable as those offered by the Company to one or more other Persons; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xxv)&nbsp;&nbsp;&nbsp;&nbsp;any Contracts to which the Company is a party that provide for any joint venture, partnership or similar
arrangement by the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xxvi)&nbsp;&nbsp;&nbsp;&nbsp;any labor or collective bargaining Contract; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(xxvii)&nbsp;&nbsp;&nbsp;&nbsp; any Contract not covered in clauses (i)&nbsp;through (xxvii) above, which is reasonably likely to involve
revenues, receipts, expenditures or Liabilities in excess of $100,000 per annum or $250,000 in the aggregate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each Material Contract has been Made Available to Parent by the Company. Each Material Contract (i)&nbsp;is in full
force and effect, is a valid and binding obligation of the Company and, to the Knowledge of the Company, of each other party thereto and (ii)&nbsp;is enforceable against the Company and, to the Knowledge of the Company, against each other party
thereto, except as such enforceability may be limited by the General Enforceability Exceptions. Each Material Contract will continue to be (x)&nbsp;valid, binding and enforceable against the Company and, to the Knowledge of the Company, of each
other party thereto, and (y)&nbsp;in full force and effect immediately following the consummation of the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company is not, and is not alleged in writing to be and, to the Knowledge of the Company, no other party is or
is alleged to be, in, or has received notice of, in any material respect, any, default under, or breach or violation of, any Material Contract that has not been cured. Except as set forth in <U>Section</U><U></U><U>&nbsp;3.13(c)</U> of the Company
Disclosure Letter, no event has occurred which, with or without the giving of notice or passage of time or both, would reasonably be expected to result, in any material respect, in a default, breach or violation of any Material Contract by the
Company, or give any Person the right (i)&nbsp;to declare a breach and obtain any material remedy thereunder, (ii)&nbsp;to accelerate the maturity, performance or payment of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-59- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obligation of the Company thereunder, (iii)&nbsp;to make operative any provision that varies any of the material rights or obligations of the Company from those that would apply if the event had
not occurred, or (iv)&nbsp;to cancel, terminate or modify (in a manner adverse to the Company) the Material Contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not received written notice since January&nbsp;1, 2017 from any such counterparty to the effect
that such counterparty intends to terminate or otherwise alter or modify the terms of any such Material Contract. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, the Company is, and since January&nbsp;1, 2016, the Company has been, in compliance
in all material respects with all applicable Laws (including all Health Care Laws) and Orders. To the Knowledge of the Company, neither the Company, nor any of its officers, directors, managers, managing directors or employees has in their capacity
as such, has received any written or other notice of, been charged with, or received any inquiry concerning, the possible violation of any applicable Law (including any Health Care Law). To the Knowledge of the Company, (A)&nbsp;neither the Company,
nor any of its officers, directors, managers, managing directors or employees in their capacity as such, is under Governmental Investigation with respect to the violation of any applicable Law (including any Health Care Law), Permit or Order and
(B)&nbsp;the Company has not been charged with, threatened to be charged with or received notice of any revocation or modification of any Permit or any Law or Order applicable to the Company. Since January&nbsp;1, 2016, neither the Company, nor any
of its officers, directors, managers, managing directors or employees in their capacity as such, has made, or been ordered to make, any payment in respect of any Governmental Damages, and there are no current or outstanding reimbursement audits,
recoupment efforts or appeals by any Governmental Authority pending. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 3.14(b)</U> of the Company
Disclosure Letter sets forth a complete and accurate list of all material Permits of Governmental Authorities issued to or held by the Company. The Company holds all material Permits of Governmental Authorities that are required for the Company to
conduct its businesses, activities and operations as presently conducted. Each such Permit is in full force and effect. Since January&nbsp;1, 2016, the Company has been and is in material compliance with the terms of each such Permit. To the
Knowledge of the Company, no revocation, suspension, cancellation or material adverse modification of any such Permit is threatened. All applications required to have been filed for the renewal of the Permits have been duly filed with the
appropriate Governmental Authority, and all other filings required to have been made with respect to the Permits and applicable Laws have been duly made on a timely basis with the appropriate Governmental Authority, except where any failure to have
made a filing would not be materially adverse to the Company taken as a whole. Each such Permit will continue in full force and effect immediately following the Effective Time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with Privacy Laws</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company and any of the Employee Benefit Plans that meet the definition of a &#147;group health plan&#148; under
HIPAA (each, a &#147;<U>Group Health Plan</U>&#148;) are, and have been for the past three (3)&nbsp;years, in compliance in all material respects with all applicable Laws </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-60- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
governing the collection, maintenance, use, processing, disclosure, privacy, protection or security of, and standard transactions related to, Personal Data, including, HIPAA, the Federal Trade
Commission Act, the Genetic Information Nondiscrimination Act of 2008 (GINA) and its implementing Regulations (29 C.F.R. &#167; 1635), applicable state health information privacy laws, applicable state data breach notification laws and all
applicable international privacy and data security laws, each as amended from time to time, and applicable regulations implemented pursuant to any of the foregoing (collectively, &#147;<U>Applicable Privacy Laws</U>&#148;). Neither the Company, nor
to the Company&#146;s Knowledge, its officers, directors, managers, managing directors or employees or any Group Health Plan has received any written notice of, or been charged with, the violation of any Applicable Privacy Laws, and to the Knowledge
of the Company, there are no pending investigations of the Company by any Governmental Authority relating to Applicable Privacy Laws, or to the Knowledge of the Company, civil actions against the Company alleging any material violation of Applicable
Privacy Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, there are no facts, circumstances or conditions that would
reasonably be expected to form the basis for any Claim against or affecting the Company nor any of its officers, directors, managers, managing directors or employees relating to or arising under Applicable Privacy Laws. To the Knowledge of the
Company, Personal Data that the Company has shared, or will share, with Parent or any of its Affiliates, or that will be transferred to Parent or any of its Affiliates pursuant to the terms of this Agreement (including indirectly by virtue of the
Mergers), has been collected, maintained and used in compliance in all material respects with (i)&nbsp;the requirements of the Applicable Privacy Laws, (ii)&nbsp;the requirements of Contracts to which the Company is a party and (iii)&nbsp;applicable
consents or authorizations received from Persons about whom the Personal Data relates (&#147;<U>Data Subject Consents</U>&#148;), where such consents are required by Applicable Privacy Laws. Without limitation to the foregoing, for the past three
(3)&nbsp;years, the Company has received and maintained applicable Data Subject Consents that are necessary in order for the Company to use and disclose Personal Data in the manner in which it has used and disclosed that Personal Data. To the
Knowledge of the Company, none of (A)&nbsp;the Company&#146;s sharing of Personal Data with Parent or any of its Affiliates, (B)&nbsp;the Company&#146;s transfer of Personal Data to Parent or any its Affiliates pursuant to the terms of this
Agreement (including indirectly by virtue of the Mergers) or (C)&nbsp;use of that Personal Data in a manner consistent with the manner in which the Company has used that Personal Data, will breach the Company&#146;s obligations material under
Applicable Privacy Laws, Material Contracts to which the Company is a party or applicable Data Subject Consents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;When required by Applicable Privacy Laws, each Group Health Plan has entered into a Contract that addresses the
provisions for &#147;business associate contracts&#148; required by 45 C.F.R. &#167; 164.504(e) or &#167; 164.314(a), as amended, with the applicable third party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company has implemented reasonable administrative, physical and technical safeguards to protect the
confidentiality, integrity and security of Personal Data and computer systems under its control, used or held for use by or on behalf of the Company in connection with the conduct of their businesses (&#147;<U>IT Assets</U>&#148;) against any
unauthorized control, use, access, interruption, modification or corruption in material conformance with Applicable Privacy Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-61- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, since January&nbsp;1, 2016,
there has been no material data security breach or material unauthorized access, control, use, modification or destruction of any IT Asset, or material unauthorized access, use, acquisition or disclosure of any Personal Data owned, used, stored, or
controlled by or on behalf of the Company, including any unauthorized access, use or disclosure of Personal Data that would constitute a breach for which notification to individuals or Governmental Authorities is required under Applicable Privacy
Laws or Contracts to which the Company or any Group Health Plan is a party. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Medical Device
Regulatory and Related Matters</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company is, and has been within the last three
(3)&nbsp;years, in compliance in all material respects with (i)&nbsp;the Federal Food, Drug, and Cosmetic Act (the &#147;<U>FD&amp;C Act</U>&#148;), 21 U.S.C. &#167; 301 et. seq., (ii) applicable EU Medical Device Directives and any related national
legislation of individual EU Member States implementing the provisions of the EU Medical Device Directives into their national laws and (iii)&nbsp;applicable equivalent Laws, including those relating to investigational devices, clinical studies,
premarket clearance or approval, device listing, facility registration, good manufacturing practices, informed consent, good clinical practices, good laboratory practices, labeling, promotion, export, recalls, record keeping and filing of reports
(the legislation, directives, regulations and other Laws described in the foregoing clauses (i), (ii) and (iii), collectively, &#147;<U>FDA Law and Regulation</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <U>Section</U><U></U><U>&nbsp;3.16(a)</U> and <U>(b)</U>&nbsp;of the Company Disclosure
Letter, none of the Company&#146;s facilities have been inspected by the FDA or a comparable foreign Governmental Authority within the past three (3)&nbsp;years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Since January&nbsp;1, 2016, the Company has not received any written notice or written communication from the FDA
or comparable foreign Governmental Authority alleging noncompliance with any applicable FDA Law and Regulation. The Company is not subject to any enforcement proceedings by the FDA or comparable foreign Governmental Authority and, to the Knowledge
of the Company, no such proceedings have been threatened. There is no Claim, warning letter, untitled letter, Governmental Investigation or enforcement action pending against the Company. To the Knowledge of the Company, no director, manager,
managing director, officer, employee, contract worker or agent of the Company in their capacity as such: (i)&nbsp;has made any untrue statement of material fact or fraudulent statement to the FDA or any other Governmental Authority; (ii)&nbsp;has
failed to disclose a material fact required to be disclosed to the FDA or any other Governmental Authority, (iii)&nbsp;has committed an act, made a statement or failed to make a statement that would reasonably be expected to provide the basis for
the FDA to invoke its policy respecting &#147;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,&#148; as set forth in 56 Fed. Reg. 46191 (September 10, 1991), (iv) has been convicted of any crime or engaged in any conduct
for which debarment is mandated or permitted by 21 U.S.C. &#167; 335a or (v)&nbsp;has been convicted of any crime or engaged in any conduct for which such Person or entity could be excluded from participating in the federal health care programs
under Section&nbsp;1128 of the Social Security Act, as amended, or any similar law or regulation. Since January&nbsp;1, 2016, the Company has never been and is not now subject to FDA&#146;s Application Integrity Policy or comparable Law enacted by a
comparable foreign Governmental Authority. No current director, manager, managing director, officer, employee, contract worker or agent of the Company is listed on an &#147;<U>Exclusion List</U>,&#148; meaning the current (A)&nbsp;HHS/OIG List
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-62- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Excluded Individuals/Entities (available through the Internet at http://www.oig.hhs.gov), (B) General Services Administration&#146;s System for Award Management (available through the Internet
at http://www.sam.gov/SAM/) or (C)&nbsp;FDA Debarment List (available through the Internet at http://www.fda.gov/ora/compliance_ref/debar/). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not introduced in commercial distribution or exported outside the U.S. within the past three
(3)&nbsp;years any Products that were upon their shipment by the Company adulterated or misbranded in violation of 21 U.S.C. &#167; 331 or comparable foreign Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;All preclinical testing and clinical trials conducted by, or on behalf of, the Company were conducted in material
compliance with experimental protocols, procedures and controls, accepted professional scientific standards and applicable Laws. The Company has not received any notices, correspondence or other communication from the FDA, the FDA&#146;s Center for
Devices and Radiological Health, or any other Governmental Authority requiring the termination or suspension of any clinical trials conducted by, or on behalf of, the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;The Company is, and has been for the past three (3)&nbsp;calendar years, in material compliance with, and each
Product regulated as a medical device in current commercial distribution is, to the extent applicable, designed, manufactured, prepared, assembled, packaged, labeled, stored, installed, serviced, exported, distributed and processed in material
compliance with, the Quality System Regulation set forth in 21 C.F.R. Part 820 (as may be amended from time to time), or, as applicable, a quality management system that is accepted by a comparable foreign Governmental Authority, including ISO 13485
and ISO 9000 series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 3.16(g)</U> of the Company Disclosure Letter sets forth a true and complete
list of all permits, licenses, registrations, certificates, orders, clearances or other Permits issued under the FD&amp;C Act or foreign equivalent Law (collectively, the &#147;<U>Regulatory Permits</U>&#148;) and held exclusively by the Company.
Such listed Regulatory Permits are the only permits (including licenses, registrations, certificates, orders, clearances or approvals) issued under the FD&amp;C Act and foreign equivalent Law that are required for the Company to conduct its business
as currently conducted. Since January&nbsp;1, 2016, the Company has been and is in material compliance with the terms of each such Regulatory Permit. No revocation, suspension, cancellation or material adverse modification of any such Regulatory
Permit is threatened and there is no basis for believing that such Regulatory Permit will not be renewable upon expiration. All material applications required to have been filed for the renewal of the Regulatory Permits have been duly filed with the
appropriate Governmental Authority, and all other material filings required to have been made with respect to the Regulatory Permits and applicable Laws have been duly made on a timely basis with the appropriate Governmental Authority. Each such
Regulatory Permit is currently in full force and effect and will continue in full force and effect immediately following the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Company&#146;s facilities is registered with the FDA and each Product is listed with the FDA under the
applicable FDA registration and listing regulations for medical devices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Since January&nbsp;1, 2016, the
Company has not initiated, participated in or experienced, either voluntarily or at the request of any Governmental Authority, any withdrawal, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-63- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
removal, recall, field safety corrective action, suspension of a clinical trial or clinical hold as a result of the design, manufacture, ownership, possession, preclinical testing, clinical
development, clinical investigation, clinical evaluation, distribution, marketing promotion, sale, provision, implanting or other use of any Products or any services performed, nor are there any pending or, to the Knowledge of the Company,
threatened withdrawals, removals, recalls, field safety corrective actions, suspensions of clinical trials, clinical holds or claims with respect to any Products or any services performed for which the Company has or may have a continuing Liability.
Since January&nbsp;1, 2016, no seizures have been made and no adverse regulatory actions have been taken, and there are no pending or, to the Knowledge of the Company, threatened seizures or regulatory actions, by the FDA or any other Governmental
Authority with respect to any of the Products, including with respect to any facilities where any of the Products are manufactured, processed, packaged or stored. To the Knowledge of the Company, there are no facts that would reasonably be expected
to cause the Company to withdraw, remove, recall, correct or suspend any Products from the market, to issue a field safety notice, or to suspend any clinical trial. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Health Care Regulatory and Related Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, the Company is currently and, for the three (3)&nbsp;year period prior to the date
of this Agreement has been, operating in compliance, in all material respects, with applicable Health Care Laws and no officer, director, manager, managing director or employee of the Company, or, to the Knowledge of the Company, any other Person,
has engaged in any act on behalf of the Company that violates any Health Care Law. &#147;<U>Health Care Laws</U>&#148; shall mean all Laws relating to the development, manufacture, production, assembly, processing, pricing, marketing, promotion,
sale, or distribution, coverage or reimbursement of a device, including (i)&nbsp;the Federal Health Care Program Anti-Kickback Statute, 42 U.S.C. &#167; 1320a- 7b(b); the Federal civil False Claims Act, 31 U.S.C. &#167;&#167; 3729-3733; the criminal
provisions under HIPAA; the Program Fraud Civil Remedies Act, 31 U.S.C. &#167;&#167; 3801-3812; the criminal False Claims Law, 42 U.S.C. &#167;&#167; <FONT STYLE="white-space:nowrap">1320a-7b(a),</FONT> the Civil Monetary Penalties Law, 42 U.S.C.
&#167; <FONT STYLE="white-space:nowrap">1320a-7a;</FONT> the exclusion authorities, 42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7;</FONT> the Physician Payment Sunshine Act, 42 U.S.C. &#167;
<FONT STYLE="white-space:nowrap">1320a-7h;</FONT> Medicare and Medicaid coverage and reimbursement provisions (Titles XVIII and XIX of the Social Security Act); and the applicable requirements of Medicare, Medicaid and other health care programs of
other Governmental Authorities, including the Veterans Health Administration and U.S. Department of Defense health care and contracting programs, each as amended, and any regulations promulgated thereunder; and (ii)&nbsp;any applicable comparable
foreign, local, state or federal health care Laws, including &#167;&#167; 299, 299a/b and 331 et seq. of the German Criminal Code (Strafgesetzbuch), the German Act on Advertising in the Health Care Sector (Heilmittelwerbegesetz), the German Act
against Unfair Competition (Gesetz gegen den unlauteren Wettbewerb), and &#167; 128 of the German Social Code V (Sozialgesetzbuch V), each as amended, and the applicable regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, Contracts, participations in the Company, and other business relationships with
potential customers, prescribers or other sources of orders or referrals, including consulting, speaker, development, sponsorship, grant and royalty agreements with, and training events for, physicians, other health care professionals or providers,
governmental representatives or health care organizations, comply in all material respects with all Health Care Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-64- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Since January&nbsp;1, 2016, none of the Company, nor to the
Knowledge of the Company, any of its employees, officers, directors, managers or managing directors has received written notice or other communication from a Governmental Authority or other Person that alleges that the Company (or such employee,
officer, director, manager or managing director) is in violation of any Health Care Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Since January&nbsp;1,
2016, the Company has not (i)&nbsp;received any subpoena, civil investigative demand or formal request for documents, or, (ii)&nbsp;to the Knowledge of the Company, been the subject of a Governmental Investigation, in connection with any violation
of, or any suspected or alleged violation of, any Health Care Law. To the Knowledge of the Company, no Governmental Investigation with respect to the Company is pending or threatened. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;None of the Company, or any of its officers, directors, managers, managing directors or employees is excluded from
any federal health care program as that term is defined by 42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(f)</FONT> or is debarred, restricted or prohibited from participation in any health care, procurement or nonprocurement program or
reimbursement system authorized, funded, administered or sponsored by any Governmental Authority. Since January&nbsp;1, 2016, neither the Company, nor to the Knowledge of the Company, any of its officers, directors, managers, managing directors or
employees (i)&nbsp;has been convicted of any conduct that would reasonably be expected to result in exclusion from any federal health care program or debarment or (ii)&nbsp;has otherwise been convicted of engaging in any activities that would
reasonably be expected to provide cause for civil, criminal or administrative penalties or sanctions or mandatory or permissive exclusion under applicable Health Care Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Since January&nbsp;1, 2016, there have not been and, to the Knowledge of the Company, currently are no actions
(including enforcement, criminal, regulatory or administrative proceedings), audits (outside the Ordinary Course of Business) or recoupment by or before any Governmental Authority alleging a violation of Health Care Laws by the Company, or any of
its employees, officers, directors, managers or managing directors. The Company is not a party to any corporate integrity agreement, monitoring agreement, consent decree, settlement order, deferred prosecution agreement, <FONT
STYLE="white-space:nowrap">non-prosecution</FONT> agreement or similar agreement with or imposed by any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, material documents, reports and notices required to be maintained or filed with
any Governmental Authority by the Company with respect Health Care Laws have been so maintained or filed on a timely basis, and were complete and accurate in all material respects as of the date of filing. To the Knowledge of the Company, no such
filing with any Governmental Authority contains any statement or information that, as of the date such filing was made, was (expressly or due to omission of material information) materially false or misleading. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18.&nbsp;&nbsp;&nbsp;&nbsp;<U>Trade Compliance Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, the Company is, and during the past three (3)&nbsp;years has been, in compliance in
all material respects with all applicable export control and economic sanctions laws and regulations of the United States (collectively, the &#147;<U>Trade Control Laws</U>&#148;), including the U.S. Export Administration Regulations
(&#147;<U>EAR</U>&#148;) (15 C.F.R. Part </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-65- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
730 et seq.), the EAR&#146;s rules on Restrictive Trade Practices or Boycotts (15 C.F.R. Part 760, the <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;<U>Anti-Boycott
Regulations</U>&#148;), the Arms Export Control Act and the International Traffic in Arms Regulations (22 C.F.R. Part 120 et seq.) and the economic sanctions laws and regulations implemented under statutory authority or Presidential Executive Orders
and administered by the U.S. Department of the Treasury&#146;s Office of Foreign Assets Control (31 C.F.R. Part 500 et seq.; collectively, the &#147;<U>OFAC Regulations</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;During the past three (3)&nbsp;years, the Company has obtained from the relevant government agencies all required
licenses and other material consents, notices, waivers, approvals, orders, authorizations, registrations, declarations, and classifications required for the sale, supply, export, transfer and import of hardware, software, technology and services in
accordance with applicable Trade Control Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company, nor, to the Knowledge of the Company, any
of its officers, directors, managers, managing directors, employees or agents, appear on applicable restricted-party lists maintained by the Office of Foreign Assets Control or the Bureau of Industry and Security, including the Specially Designated
Nationals and Blocked Persons List, Denied Persons List, Unverified List, and Entity List (collectively, &#147;<U>Restricted Parties</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company (i)&nbsp;does not and has not in the past three (3)&nbsp;years had any transactions with, accounts
receivable from or accounts payable to, (ii)&nbsp;is not and in the past three (3)&nbsp;years has not been, a party to or a beneficiary under any Contract with or (iii)&nbsp;is not and in the past three (3)&nbsp;years has not been, engaged in any
other activities directly or indirectly with or involving, in each case of the foregoing clauses (i), (ii) and (iii), Cuba, Iran, North Korea, Sudan, Syria, Crimea, or any Restricted Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;At no time during the past three (3)&nbsp;years has the Company (i)&nbsp;been cited or fined for failure to comply
with Trade Control Laws, and no charge, proceeding or, to the Knowledge of the Company, investigation, complaint, or inquiry by any Governmental Authority with respect to any alleged <FONT STYLE="white-space:nowrap">non-compliance</FONT> with Trade
Control Laws by the Company is pending or, to the Knowledge of the Company, has been asserted or threatened with respect to the Company or (ii)&nbsp;made any disclosures (voluntary or otherwise) to any relevant governmental agency with respect to
any potential violation or liability of the Company arising under or relating to any Trade Control Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Anti-Money Laundering</U>. The operations of the Company are, and during the past three
(3)&nbsp;years have been, conducted in compliance in all material respects with all anti-money laundering Laws and all applicable financial record keeping and reporting requirements, rules, regulations applicable to the Company (collectively,
&#147;<U>Money Laundering Laws</U>&#148;) and no Claim by or before any Governmental Authority involving the Company with respect to Money Laundering Laws is pending and, to the Knowledge of the Company, no such Claims are threatened or
contemplated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20. <U>Ethical Practices</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company, nor to the Knowledge of the Company any of its directors, managers, managing directors,
officers, employees, agents, contract workers or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-66- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
representatives, in each case acting for or on behalf of (or, to the Knowledge of the Company, purporting to act for or on behalf of) the Company, directly or indirectly, has: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;violated or is in violation of any provision of any Improper Payment Law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;(A) made, given, undertaken, caused to be made or given, offered to make or give, promised to make or give, or
authorized, ratified or facilitated the making or giving of any bribe, rebate, payoff, influence payment, facilitation payment, kickback or other payment or gift of money or any other thing of value to any Person or (B)&nbsp;given, caused to be
given, offered to give, promised to give, or authorized, ratified or facilitated the giving of any political contribution or charitable contribution, or any advantage, to any Person, in each case of the foregoing clauses (A)&nbsp;and (B), (x) in
violation of, or that is prohibited under, any Improper Payment Law or (y)&nbsp;otherwise for the purpose of influencing any act or decision of such payee in his official capacity, inducing such payee to do or omit to do any act in violation of his
lawful duty, securing any improper advantage, inducing such payee to use his influence with a government or instrumentality thereof to affect or influence any act or decision of such government or instrumentality or to secure any improper advantage,
or inducing such payee to enter into a commercial arrangement in violation of applicable Law; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;requested or
received any payment, gift, political contribution, charitable contribution or other thing of value or advantage in violation of, or that is prohibited under, any Improper Payment Law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;(A) been subject to, or received notice with respect to, any actual, pending or, to the Knowledge of the Company,
threatened or reasonably anticipated civil, criminal or administrative Claim with respect to any matter or conduct of the type described in the foregoing clause (i), (ii) or (iii), (B) been subject to, or received notice of, any allegation of
(x)&nbsp;any violation of, or conduct violative of, any Improper Payment Law or (y)&nbsp;any matter or conduct of the type described in the foregoing clause (i), (ii) or (iii)&nbsp;or (C) made any voluntary disclosure to any Governmental Authority
with respect to any matter or conduct of the type described in the foregoing clause (i), (ii) or (iii); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;established or maintained a secret or unrecorded fund (or made any promise or undertaking in such regard). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;There have been no false or fictitious entries made in the books or records of the Company relating to (i)&nbsp;any
secret or unrecorded fund or (ii)&nbsp;any unlawful payment, gift, political contribution, charitable contribution or other thing of value or advantage (including any payment, gift, political contribution, charitable contribution or other thing of
value or advantage of the type described in <U>Section</U><U></U><U>&nbsp;3.20(a)(ii)</U> or <U>Section</U><U></U><U>&nbsp;3.20(a)(iii)</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;For the avoidance of doubt, any reference to &#147;other thing of value&#148; in this
<U>Section</U><U></U><U>&nbsp;3.20</U> includes meals, entertainment, travel and lodging, and any reference to &#147;representatives&#148; of the Company in this <U>Section</U><U></U><U>&nbsp;3.20</U> includes distributors, sales agents, third-party
representatives, commercial intermediaries, partners and joint venturers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-67- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21.&nbsp;&nbsp;&nbsp;&nbsp;<U>Customers and Suppliers</U>.
<U>Section</U><U></U><U>&nbsp;3.21</U> of the Company Disclosure Letter lists: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;the names of (i)&nbsp;the
twenty (20)&nbsp;most significant customers of the Company (measured by dollar volume of sales by the Company to such customers) for the period from January&nbsp;1, 2018 through December&nbsp;31, 2018 (&#147;<U>Significant Customers</U>&#148;), (ii)
the ten (10)&nbsp;most significant suppliers from which the Company of the Company purchased materials, supplies, services or other goods (measured by dollar volume of purchases by the Company from such suppliers) for the period from January&nbsp;1,
2018 through December&nbsp;31, 2018 and (iii)&nbsp;each sole source supplier of the Company for which a commercially reasonable alternative is not available (such suppliers in clauses (ii)&nbsp;and (iii) are collectively referred to as
&#147;<U>Significant Suppliers</U>&#148;), and the amount for which each such Significant Supplier invoiced the Company during such period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not received any written or, to the Knowledge of the Company, oral notice that (i)&nbsp;any
Significant Customer has ceased or will cease to purchase or use the Products, equipment, goods or services of the Company or has substantially reduced or will substantially reduce the purchase or use of such Products, equipment, goods or services,
(ii)&nbsp;that any Significant Customer will return any of the Products, equipment or goods of the Company that it has purchased from the Company, (iii)&nbsp;that any Significant Supplier has ceased or will cease to supply materials, supplies,
services or other goods to the Company after the date hereof on terms and conditions similar in all material respects to those imposed on current sales to the Company or (iv)&nbsp;that any Company distributor has ceased or will cease to purchase,
sell or use the Products, equipment, goods or services of the Company or has substantially reduced or will substantially reduce the purchase, sale or use of such Products, equipment, goods or services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not received any written or, to the Knowledge of the Company, oral notice that any clinical trial
site participating in the aMAZE IDE Clinical Trial has ceased enrolling participants, become inactive in the aMAZE IDE Clinical Trial or will cease to enroll participants or cease to remain active in the aMAZE IDE Clinical Trial or has substantially
reduced or will substantially reduce its activity in the aMAZE IDE Clinical Trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22.&nbsp;&nbsp;&nbsp;&nbsp;<U>Inventory</U>. All items included in the inventories of the Company consist of items of a quality
usable or saleable in the Ordinary Course of Business consistent with past practice (except for obsolete or damaged items that have been written off or for which adequate reserves have been established in the Financial Statements) and are in
quantities sufficient for the normal operation of the business in accordance with past practice. All of the inventories are owned by the Company free and clear of all Liens (other than Permitted Liens). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23.&nbsp;&nbsp;&nbsp;&nbsp;<U>Product Liability; Product Warranty</U>. The Company has Made Available to Parent a copy of the
standard warranties still in effect or currently offered by the Company. Except as set forth in <U>Section</U><U></U><U>&nbsp;3.23</U> of the Company Disclosure Letter, all Products and services sold, provided or delivered within the last three
(3)&nbsp;years by the Company were designed, manufactured, prepared, assembled, packaged, labeled, sterilized, stored, serviced and processed in compliance, in all material respects, with applicable Law, applicable contractual commitments, Product
and service specifications and quality standards, and, to the Knowledge of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-68- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company, other than as reserved for in the Ordinary Course of Business, the Company has no Liability for replacement or repair thereof or other damages in connection therewith. Except as set
forth in <U>Section</U><U></U><U>&nbsp;3.23</U> of the Company Disclosure Letter, no Product or service sold, provided or delivered by the Company to customers on or prior to the Closing is subject to any guaranty, warranty (other than warranties
imposed by law) or other indemnity beyond the applicable standard terms and conditions of sale. Except as set forth in <U>Section</U><U></U><U>&nbsp;3.23</U> of the Company Disclosure Letter, there are no actual or, to the Knowledge of the Company,
threatened Claims arising out of any injury to a Person or property as a result of the ownership, design, manufacture, possession, provision, clinical development, distribution, marketing, promotion, sale, implanting, or other use of any equipment,
Product or service sold, provided or delivered by the Company on or prior to the Closing. All material Claims (including those relating to clinical trials) against or involving or, to the Knowledge of the Company, threatened against the Company that
are pending or were asserted within the last three (3)&nbsp;years and that relate in any way to one or more Products, whether covered by insurance or not and whether litigation has resulted or not, are listed and summarized in
<U>Section</U><U></U><U>&nbsp;3.23</U> of the Company Disclosure Letter. All Claims (including those relating to clinical trials) against or involving or, to the Knowledge of the Company, threatened against the Company that are pending or were
asserted within the last three (3)&nbsp;years and that relate in any way to one or more Products, whether covered by insurance or not and whether litigation has resulted or not, are listed and summarized in <U>Section</U><U></U><U>&nbsp;3.23</U> of
the Company Disclosure Letter. Except as set forth in <U>Section</U><U></U><U>&nbsp;3.23</U> of the Company Disclosure Letter, within the last three (3)&nbsp;years, no allegation has been asserted in writing that any of the Products contains a
design defect or a manufacturing defect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24.&nbsp;&nbsp;&nbsp;&nbsp;<U>Labor and Employment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 3.24(a)</U> of the Company Disclosure Letter sets forth a true, correct and complete list of the job
titles; date of hire; work location (city and state); current annual base salaries or hourly wages; any other compensation payable to them (including housing allowances, compensation payable pursuant to bonus, deferred compensation or commission
arrangements or other compensation); Fair Labor Standards Act classification (i.e., exempt or <FONT STYLE="white-space:nowrap">non-exempt)</FONT> and status (i.e., active or inactive and if inactive, the type of leave and, if known, estimated
duration) of the employees of the Company. Except as provided on <U>Section</U><U></U><U>&nbsp;3.24(a)</U> of the Company Disclosure Letter, all employees are employed <FONT STYLE="white-space:nowrap">&#147;at-will&#148;</FONT> and are not entitled
to severance pay or other compensation (except accrued salary and benefits) upon termination of employment or the Closing of the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed on <U>Section</U><U></U><U>&nbsp;3.24(b)</U> of the Company Disclosure Letter, the Company is
not and has never been a party to any collective bargaining or similar agreement with any labor union or organization, nor are any of its employees or independent contractors represented by any labor union. Since January&nbsp;1, 2016, no union or
other labor organization has sought to represent employees or independent contractors of the Company or filed a petition for representation. Except as disclosed in <U>Section</U><U></U><U>&nbsp;3.24(b)</U> of the Company Disclosure Letter, there is
no pending, or to the Company&#146;s Knowledge, threatened, labor dispute, work slowdown, work stoppage, strike, or lockout involving the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in <U>Section</U><U></U><U>&nbsp;3.24(b)</U> of the Company Disclosure Letter, of the Company
Disclosure Letter, since January&nbsp;1, 2016: (i) there has been no Legal Proceeding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-69- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
related to any current or former employee of the Company related to a breach or default of any restrictive covenant, <FONT STYLE="white-space:nowrap">non-compete</FONT> agreement, <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> agreement, confidentiality or <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement with the Company or with any other Person as a result of the employee&#146;s performance of services
for the Company and (ii)&nbsp;to the Company&#146;s Knowledge, no employee of the Company is in breach or default of any restrictive covenant, <FONT STYLE="white-space:nowrap">non-compete</FONT> agreement,
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement, confidentiality or <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement with the Company or with any other Person as a result of the employee&#146;s performance of
services for the Company, and the Company has not hired any employee in violation of any restrictive covenant, <FONT STYLE="white-space:nowrap">non-compete</FONT> agreement, <FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement, or
confidentiality or <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement to which such employee is a party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in <U>Section</U><U></U><U>&nbsp;3.24(d)</U> of the Company Disclosure Letter, no Person not
affiliated or associated with the Company has claimed or, to the Company&#146;s Knowledge, has reason to claim that any Person affiliated or associated with the Company: (i)&nbsp;is in violation of any term of any employment contract, patent
disclosure agreement, <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement or any restrictive covenant with such <FONT STYLE="white-space:nowrap">non-affiliated</FONT> Person; (ii)&nbsp;has disclosed or utilized any Trade Secret or
proprietary information or documentation of such <FONT STYLE="white-space:nowrap">non-affiliated</FONT> Person; or (iii)&nbsp;has interfered in the employment relationship between such <FONT STYLE="white-space:nowrap">non-affiliated</FONT> Person
and any of its present or former employees. To the Knowledge of the Company, no Company Associate has used or proposed to use any Trade Secret, information or documentation proprietary to any former employer or violated any confidential relationship
with any Person in connection with the development, manufacture or sale of any product or proposed product, or the development or sale of any service or proposed service, of the Company. Each Company Associate has successfully passed all industry
standard background checks and all other verification required, expressly or impliedly, by any Company Contract or applicable industry standard, certification or accreditation requirement, or other license, registration or membership requirements.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company and, to the Knowledge of the Company, no employee or other Representative of the Company,
has committed or engaged in any unfair labor practice in connection with the conduct of the Business. No proceeding, claim, charge, complaint or audit or, to the Company&#146;s Knowledge, investigation by a Governmental Authority against the Company
has been instituted since January&nbsp;1, 2016, is pending or, to the Knowledge of the Company, has been threatened or is reasonably anticipated relating to any employment or labor matters involving any Company employee or independent contractor,
including but not limited to matters related to unfair labor practices, misclassification (with respect to classification under the Fair Labor Standards Act or classification as an independent contractor), wage payment, overtime or unpaid breaks,
paid leave, employee safety, wrongful termination, discrimination, harassment or retaliation. The Company is and has at all times been in compliance with all applicable Laws relating to the employment of labor and engagement of independent
contractors, including all such Laws relating to employment discrimination, harassment, civil rights, equal pay, labor relations, safety and health, workers&#146; compensation, payment of wages, hours and overtime, paid breaks, paid leave,
misclassification (with respect to classification under the Fair Labor Standards Act or classification as an independent contractor), tax contributions, severance pay, the Worker Adjustment and Retraining Notification Act of 1988, as amended, and
any similar foreign, state or local &#147;<U>mass layoff</U>&#148; or &#147;<U>plant closing</U>&#148; Laws (collectively, &#147;<U>WARN</U>&#148;), collective bargaining, collection and payment of tax withholding or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-70- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
social security taxes and any similar tax, leaves of absence, paid sick leave, paid time off, immigration, employee benefits, and affirmative action. Each current employee and independent
contractor of the Company is lawfully authorized to work in the jurisdiction in which he or she is employed. The Company fully and accurately completes <FONT STYLE="white-space:nowrap">I-9</FONT> Forms for each employee and retains them in
accordance with applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>WARN Act, Notice and Consultation</U>. The Company has not had any plant
closing, mass layoff or other termination of any Company employee or independent contractor that has imposed or would impose any obligation or other Liability upon the Company, Parent or any of Parent&#146;s Affiliates under WARN. Neither the
Company nor Parent or any of its Affiliates has or will become subject to any obligation under applicable Laws or otherwise to notify or consult with, prior to or after the Effective Time, any employee, Governmental Authority or other Person with
respect to the impact of the Transactions on the employment of any of the Company&#146;s employees or engagement of any of the Company&#146;s independent contractors or the compensation or benefits provided to any of the Company&#146;s employees or
independent contractors. The Company is not a party to any Contract or arrangement or subject to any requirement that in any manner restricts the Company from relocating, consolidating, merging or closing any portion of the Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Misclassification</U>. Set forth in <U>Section</U><U></U><U>&nbsp;3.24(g)</U> of the Company Disclosure Letter
is a list of all independent contractors who have provided services to the Company since January&nbsp;1, 2016, with their dates of engagement, work locations, type of services provided, compensation received each year, and whether they entered into
an independent contractor agreement with the Company. The Company has properly classified and treated its current and former independent contractors as <FONT STYLE="white-space:nowrap">non-employees</FONT> and is not in violation of any applicable
Laws concerning classification or retention of independent contractors. Except as set forth in <U>Section</U><U></U><U>&nbsp;3.24(g)</U> of the Company Disclosure Letter, no independent contractor is eligible to participate in any Company Benefit
Plan. The Company has never had any temporary or leased employees who were not treated and accounted for in all respects as employees of the Company. The employees of the Company are correctly classified as either exempt or <FONT
STYLE="white-space:nowrap">non-exempt</FONT> employees under the applicable Laws of all jurisdictions in which the Company maintains employment relationships. The Company maintains accurate and complete records of all overtime hours worked by each
employee eligible for overtime compensation and compensates all employees in accordance with the requirements of the Fair Labor Standards Act and the applicable Laws of all jurisdictions in which the Company maintains employees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25.&nbsp;&nbsp;&nbsp;&nbsp;<U>Employee Benefit Plans</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 3.25(a)</U> of the Company Disclosure Letter lists each material Company Benefit Plan. With respect to
each Company Benefit Plan, the Company has Made Available, to the extent applicable, accurate and complete copies of all plan documents and summary plan descriptions, the most recent determination letter (or opinion letter) received from the
Internal Revenue Service, the most recent actuarial report, if any, copies of the most recently filed Form 5500 Annual Report and <FONT STYLE="white-space:nowrap">non-discrimination</FONT> testing results for the last two years, all related trust
agreements and funding agreements associated with such Company Benefit Plan, all insurance policies, all material Contracts currently in force with third-party administrators, actuaries, investment managers, consultants, and other service providers,
and all material notices </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-71- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
within the last six (6)&nbsp;years to or from the IRS or any office or representative of the Department of Labor or other applicable Governmental Authority relating to any unresolved compliance
issues in respect of any such Company Benefit Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its ERISA Affiliates has
ever contributed or has been obligated to contribute to, or has had any Liability in respect of, any &#147;employee pension plans&#148; as defined in Section&nbsp;3(2) of ERISA, subject to Title IV of ERISA or Section&nbsp;412 of the Code, including
a &#147;multiemployer plan&#148; as defined in Section&nbsp;3(37) of ERISA, or any multiemployer welfare arrangement (as defined in Section&nbsp;3(40) of the Code). None of the Company Benefit Plans provide for post-employment life or health
insurance benefits or coverage for any participant or any beneficiary of a participant, except as may be required under Section&nbsp;4980B of the Code or other similar state statute of a state of the United States, and at the sole expense of the
participant or the participant&#146;s beneficiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Each Company Benefit Plan (and each related trust,
insurance contract or fund) has been administered, funded and operated in all material respects in accordance with the terms of the applicable controlling documents and with the applicable provisions of ERISA, the Code and all other applicable Laws.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;All required reports, descriptions and disclosures have been filed or distributed in accordance in all
material respects with applicable Laws with respect to each Company Benefit Plan. The requirements of Part 6 of Subtitle B of Title I of ERISA and of Section&nbsp;4980B of the Code have been met in all material respects with respect to each Company
Benefit Plan that is a Group Health Plan subject to ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;All contributions (including all employer
contributions and employee salary reduction contributions) that are due and owing have been paid to each Company Benefit Plan (or related trust or held in the general assets of the Company and accrued, as appropriate), and all contributions for any
period ending on or before the Closing Date that are not yet due have been paid to each Company Benefit Plan (or related trust) or accrued in accordance with GAAP or other local law accounting requirements. All premiums or other payments for all
periods ending on or before the Closing Date have been paid with respect to each Company Benefit Plan that is an Employee Welfare Benefit Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Each Company Benefit Plan that is an Employee Pension Benefit Plan and that is intended to meet the requirements of
a &#147;qualified plan&#148; under Section&nbsp;401(a) of the Code has either received or applied for (or has time remaining to apply for) a favorable determination letter (or, in the case of a prototype plan, an opinion letter) from the Internal
Revenue Service within the applicable remedial amendment periods. No such determination letter or advisory letter has been revoked, no Governmental Authority has threatened to revoke any such determination letter or advisory letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor, to the Knowledge of the Company, any employee or Representative of the Company, has made
any oral or written representation or commitment with respect to any aspect of any Company Benefit Plan that is not in accordance with the written or otherwise preexisting terms and provisions of such Company Benefit Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-72- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;There are no unresolved claims, proceedings, audits,
investigations or other Legal Proceedings, or disputes, under the terms of, or otherwise relating to or in connection with, any Company Benefit Plan (other than routine undisputed claims for benefits), and no action, legal or otherwise, has been
commenced, or, to the Knowledge of the Company, will or would reasonably be expected to be commenced, with respect to any such claim, proceeding, audit, investigation, Legal Proceeding or dispute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;With respect to each Company Benefit Plan: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;there have been no &#147;prohibited transactions&#148; with respect to any such Company Benefit Plan that would
subject the Company to a material Tax or penalty imposed pursuant to Section&nbsp;4975 of the Code or Section&nbsp;502(c), (i) or (l)&nbsp;of ERISA; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Company (by way of indemnification, directly or otherwise) does not have and, to the Knowledge of the
Company, no fiduciary has, any material Liability for breach of fiduciary duty or any failure to act or comply in connection with the administration or investment of the assets of such Company Benefit Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Neither the execution and delivery of this Agreement or any other Transaction Document nor the consummation of any
of the Transactions could (alone or in combination with one or more events or circumstances): (i) result in any payment (including severance, unemployment compensation, golden parachute, bonus or otherwise) becoming due to any Company Associate,
(ii)&nbsp;increase any compensation or benefits otherwise payable by the Company, (iii)&nbsp;result in the acceleration of the time of payment, funding or vesting of any such compensation or benefits, (iv)&nbsp;require any contributions or payments
to fund any obligations under any Company Benefit Plan, (v)&nbsp;result in forgiveness of indebtedness of any Company Associate or (vi)&nbsp;create any limitation or restriction on the right of the Company to merge, amend or terminate any Company
Benefit Plan. Without limiting the generality of the foregoing, no amount paid or payable in connection with any of the Transactions (either solely as a result thereof or as a result of any of the Transactions in conjunction with any other event)
could be a Section&nbsp;280G Payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;Each Company Benefit Plan that is subject to Section&nbsp;409A(a) of the
Code has been operated and maintained in all material respects in operational and documentary compliance with Section&nbsp;409A(a) of the Code and applicable guidance thereunder. The Company is not a party to, or otherwise obligated under, any
Contract, plan or arrangement that provides for a <FONT STYLE="white-space:nowrap">&#147;gross-up,&#148;</FONT> make-whole or similar payment in respect of any Tax that may become payable under Section&nbsp;409A or Section&nbsp;4999 of the Code.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.26.&nbsp;&nbsp;&nbsp;&nbsp;<U>Broker</U>. Except as disclosed on <U>Section</U><U></U><U>&nbsp;3.26</U> of the Company
Disclosure Letter, no broker, finder, investment banker or other Person is entitled to any brokerage, finder&#146;s or other fee or commission in connection with the Transactions based upon arrangements made by or on behalf of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.27.&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>. <U>Section</U><U></U><U>&nbsp;3.27</U> of the Company Disclosure Letter discloses
a true, correct, and complete list of the insurance policies which cover the Assets and operations of the Company, in each case setting forth the policy number and type of coverage, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-73- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
maintained on its respective Assets, and with respect to its employees and the Business. All such insurance policies are in full force and effect. The Company has not received any written notice
of cancellation of, material premium increase with respect to, or material alteration of coverage under, any of such insurance policies. No such insurance policy has been subject to any lapse in coverage. Except as set forth on
<U>Section</U><U></U><U>&nbsp;3.27</U> of the Company Disclosure Letter, there are no claims related to the Business of the Company pending under any such insurance policies as to which coverage has been denied or disputed in writing or in respect
of which there is an outstanding reservation of rights. The Company is not in payment default under, and has not otherwise failed to comply with any provision contained in any such insurance policy. The insurance policies are of the type and in the
amounts customarily carried by Persons conducting a business similar to the Company and are sufficient for compliance with all applicable Laws and Contracts to which the Company is a party or by which it is bound. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.28.&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Certain Changes or Events</U>. Since the Interim Balance Sheet Date, no Company
Material Adverse Effect has occurred. Except as contemplated or permitted by, or as a consequence of, this Agreement, since the Interim Balance Sheet Date, the Company has conducted the Business in the Ordinary Course. Without limiting the
generality of the foregoing, except as set forth on <U>Section</U><U></U><U>&nbsp;3.28</U> of the Company Disclosure Letter, since the Interim Balance Sheet Date, the Company has not:(a) amended the charter,
<FONT STYLE="white-space:nowrap">by-laws</FONT> or other Organizational Documents of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;granted any
Lien (other than a Permitted Lien) upon any of its material Assets; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;sold, transferred, licensed or leased any
of its material Assets, except in the Ordinary Course of Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;sold, assigned, granted or otherwise
transferred or disposed of rights under any of its Intellectual Property, or, except in the Ordinary Course of Business, abandoned, cancelled or otherwise failed to maintain any such rights; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;declared or paid dividends on or distributions in respect of its equity interests or directly or indirectly
redeemed, purchased or otherwise acquired its equity interests; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;issued, sold or otherwise disposed of any of
its capital stock, or granted any options, warrants or other rights to purchase or obtain (including upon conversion, exchange or exercise) any of its capital stock; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;made any material change in the accounting principles, methods, or practices followed by it or depreciation or
amortization policies or rates theretofore adopted; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;incurred, assumed or guaranteed any Indebtedness for
borrowed money except unsecured current obligations and Liabilities incurred in the Ordinary Course of Business consistent with past practice; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-74- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;other than in the Ordinary Course of Business, entered into,
amended or terminated any Material Contract; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;sustained any damage, destruction or loss (whether or not covered
by insurance) in excess of $50,000; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;other than in the Ordinary Course of Business, established, adopted,
amended or terminated any Company Benefit Plan, labor agreement or employment agreement affecting any current employee, independent contractor or consultant of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;hired any employee with an annual base salary in excess of $200,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;(i) granted any bonuses, whether monetary or otherwise, or increase in any wages, salary, severance, pension or
other compensation or benefits in respect of its current or former employees, officers, directors, independent contractors or consultants, other than as provided for in any written agreements or required by applicable Laws, (ii)&nbsp;changed the
terms of employment for any employee or any termination of any employees or (iii)&nbsp;taken any action to accelerate the vesting or payment of any compensation or benefit for any current or former employee, officer, director, independent contractor
or consultant; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;except as required by applicable Laws, (i)&nbsp;settled or compromised any claim, controversy
or Legal Proceeding relating to a material amount of Taxes, (ii)&nbsp;made any change to any of its material Tax elections or methods of Tax accounting, (iii)&nbsp;amended or refiled any previously filed material Tax Return or (iv)&nbsp;entered into
or terminated any material agreements with a Taxing Authority; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;entered into any contract to do any of the
foregoing, or taken any action or omission that obligated itself to do any of the foregoing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.29.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;(i) all Tax Returns required to be filed by or with respect to the Company have been duly and timely filed with the appropriate Taxing
Authority, (ii)&nbsp;all items of income, gain, loss, deduction and credit or other items (&#147;<U>Tax Items</U>&#148;) required to be included in each such Tax Return have been so included and all such Tax Items and any other information provided
in each such Tax Return is accurate and complete, (iii)&nbsp;all Taxes owed by the Company or for which the Company is liable that are or have become due have been timely paid in full, (iv)&nbsp;the Company will have no liability for any Taxes
relating to any Tax period ending on (and including) the Closing Date, the portion of any Tax period that includes (but does not end on) the Closing Date or any Tax period ending prior to the Closing Date for which Tax Returns are not yet due, other
than those Taxes to be taken into account in the Closing Working Capital Amount, (v)&nbsp;no penalty, interest or other charge is or will become due with respect to the late filing of any Tax Return or late payment of any Tax, (vi)&nbsp;all material
Tax withholding and deposit requirements imposed on or with respect to the Company have been satisfied in full and (vii)&nbsp;there are no Liens on any of the assets of the Company that arose in connection with any failure (or alleged failure) to
pay any Tax other than those described in clause (a)&nbsp;of the definition of Permitted Liens. In the case of a Tax period that does not end on the Closing Date in <U>Section</U><U></U><U>&nbsp;3.29</U><U>(a)(iv)</U>, the amount of any Taxes based
on or measured by income, receipts, payroll or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-75- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
similar Taxes of the Company for the Tax period (or portion thereof) ending on (and including) the Closing Date shall be determined based on an interim closing of the books as of the close of
business on the Closing Date (and for such purpose, the taxable period of any partnership or other pass-through entity in which the Company holds a beneficial interest shall be deemed to terminate at such time) and the amount of other Taxes of the
Company for a Tax period that includes but does not end on the Closing Date that relates to the portion of the Tax period that includes the Closing Date shall be deemed to be the amount of such Tax for the entire taxable period multiplied by a
fraction, the numerator of which is the number of days in the taxable period ending on the Closing Date, and the denominator of which is the number of days in such taxable period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Returns</U>. <U>Section</U><U></U><U>&nbsp;3.29(b)</U> of the Company Disclosure Letter: (i)&nbsp;lists all
federal, state, local and foreign income Tax Returns filed with respect to the Company for the six (6)&nbsp;taxable years ending prior to the Closing Date, (ii)&nbsp;indicates those Tax Returns that are currently the subject of audit and
(iii)&nbsp;indicates those Tax Returns whose audits have been closed. The Company has Made Available copies of all income Tax Returns and other material Tax Returns filed by the Company during the past six (6)&nbsp;years and all material
correspondence to the Company from, or from the Company to, a Taxing Authority relating thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Claims;
Proceedings</U>. No assessment, deficiency or adjustment has been asserted, proposed or threatened in writing with respect to any Tax Return of or with respect to the Company, other than those disclosed (and to which are attached accurate and
complete copies of all correspondence to or from the relevant Taxing Authority pertaining thereto) in <U>Section</U><U></U><U>&nbsp;3.29(c)</U> of the Company Disclosure Letter. No Tax audits or administrative or judicial proceedings are being
conducted, are pending or have been threatened in writing with respect to the Company, other than those disclosed (and to which are attached accurate and complete copies of all correspondence to or from the relevant Taxing Authority pertaining
thereto) in <U>Section</U><U></U><U>&nbsp;3.29(c)</U> of the Company Disclosure Letter. No claim has ever been made by an authority in a jurisdiction where the Company does not file Tax Returns that the Company is or may be subject to taxation in
that jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Extensions</U>. There is not in force any extension of time with respect to the due date
for the filing of any Tax Return of or with respect to the Company or any waiver or agreement for any extension of time for the assessment or payment of any Tax of or with respect to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Sharing</U>. The Company is not a party to or bound by any Tax allocation, sharing or indemnity agreement or
arrangement, other than commercial agreements entered into in the Ordinary Course of Business, the principal purpose of which is not related to Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Investments, Etc</U>. None of the property of the Company is held in an arrangement that is classified as a
partnership for U.S. federal income Tax purposes. The Company does not own any interest in any controlled foreign corporation (as defined in Section&nbsp;957 of the Code), passive foreign investment company (as defined in Section&nbsp;1297 of the
Code) or other Entity the income of which is or could be required to be included in the income of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-76- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Income</U>. The Company will not be required to include any
item of income in, or exclude any item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i)&nbsp;change in method of accounting for a taxable period (or portion thereof)
ending on or before the Closing Date, including by reason of the application of Section&nbsp;481 of the Code (or any analogous provision of state, local, or foreign Laws), (ii) &#147;closing agreement&#148; as described in Code Section&nbsp;7121 (or
any corresponding or similar provision of state, local or foreign Laws) executed on or prior to the Closing Date, (iii)&nbsp;intercompany transactions or any excess loss account described in Treasury Laws under Code Section&nbsp;1502 (or any
corresponding or similar provision of state, local or foreign Laws), (iv) installment sale or open transaction disposition made on or prior to the Closing Date, (v)&nbsp;prepaid amount received or economically realized on or prior to the Closing
Date outside Ordinary Course of Business or (vi)&nbsp;adjustments pursuant to Code Section&nbsp;263A (or any comparable provision under state, local, or foreign Tax Laws). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;<U>Group Liability</U>. The Company does not have any Liability for the Taxes of any Person under Treasury Laws <FONT
STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any corresponding provisions of state, local or foreign Laws), or as a transferee or successor, or by Contract, assumption or otherwise. The Company is not, and the Company has not ever
been, a member of an affiliated, consolidated, combined or unitary group filing for federal or state income Tax purposes, other than a group the common parent of which was and is the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Agreements</U>. The Company has not entered into any Contract or arrangement with any Taxing Authority that
requires the Company to take any action or to refrain from taking any action. The Company is not a party to any Contract with any Taxing Authority that would be terminated or adversely affected as a result of the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Shelters, Etc.</U> The Company has not participated, within the meaning of Treasury Laws <FONT
STYLE="white-space:nowrap">Section&nbsp;1.6011-4(c),</FONT> in: (i)&nbsp;any &#147;reportable transaction&#148; within the meaning of Section&nbsp;6011 of the Code and the Treasury Laws thereunder, (ii)&nbsp;any &#147;tax shelter&#148; or
&#147;confidential corporate tax shelter&#148; within the meaning of Section&nbsp;6111 of the Code and the Treasury Laws thereunder or (iii)&nbsp;any &#147;potentially abusive tax shelter&#148; within the meaning of Section&nbsp;6112 of the Code and
the Treasury Laws thereunder. The Company has disclosed on its Tax Returns all positions taken therein that could give rise to a substantial understatement of Tax within the meaning of Section&nbsp;6662 of the Code (or any similar provision of
state, local or foreign Laws). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;<U>Escheat</U>. There is no material property or obligation of the Company,
including uncashed checks to vendors, customers, or employees, <FONT STYLE="white-space:nowrap">non-refunded</FONT> overpayments or unclaimed subscription balances, that is escheatable to any state or municipality under any applicable escheatment
laws, as of the date hereof or that may at any time after the date hereof become escheatable to any state or municipality under any applicable escheatment Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer Pricing, Etc.</U> The Company is not subject to Tax in any jurisdiction, other than the country in
which it is organized, by virtue of having a permanent establishment, fixed place of business, or otherwise. All payments by or to the Company materially comply with all applicable transfer pricing requirements imposed by any Taxing Authority, and
the Company has Made Available accurate and complete copies of all transfer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-77- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pricing documentation prepared pursuant to Treasury Law <FONT STYLE="white-space:nowrap">Section&nbsp;1.6662-6</FONT> (or any similar foreign statutory, regulatory, or administrative provision)
by or with respect to the Company during the past six (6)&nbsp;years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exemptions</U>. The Company is not a
party to any Tax exemption, Tax holiday or other Tax reduction agreement or Order of a Taxing Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Liabilities</U>. The provisions for Taxes set forth on the balance sheets included in the Financial
Statements have been made in accordance with GAAP, as of the respective dates thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;<U>Distributions</U>.
The Company has not constituted either a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; in a distribution of stock intended to qualify under Section&nbsp;355 of the Code: (i)&nbsp;in the two (2)&nbsp;years prior to the
Closing Date or (ii)&nbsp;in a distribution that could otherwise constitute part of a &#147;plan&#148; or &#147;series of related transactions&#148; (within the meaning of Section&nbsp;355(e) of the Code) in conjunction with the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;<U>FIRPTA</U>. The Company is not and has never been a &#147;United States real property holding corporation&#148;
within the meaning of Section&nbsp;897 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;<U>Partnerships, Etc.</U> The Company is not and has never
been treated as a partnership and the Company is not disregarded as an entity separate from its owner, in each case, for U.S. federal income Tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r)&nbsp;&nbsp;&nbsp;&nbsp;<U>Boycott</U>. The Company has not participated in, or cooperated with, an international boycott within the
meaning of Section&nbsp;999 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s)&nbsp;&nbsp;&nbsp;&nbsp;<U>Gain Recognition</U>. Company is not a party to any gain
recognition agreement under Section&nbsp;367 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.30.&nbsp;&nbsp;&nbsp;&nbsp;<U>Real Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company does not own any Real Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 3.30(b)</U> of the Company Disclosure Letter discloses a correct and complete list of (i)&nbsp;all Real
Property Leases relating to all Real Property leased by the Company, including all modifications, extensions, amendments and assignments thereof (the &#147;<U>Leased Real Property</U>&#148;) and (ii)&nbsp;the Leased Real Property. Copies of the Real
Property Leases have been Made Available to Parent. The Real Property Leases Made Available to Parent pursuant to this <U>Section</U><U></U><U>&nbsp;3.30(b)</U> are, as of the date of their delivery, accurate and complete in all material respects.
The Company has good and valid leasehold interest in the Leased Real Property, free and clear of all Liens, except Permitted Liens. Each such Real Property Lease is a legal, valid and binding obligation, enforceable in accordance with its terms, of
the Company and, to the Knowledge of the Company, the other parties thereto, except as such enforceability may be limited by the General Enforceability Exceptions. Each such Real Property Lease is in full force and effect in accordance with its
terms, and all rents and additional rents due to date from the Company pursuant to each Real Property Lease have been paid. The Company has not assigned or licensed any or all of its interest under any Real Property Lease or subleased or sublet any
part </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-78- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Leased Real Property or permitted any other Person to occupy the Leased Real Property (whether pursuant to a formal or informal arrangement, and whether or not for consideration), and the
Company has not received written notice of any default (with or without notice or lapse of time or both) with respect to any Real Property Lease. There exists no default by the Company or, to the Knowledge of the Company, by any other party under
any Real Property Lease. The Company is not obligated under or bound by any option, right of first refusal, purchase contract, or other Contract to sell or otherwise dispose of any interest in any Leased Real Property. The Leased Real Property and
the improvements located thereon are (i)&nbsp;suitable and sufficient to permit the continued conduct of the Company&#146;s business as presently conducted and (ii)&nbsp;to the Knowledge of the Company, in good working order (reasonable wear and
tear excepted). The Company has not received any written notice that the Leased Real Property is not in compliance with any applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not received any written notice within the past twenty-four (24)&nbsp;months of any pending or
threatened condemnations, planned public improvements, annexation, special assessments, zoning or subdivision changes, or other adverse claims affecting the Leased Real Property. To the Knowledge of the Company, the Company has received all zoning
approvals, to the extent required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Leased Real Property and the operation thereof by the Company comply in
all material respects with all applicable Laws and any restrictive covenants applicable to the Leased Real Property. The Company has not received any written notice from any Governmental Authority of any violations of any Law affecting any portion
of the Leased Real Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.31.&nbsp;&nbsp;&nbsp;&nbsp;<U>Takeover Statutes</U>. The Company Board has taken all
necessary actions such that the restrictions on business combinations set forth in Section&nbsp;203 of the DGCL and any other &#147;fair price,&#148; &#147;moratorium,&#148; &#147;control share acquisition&#148; or other similar anti-takeover Law
enacted under state or federal Laws in the United States applicable to the Company (each, a &#147;<U>Takeover Statute</U>&#148;) will not be applicable to the Company in connection with this Agreement, the Mergers or the other transactions
contemplated by this Agreement, and no such Takeover Statute is applicable to this Agreement, the Mergers or the other transactions contemplated hereby. The Company does not have any shareholder rights plan, &#147;poison pill&#148; or similar plan
or arrangement in effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.32.&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate Records</U>. <U>Section</U><U></U><U>&nbsp;3.32</U> of
the Company Disclosure Letter contains a true and complete list of all bank accounts and safe deposit boxes of the Company and the names of Persons having signature authority with respect thereto or access thereto. The books and records of the
Company are true and complete in all material respects and have been maintained in accordance with sound business practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.33.&nbsp;&nbsp;&nbsp;&nbsp;<U>Government Grants</U><U> and Incentives</U>. <U>Section</U><U></U><U>&nbsp;3.33</U> of the
Company Disclosure Letter provides a complete list of all pending and outstanding grants, incentives, benefits, qualifications and subsidies from any Governmental Authority, granted to Company within the last two (2)&nbsp;years (collectively,
&#147;<U>Government Grants</U>&#148;). The Company does not have any Liability whatsoever with respect to royalties or other payments relating to, arising out of or in connection with such Government Grants. The Company is in material compliance
with all of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-79- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the terms, conditions and requirements of the Government Grants. Neither Company nor any of its agents, contractors, vendors, licensors or otherwise has developed any Scheduled Company
Intellectual Property or other Intellectual Property owned by the Company through the application of any financing made available by any Government Grants, and no Scheduled Company Intellectual Property or other Intellectual Property owned by the
Company is subject to any assignment, grant-back, license or other right of any Governmental Authority as a result of any Government Grants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.34.&nbsp;&nbsp;&nbsp;&nbsp;<U>Health Care Professionals</U>. To the Knowledge of the Company, none of Company Securityholders
owning at least one percent (1%) of the Company Capital Stock outstanding immediately prior to the Effective Time is a Health Care Professional. &#147;<U>Health Care Professional</U>&#148; means any Person that is licensed or otherwise authorized by
Law to provide health care directly to individuals, or an officer, employee, agent or contractor of such Person acting in the course and scope of his or her employment, agency or contract related to or in support of the provision of health care
directly to individuals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.35.&nbsp;&nbsp;&nbsp;&nbsp;<U>Affiliated Transactions</U>. Except as set forth on
<U>Section</U><U></U><U>&nbsp;3.35</U> of the Company Disclosure Letter, no officer, director, Company Securityholder or Affiliate of the Company is a party to any agreement, Contract, commitment or transaction with the Company or has any interest
in any property used by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.36.&nbsp;&nbsp;&nbsp;&nbsp;<U>Exclusivity of Representations</U>. The representations
and warranties made by the Company in this <U>Article 3</U> are in lieu of and are exclusive of all other representations and warranties, including any implied warranties. The Company disclaims any such other or implied representations or
warranties, notwithstanding the delivery or disclosure to Parent or its respective Representatives of any documentation or other information (including any pro forma financial information, supplemental data or financial projections or other
forward-looking statements). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF PARENT, MERGER SUB 1 AND MERGER SUB 2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Parent, Merger Sub 1 and the Merger Sub 2 hereby represent and warrant to the Company as of the date hereof as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Due Organization; Good Standing; Corporate Power</U>. Each of Parent, Merger Sub 1 and Merger Sub
2 is a legal entity duly organized, validly existing and in good standing under the Laws of its respective jurisdiction of organization and with the requisite power and authority to conduct the Business as it is currently being conducted and to own,
lease or license, as applicable, its Assets. Parent has delivered to the Company true, correct and complete copies of the Organizational Documents of Parent, Merger Sub 1 and Merger Sub 2, each as in effect on the date of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-80- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;(i) Parent is authorized to issue 90,000,000 shares of Parent
Common Stock, of which 38,793,503 are issued and outstanding as of the date hereof. Parent has no other authorized, issued or outstanding shares of capital stock. All of the outstanding shares of capital stock of Parent have been duly authorized and
validly issued, and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;No shares of
capital stock of Parent are subject to any right of repurchase, option or forfeiture provision or any restriction on transfer (other than restrictions on transfer imposed by virtue of applicable Laws).<I> </I>As of the date hereof, equity
instruments to purchase 1,688,255 shares of Parent Common Stock are available pursuant to the Amended and Restated AtriCure, Inc. 2014 Stock Incentive Plan and 3,553,709 equity instruments to purchase shares of Parent Common Stock are issued and
outstanding pursuant thereto. Except as set forth in the Parent Reports and as issued in accordance with the terms of the plans described in the Parent Reports, there are no outstanding or authorized options, warrants, convertible securities or
other similar rights or agreements relating to the equity securities of Parent or obligating Parent to issue or sell any equity securities of Parent. All of the shares of capital stock of Parent are not subject to any preemptive rights created by
statute, the Organizational Documents of Parent or any agreement to which Parent is a party, and all such shares are free of any Liens created by Parent in respect thereof. All issued and outstanding shares of capital stock of Parent (i)&nbsp;were
issued in compliance with applicable Laws concerning the issuances securities and (ii)&nbsp;were not issued in violation of or subject to any purchase option, call option, right of first refusal or offer, voting trust or similar arrangement,
shareholders agreement, preemptive right, subscription right or similar right. No shares of capital stock of Parent are held as treasury stock or are owned by Parent. Parent has never declared or paid any dividends on any shares of capital stock of
Parent, and there are no accrued dividends remaining unpaid with respect to any shares of capital stock of Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Authority and Enforceability</U>. Each of Parent, Merger Sub 1 and Merger Sub 2 has full corporate
power and authority to execute and deliver this Agreement and each of the Transaction Documents to which it is or will be a party, and to perform its obligations hereunder and thereunder and to consummate the Transactions. The execution, delivery
and performance by each of Parent, Merger Sub 1 and Merger Sub 2 of this Agreement and the Transaction Documents to which each is a party, have been, or will be when executed and delivered on the Closing Date, duly authorized by all necessary
corporate action by Parent, Merger Sub 1 or Merger Sub 2, as applicable, and no other corporate proceedings on the part of Parent, Merger Sub 1 or Merger Sub 2 will be necessary to authorize the execution, delivery and performance of this Agreement
or to consummate the Mergers and the other transactions contemplated hereby and thereby. This Agreement and the Transaction Documents to which Parent, Merger Sub 1 or Merger Sub 2 is a party has been, or will be when executed and delivered on the
Closing Date, duly executed and delivered by the Parent, Merger Sub 1 or Merger Sub 2, as applicable, and, assuming the due execution and delivery by the other parties thereto, constitutes (or will constitute) a valid and legally binding obligation
of Parent, Merger Sub 1 or Merger Sub 2, applicable enforceable against such party in accordance with the terms hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Contravention</U>. The execution, delivery and performance by Parent, Merger Sub 1 and Merger
Sub 2 of this Agreement and the Transaction Documents to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-81- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which they are a party, and the consummation of the transactions contemplated hereby and thereby, do not and will not: (a)&nbsp;conflict with or result in a violation or breach of, or default
under, any provision of the Organizational Documents of Parent, Merger Sub 1 or Merger Sub 2, (b) conflict with or result in a violation or breach of any provision of any Law or Order applicable to Parent, Merger Sub 1 or Merger Sub 2 or
(c)&nbsp;require the consent, notice or other action by any Person under any Contract to which Parent, Merger Sub 1 or Merger Sub 2 is a party. No consent, approval, Permit, Order, declaration or filing with, or notice to, any Governmental Authority
is required by or with respect to Parent, Merger Sub 1 or Merger Sub 2 in connection with the execution, delivery and performance of this Agreement and the Transaction Documents and the consummation of the transactions contemplated hereby and
thereby, except for the filing of the Certificates of Merger with the Secretary of State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Legal Proceedings</U>. As of the date hereof, there is no Legal Proceeding pending or, to the
Knowledge of each of Parent, Merger Sub 1 or Merger Sub 2, threatened in writing against, Parent, Merger Sub 1 or Merger Sub 2 which seeks to prevent or challenge the Transactions or which would, individually or in the aggregate, reasonably be
likely to result in a Parent Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Brokers</U>. Except for Piper Jaffray
Companies, no broker, finder or investment banker is entitled to any brokerage, finder&#146;s or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of Parent,
Merger Sub 1 or Merger Sub 2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance of Parent Common Stock</U>. The issuance and delivery
of Parent Common Stock in accordance with this Agreement has been duly authorized by all necessary corporate action on the part of Parent and, when issued as contemplated hereby, such Parent Common Stock shall be duly and validly issued, fully paid
and nonassessable. Such Parent Common Stock when so issued and delivered in accordance with the provisions of this Agreement, shall be free and clear of all Liens, other than restrictions on transfer created by applicable securities Laws and will
not have been issued in violation of applicable Laws, applicable NASDAQ rules or regulations, or any preemptive rights or rights of first refusal or similar rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Merger Sub 1 and Merger Sub 2</U>. Merger Sub 1 and Merger Sub 2 were each organized solely for
the purpose of entering into this Agreement and consummating the Transactions and have not engaged in any activities or business, and have incurred no liabilities or obligations whatsoever, in each case, other than those incident to its organization
and the execution of this Agreement and the consummation of the transactions contemplated hereby. Merger Sub 1 is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware. Merger Sub 2 is a limited
liability company duly organized, validly existing and in good standing under the Laws of the State of Delaware. Merger Sub 1 has full corporate power and authority to enter into this Agreement, to carry out its obligations hereunder and to
consummate the transactions contemplated hereby. Merger Sub 2 has full limited liability company power and authority to enter into this Agreement, to carry out its obligations hereunder and to consummate the transactions contemplated hereby. The
execution and delivery by Merger Sub 1 and Merger Sub 2 of this Agreement, the performance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-82- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by Merger Sub 1 and Merger Sub 2 of their obligations hereunder and the consummation by Merger Sub 1 and Merger Sub 2 of the transactions contemplated hereby have been duly authorized by all
requisite action on the part of Merger Sub 1 and Merger Sub 2, as applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial
Statements; No Liabilities.</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Parent has filed or furnished, as applicable, on a timely basis, all material
forms, statements, certifications, reports and documents required to be filed or furnished by it with or to the Securities and Exchange Commission (the &#147;<U>SEC</U>&#148;) pursuant to the Exchange Act or the Securities Act since
December&nbsp;31, 2016, (the forms, statements, reports and documents filed with or furnished to the SEC since December&nbsp;31, 2016 and those filed with or furnished to the SEC subsequent to the date of this Agreement, in each case as amended, the
&#147;<U>Parent Reports</U>&#148;). Each of the Parent Reports, at the time of its filing or being furnished complied or, if not yet filed or furnished, will comply in all material respects with the applicable requirements of the Securities Act, the
Exchange Act and the Sarbanes-Oxley Act of 2002 (the &#147;<U>Sarbanes-Oxley Act</U>&#148;), and any rules and regulations promulgated thereunder applicable to the Parent Reports. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Parent is in compliance in all respects with the applicable listing and corporate governance rules and regulations
of the NASDAQ. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Parent maintains a system of internal accounting controls sufficient to provide reasonable
assurance that, in all material respects: (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation of Parent&#146;s financial
statements in conformity with GAAP and to maintain asset accountability, (iii)&nbsp;access to Assets is permitted only in accordance with management&#146;s general or specific authorization and (iv)&nbsp;the recorded accountability for Assets is
compared with the existing Assets at reasonable intervals and appropriate action is taken with respect to any differences. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>SEC Filings; Securities Law and Other Matters; Absence of Certain Changes or Events</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Parent is eligible to register securities on Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities
Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Parent has filed all Parent Reports, each of which has complied in all material respects with the
applicable requirements of the Securities Act and the Exchange Act, and the rules and regulations of the SEC promulgated thereunder, as applicable, and applicable to the Parent Reports. None of the Parent Reports contained as of their respective
dates, and as of the date of the last amendment thereof, if amended after filing, any untrue statement of a material fact or omitted or omits to state a material fact required to be stated or incorporated by reference therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;All of the financial statements included in the Parent Reports, in each case, including any related notes thereto,
as filed with the SEC (collectively, the &#147;<U>Parent Financial Statements</U>&#148;), have been prepared in accordance with GAAP applied on a consistent basis throughout the periods involved and fairly present the consolidated financial position
of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-83- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Parent and its Subsidiaries at the respective date thereof and the consolidated results of its operations and changes in cash flows for the periods indicated (except, in each case as may be
indicated in the notes thereto and subject, in the case of the unaudited statements, to normal, <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments and the absence of footnotes otherwise required by GAAP). To the knowledge of Parent, there
are no circumstances that would require Parent to restate any of the Parent Financial Statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;There are no
material liabilities of Parent or any of its Subsidiaries, taken as a whole, of any kind whatsoever, whether or not accrued and whether or not contingent or absolute, other than (i)&nbsp;liabilities disclosed in Parent&#146;s consolidated balance
sheet (the &#147;<U>Parent Balance Sheet</U>&#148;) as of March&nbsp;31, 2019 (the &#147;<U>Parent Balance Sheet Date</U>&#148;), included in Parent&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended
April&nbsp;26, 2019; (ii) liabilities incurred by or on behalf of Parent in connection with this Agreement and the transactions contemplated hereby; (iii)&nbsp;liabilities disclosed in Parent Reports filed since the filing of the Parent Balance
Sheet and (iv)&nbsp;liabilities incurred in the ordinary course of business since the Parent Balance Sheet Date, none of which, individually or in the aggregate, would reasonably be expected to result in a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Parent Common Stock are, or will be pursuant to <U>Section</U><U></U><U>&nbsp;2.13</U>, registered pursuant to
Section&nbsp;12(b) of the Exchange Act and are listed on the NASDAQ and Parent has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Parent Common Stock under the Exchange Act or delisting
the Parent Common Stock from the NASDAQ, nor has Parent received any notification that the SEC or the NASDAQ is contemplating terminating such registration or listing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Since the Parent Balance Sheet Date, and other than in the ordinary course of business consistent with past
practice, there has not been, with respect to Parent, any event, occurrence or development that has had, or could reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Certain Changes or Events</U>. Since December&nbsp;31, 2018, no Parent Material
Adverse Effect has occurred. Except as contemplated or permitted by, or as a consequence of, this Agreement, since December&nbsp;31, 2018, Parent has conducted its business in the Ordinary Course of Business, consistent with the past customs and
practices of Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance</U>. Parent is, and since January&nbsp;1, 2017, Parent has
been, in compliance in all material respects with all applicable Laws and Orders. Except as disclosed in the Parent Reports, since January&nbsp;1, 2017, Parent has not received any written or other notice of, been charged with, or received any
inquiry concerning, the possible violation of any applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section 4.13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Takeover Statutes</U>. The
board of directors of Parent has taken all necessary actions such that no Takeover Statute will be applicable to Parent, Merger Sub 1, Merger Sub 2 or any other Subsidiary of Parent in connection with this Agreement, the Mergers or the other
transactions contemplated by this Agreement, and no such Takeover Statute is applicable to this Agreement, the Mergers or the other transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-84- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Intended Tax Treatment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Merger Sub 1 is a corporation and Merger Sub 2 is a disregarded entity for U.S. federal income Tax purposes. Each of
Merger Sub 1 and Merger Sub 2 will be a wholly-owned direct Subsidiary of the Parent immediately prior to the Effective Time. Merger Sub 1 was formed solely for the purpose of engaging in a transaction similar to the transactions contemplated by
this Agreement and, since its formation, Merger Sub 1 has not and, as of the Effective Time, will not have, (a)&nbsp;carried on any business, (b)&nbsp;conducted any operations, (c)&nbsp;incurred any liabilities or obligations other than the
execution of this Agreement, the performance of its obligations hereunder and matters ancillary thereto, (d)&nbsp;owned any assets (other than assets with nominal value contributed upon its formation and assets that are part of the consideration
that will be distributed to Company Securityholders in the Reverse Merger), or (e)&nbsp;issued any stock or other equity interests to any Person other than the Parent. Merger Sub 2 was formed solely for the purpose of engaging in the transactions
contemplated by this Agreement and, since its formation, Merger Sub 2 has not and, as of the Effective Time, will not have, (a)&nbsp;carried on any business, (b)&nbsp;conducted any operations, (c)&nbsp;incurred any liabilities or obligations other
than the execution of this Agreement, the performance of its obligations hereunder and matters ancillary thereto, (d)&nbsp;owned any assets (other than assets with nominal value contributed upon its formation and assets that are part of the
consideration for the Second-Step Merger), or (e)&nbsp;issued any stock or other equity interests to any Person other than the Parent. The Surviving Company will be a wholly-owned direct Subsidiary of Parent immediately after the Effective Time.
Neither Parent nor any Parent Related Person owns or, prior to the Effective Time, will own (including through partnerships, intermediaries or other third parties) any stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Parent nor any Person related to the Parent within the meaning of Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.368-1(e)(4)</FONT> (a &#147;<U>Parent Related Person</U><B>&#148;</B>) has any present plan or intention to take any of the following actions, in each case, other than to the extent described in Treasury
Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-2(k):</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;sell or otherwise dispose of
&#147;substantially all of the properties&#148; (within the meaning of Code Section&nbsp;368(a)(2)(D)) of the Surviving Company and its Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;merge the Surviving Company with or into another Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;sell or otherwise dispose of any stock of the Surviving Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;acquire, or allow any Parent Related Person to acquire, directly or indirectly (including through partnerships,
intermediaries or other third parties), any equity interests of the Surviving Company (other than pursuant to this Agreement); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;redeem or otherwise reacquire, or allow any Parent Related Person to redeem or otherwise reacquire, directly or
indirectly (including through partnerships, intermediaries or other third parties), any Parent Common Stock issued in the Reverse Merger (other than pursuant to this Agreement or any employment-related forfeiture provisions with
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-85- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respect to such Parent Common Stock or with respect to any Qualified Repurchase of Parent Common Stock). For the avoidance of doubt, nothing contained herein shall preclude Parent from
repurchasing its stock in the open market through a broker or investment bank or through an accelerated share repurchase program or Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> plan; provided that the following requirements are satisfied (any
such repurchase meeting these requirements, a &#147;<U>Qualified Repurchase</U>&#148;):<B> </B>(i) the repurchase was not negotiated with the Company or any Securityholder; (ii)&nbsp;the total number of shares of Parent Common Stock repurchased will
not exceed the total number of shares of Parent Common Stock outstanding immediately prior to the Reverse Merger; (iii)&nbsp;in the case of an open market repurchase, (a)&nbsp;the repurchase of shares of Parent Common Stock is on the open market,
through a broker, for the prevailing market price and (b)&nbsp;Parent does not know the identity of the seller and the seller does not know the identity of Parent; and (iv)&nbsp;in the case of an accelerated share repurchase program or Rule <FONT
STYLE="white-space:nowrap">10b5-1</FONT> plan, (a)&nbsp;Parent&#146;s counterparty is an investment bank or dealer in Parent Common Stock not related to Parent as set forth in Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.368-1(e)(4),</FONT> (b) Parent does not know the identity of any person from whom such counterparty borrows or acquires Parent Common Stock, (c)&nbsp;any shares of Parent Common Stock borrowed by such
counterparty will be borrowed from unaffiliated third-party stock lenders that lend Parent Common Stock as part of their Ordinary Course of Business and (d)&nbsp;any shares of Parent Common Stock used by such counterparty to close out open positions
established in connection with an accelerated share repurchase program will be shares of Parent Common Stock (X)&nbsp;purchased by such counterparty (or any affiliate thereof) in open market transactions (including, for the avoidance of doubt, any
transactions executed on an exchange, off exchange, on electronic trading platforms and on other alternative trading systems, it being understood that such counterparty shall not know the identity of the seller in any of such transactions), (Y)
obtained by such counterparty (or any affiliate thereof) from unaffiliated third-party stock lenders that lend Parent Common Stock as part of their ordinary course business, so long as any open short positions with respect to such loans are closed
out in the manner consistent with clauses (X)&nbsp;and (Z) of this paragraph, or (Z)&nbsp;received by such counterparty (or any affiliate thereof) in settlement of any listed option transactions in which such counterparty does not know the identity
of the option counterparty; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;fail to cause Parent or another member of the Parent&#146;s qualified group
(within the meaning of Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-1(d)(4)(ii))</FONT> to continue the &#147;historic business&#148; of the Surviving Company or use a &#147;significant portion&#148; of the Surviving
Company&#146;s &#147;historic business assets&#148; in a business, as such terms are defined in Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-1(d);</FONT> or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;make, or allow any Parent Related Person to make, any distribution or other payment, directly or indirectly, to
former holders of stock of the Company on account of their status as former stockholders of the Company, other than pursuant to this Agreement or any ancillary agreement and other than dividend distributions made to all holders of the Parent Common
Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Independent Investigation</U>. Parent hereby acknowledges and affirms that it has
conducted and completed its own investigation, analysis and evaluation of the Company, that it has made all such reviews and inspections of the financial condition, business, results of operations, properties, assets and prospects of the Company as
it has deemed necessary or appropriate, that it has had the opportunity to request all information it has deemed relevant to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-86- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the foregoing from the Company and has received responses it deems adequate and sufficient to all such requests for information, and that in making its decision to enter into this Agreement and
to consummate the Transactions it has relied solely on (i)&nbsp;its own investigation, analysis and evaluation of the Company and (ii)&nbsp;the representations, warranties and covenants of the Company contained in <U>Article 3</U> of this Agreement.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct of Business of the Company</U>. The Company covenants and agrees that, between the date of
this Agreement and the earlier to occur of the Effective Time and the termination of this Agreement pursuant to its terms, unless Parent shall otherwise specifically consent in writing in advance or unless otherwise expressly required by this
Agreement, the Company shall conduct its business (i)&nbsp;in the Ordinary Course of Business and in a manner consistent with past practice and (ii)&nbsp;in compliance with all applicable Laws and Orders. Without limiting the generality of the
foregoing, the Company shall use its commercially reasonable efforts to (A)&nbsp;preserve intact its business organization and its rights, assets and properties, including Intellectual Property, (B)&nbsp;keep available the services of its officers,
employees, contract workers, sales representatives, distributors and sales agents (other than terminations for cause in the Ordinary Course of Business consistent with past practice), (C) maintain in effect Material Contracts (other than those
Material Contracts that expire in accordance with their terms or terminations expressly provided for by this Agreement), (D) pay Indebtedness for borrowed money and Taxes of the Company when due (except to the extent contested in good faith by the
Company) and (E)&nbsp;preserve its relationships with material customers, licensees, suppliers and other Persons with which the Company has material business relationships. In addition to and not in limitation of the foregoing, the Company shall not
between the date of this Agreement and the earlier to occur of the Effective Time and the termination of this Agreement pursuant to its terms, directly or indirectly do, or propose to do, any of the following without the prior written consent of
Parent (such consent not to be unreasonably withheld, conditioned or delayed and provided that such consent shall only be provided if consistent with applicable Law), unless otherwise expressly permitted by this Agreement, required by applicable
Law, requested by Parent or otherwise expressly set forth in <U>Section</U><U></U><U>&nbsp;5.1</U> of the Company Disclosure Letter: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;amend, propose to amend or otherwise change its Organizational Documents, alter (through merger, liquidation,
reorganization, reclassification, recapitalization, restructuring or in any other fashion) the corporate or capital structure or ownership of the Company, or commence any voluntary liquidation, dissolution or winding up of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;(A) issue, grant, sell, transfer, deliver, pledge, promise, dispose of or encumber, or authorize the issuance,
grant, sale, transfer, deliverance, pledge, promise, disposition or encumbrance of, or alter, amend or modify the terms of or rights or obligations under, (i)&nbsp;any shares of capital stock of any class or series of the Company, (ii)&nbsp;any
other ownership interests or stock-based rights of the Company, (iii)&nbsp;any securities or other instruments (including notes or other evidences of Indebtedness or stock-based rights) convertible into or exchangeable for, (B)&nbsp;subscription
rights, options or warrants to acquire </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-87- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(other than in the ordinary course consistent with past practice), or (C)&nbsp;other agreements or commitments of any character obligating it to issue, in each case of the foregoing clauses (A),
(B), and (C), any such shares, interests or stock-based rights (or any convertible or exchangeable instruments or securities) or (iv)&nbsp;any other securities (including convertible or exchangeable securities) or convertible or exchangeable
instruments of the Company, <I>provided</I>,<I> however</I>, the Company may issue shares of Company Common Stock or Series D Preferred Stock upon the valid exercise of Options or Warrants outstanding as of the date of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;establish, amend or accelerate the vesting or rights under any stock option plan, stock appreciation rights plan,
stock purchase plan, phantom stock plan or other equity incentive plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;adopt, ratify or effectuate a
stockholders&#146; rights plan or agreement or similar plan or Contract; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;(i) declare, set aside or pay any
dividend or other distribution (whether in cash, stock or property or any combination thereof) in respect of any of its capital stock, (ii)&nbsp;split, combine or reclassify any of its capital stock, (iii)&nbsp;effect a recapitalization,
(iv)&nbsp;issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for, shares of its capital stock or (v)&nbsp;redeem, purchase (or repurchase, other than in connection with an employee&#146;s termination
of service to the Company) or otherwise acquire, directly or indirectly, any of the capital stock or other securities of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;sell, transfer, assign, deliver, lease, sublease, license, sublicense, mortgage, pledge, encumber, impair or
otherwise dispose of (in whole or in part), or create, incur or assume any Lien (other than a Permitted Lien) on, or otherwise cause to be subjected to any Lien (other than a Permitted Lien), any of the material assets, material properties or
securities of the Company (including any Intellectual Property or accounts receivable), except for the sale of inventory in the Ordinary Course of Business consistent with past practice; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;(i) acquire any equity interests in, or otherwise acquire or form, any entity or other Person, (ii)&nbsp;acquire
any real property or (iii)&nbsp;acquire any rights, assets or properties with a value in excess of $350,000 in the aggregate, other than in the Ordinary Course of Business consistent with past practice and in compliance with applicable Law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;(i) incur or modify any Indebtedness or issue any debt securities or any warrants or rights to acquire any debt
security, (ii)&nbsp;assume, guarantee or endorse, or otherwise become responsible for, the obligations of any other Person, (iii)&nbsp;enter into any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet financing arrangement or any accounts
receivable or payable financing arrangement or (iv)&nbsp;make any loans, advances or enter into any other financial commitments (except for advances of reasonable business expenses in the Ordinary Course of Business consistent with past practice);
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;authorize or make any capital expenditures outside of the Ordinary Course of Business consistent with past
practice, or in excess of $350,000; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;other than as may be required pursuant to applicable Law
(i)&nbsp;increase, accelerate or provide for additional compensation or benefits (fringe or otherwise) to, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-88- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or grant, agree to grant, pay or otherwise make payable any incentive, bonus or similar compensation or rights to, any current or former director, manager, managing director, officer, employee,
contract worker or agent of the Company other than in the Ordinary Course of Business consistent with past practice, (ii)&nbsp;grant, pay or otherwise make payable any change in control, transaction-based, severance, retention, continuation or
termination pay to any current or former director, manager, managing director, officer, employee, contract worker or agent of the Company, other than as required pursuant to Company Benefit Plans in existence as of the date of this Agreement,
(iii)&nbsp;loan or advance (or forgive any such loan or advance of) any money or other property to any current or former director, manager, managing director, officer, employee, contract worker or agent of the Company (except for advances of
business expenses in the Ordinary Course of Business consistent with past practice), (iv) establish, adopt, enter into, amend, or terminate (including termination of participation in)&nbsp;(A) any Company Benefit Plan or any other plan, agreement,
program, policy, trust, fund or other arrangement that would be an Employee Benefit Plan if it was in existence as of the date of this Agreement (except for immaterial amendments in the Ordinary Course of Business consistent with past practice that
would not result in an increase in Liability to the Company, or, after the Closing, to Parent, the Surviving Company, or any of their respective Affiliates), or (B)&nbsp;collective bargaining agreement or other labor agreement or (v)&nbsp;terminate
any employee, other than termination for cause in the Ordinary Course of Business consistent with past practice, or encourage any employee to resign from the Company or any of its Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp; change any accounting or cash management policies, procedures or practices used by the Company or management of
working capital (including with respect to reserves, revenue recognition, timing for payments of accounts payable and collection of accounts receivable) unless required by a change in Law or GAAP; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;make or change any Tax election or change any method of tax accounting other than an election in the Ordinary
Course of Business consistent with the past practices of the Company, settle or compromise any federal, state, local or foreign Tax Liability, file any amended income or other material Tax Return, enter into any closing agreement relating to any
Tax, agree to an extension or waiver of any limitation period applicable to any claim or assessment in respect of Taxes, or surrender any right to claim a Tax refund; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;settle any Claim, except if such settlement (i)&nbsp;would not impose or otherwise result in any injunctive or
similar Order on the Company, (ii)&nbsp;would not restrict in any way, or otherwise result in any restriction on, the business of the Company (or the Surviving Company after the Effective Time) and (iii)&nbsp;would not exceed $50,000 in cost,
Liability or value to the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;(i) waive, assign, release or otherwise relinquish any material rights or
claims, or (ii)&nbsp;commence any suit, action or proceeding, or threaten to commence any suit, action or proceeding, against any Person (other than Parent, Merger Sub 1 or Merger Sub 2); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;engage in any transactions with, or enter into or modify or amend in any material respect any Contract or other
arrangement with, any of the directors, managers, managing directors, officers, employees, Contract workers, agents, Company Securityholders, or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-89- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other Affiliates of the Company, or any of their respective Affiliates or family members, other than offer letters and other standard documents, in the Company&#146;s standard forms that have
been Made Available to Parent (and not providing any rights to severance or similar payments), with any new employees or contract workers hired or retained after the date of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;suspend or terminate the aMAZE IDE Clinical Trial, except if so required by a Governmental Authority; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;authorize any of the foregoing, or agree or enter into or amend any Contract or commitment to do any of the
foregoing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Access to Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) From the date of this Agreement through the Effective Time, the Company will provide Parent and its Affiliates, employees, accountants,
counsel, advisors, consultants and other Representatives, upon reasonable advance notice to the Company&#146;s Representatives, with reasonable access during normal business hours to the properties, Assets, premises, Books and Records, Contracts and
other documents and data related to the Company and its respective personnel and Representatives, and the Company shall instruct its Representatives to cooperate with Parent in its investigation of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each of Parent, Merger Sub 1 and Merger Sub 2 will hold and will cause its Representatives and Affiliates to hold
in confidence all documents and information furnished to it in connection with the Transactions contemplated by this Agreement pursuant to the confidentiality provisions contained in that certain letter agreement dated March&nbsp;8, 2019, by and
among the Company and Parent with respect to the Transactions contemplated by this Agreement (the &#147;<U><FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> Agreement</U>&#148;). All materials reviewed or received in connection with this
<U>Section</U><U></U><U>&nbsp;5.2</U> shall be deemed to be Evaluation Material for the purposes of the <FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> Agreement. Effective as of the Effective Time, the
<FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> Agreement shall expire and no longer apply to Parent, Merger Sub 1, Merger Sub 2 or any of their Affiliates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notification of Certain Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Prior to Closing: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall give prompt notice to Parent of the occurrence or
<FONT STYLE="white-space:nowrap">non-occurrence</FONT> of any fact, condition or event of which the Company has Knowledge, the occurrence or <FONT STYLE="white-space:nowrap">non-occurrence</FONT> of which would reasonably be expected to
(i)&nbsp;result in any representation or warranty of the Company contained in this Agreement being untrue or inaccurate in any material respect, without giving effect to the words &#147;material&#148; or &#147;Material Adverse Effect&#148;, had such
representation or warranty been made as of the time of occurrence, <FONT STYLE="white-space:nowrap">non-occurrence</FONT> or discovery of such fact, condition or event (except to the extent such representations and warranties specifically relate to
an earlier date) or (ii)&nbsp;result in or constitute a failure of the Company to comply with or satisfy in any material respect any covenant or agreement to be complied with or satisfied by it hereunder prior to the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Company and Parent shall give prompt notice to the other of (i)&nbsp;any written or oral notice from
any Person alleging that the Permit of such Person is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-90- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or may be required in connection with this Agreement or the transactions contemplated hereby, including the Mergers, (ii)&nbsp;subject to <U>Section</U><U></U><U>&nbsp;5.3(c)(iii)</U>, as
applicable, any notice, document, request, court papers or other written or oral communication from any Governmental Authority or other third party in connection with this Agreement or the transactions contemplated hereby, including the Mergers,
(iii)&nbsp;any Claim relating to or involving or otherwise affecting such Party that relates to this Agreement or the transactions contemplated hereby, including the Mergers or (iv)&nbsp;any fact, event, change, development, circumstance, condition
or effect that such Party has determined has delayed or impeded, or would reasonably be expected to delay or impede, the ability of such Party to consummate the transactions contemplated by this Agreement or to fulfill its obligations set forth
herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall promptly notify Parent of (i)&nbsp;any material Claim that is threatened, brought,
asserted or commenced against the Company or any of its Subsidiaries that would have been required to be listed in <U>Section</U><U></U><U>&nbsp;3.9</U> of the Company Disclosure Letter or would have otherwise resulted in a breach or inaccuracy of
the representations and warranties in <U>Section</U><U></U><U>&nbsp;3.9</U> if such Claim had arisen prior to the date hereof, (ii)&nbsp;any actual, suspected or potential Material Compliance Violation, (iii)&nbsp;any Material Adverse Effect or
(iv)&nbsp;any event that would have been required to be listed in <U>Section</U><U></U><U>&nbsp;3.13(c)</U> of the Company Disclosure Letter or would have otherwise resulted in a breach or inaccuracy of the representations and warranties in
<U>Section</U><U></U><U>&nbsp;3.13(c)</U> if such event had occurred prior to the date hereof, in each case of the foregoing of clauses (i)&nbsp;through (iv), of which the Company has Knowledge. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional Agreements; Reasonable Best Efforts</U>. From the date of this Agreement through the
Effective Time, subject to the terms and conditions herein provided, (a)&nbsp;each of the parties hereto agrees to use reasonable best efforts to take or cause to be taken all actions and to do or cause to be done all things reasonably necessary,
proper or advisable under applicable Laws to consummate and make effective the Transactions, including the Mergers, contemplated by this Agreement, including (i)&nbsp;contesting any legal proceeding relating to the Mergers and (ii)&nbsp;executing
any additional instruments necessary to consummate the Transactions contemplated hereby<B> </B>and (b)<B></B>&nbsp;each of the parties hereto agrees to use reasonable best efforts to cause the Effective Time to occur as soon as reasonably
practicable after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5. <U>Bridge Note Conversion</U>. The Company shall, prior to the Closing Date, take
all actions necessary to cause the conversion of the Bridge Notes into equity securities of the Company prior to or at the Closing, in accordance with their terms and the terms of the Note Purchase Agreement, dated August&nbsp;21, 2018, by and among
the Company and the lenders party thereto, as amended. As of the Effective Time, there will be no Bridge Notes outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section 5.6.
<U>Parachute Payments</U>. As promptly as practicable after the execution and delivery of this Agreement, the Company shall submit to the holders of Company Common Stock as required by Section 280G(b)(5)(A)(ii) of the Code (in a manner reasonably
satisfactory to Parent) for execution and approval by such number of securityholders as is required by the terms of Section 280G(b)(5)(B) of the Code a written consent in favor of a single proposal to render the parachute payment provisions of
<U>Section 280G</U> of the Code and the Treasury Laws thereunder (collectively, &#147;Section 280G&#148;) inapplicable to any payments or benefits provided pursuant to Company Benefit Plans, other Material Contracts or otherwise in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-91- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection with the Transactions that might result, separately or in the aggregate, in the payment of any amount or the provision of any benefit that would not be deductible by reason of
Section&nbsp;280G or that would be subject to an excise Tax under Section&nbsp;4999 of the Code (determined without regard to the exceptions contained in Section&nbsp;280G(b)(4)) or any corresponding provision of any state, local or foreign Law
(together, the &#147;<U>Section</U><U></U><U>&nbsp;280G</U><U> Payments</U>&#148;). Any such approval shall be sought by the Company in a manner that satisfies all applicable requirements of Section&nbsp;280G(b)(5)(B) of the Code and the Treasury
Laws thereunder, including <FONT STYLE="white-space:nowrap">Q-7</FONT> of <FONT STYLE="white-space:nowrap">Section&nbsp;1.280G-1</FONT> of such Treasury Laws. The Company agrees that: (i)&nbsp;in the absence of such approval, no Section&nbsp;280G
Payments shall be made and (ii)&nbsp;reasonably promptly after execution of this Agreement, and prior to the submission of the written consent described herein and any related disclosure of the Section&nbsp;280G Payments, the Company shall deliver
to Parent waivers, in form and substance reasonably satisfactory to Parent, duly executed by each Person who might receive any Section&nbsp;280G Payment. The form and substance of all Company Securityholder approval documents contemplated by this
<U>Section</U><U></U><U>&nbsp;5.6</U>, including the waivers, disclosure statement and written consent, and any mathematical analysis of the Section&nbsp;280G Payments, shall be subject to the prior reasonable review and approval of Parent, which
shall not be unreasonably withheld. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification; Insurance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For a period of six (6)&nbsp;years from and after the Effective Time, the Surviving Company agrees to honor provisions regarding
indemnification of, and advancement of expenses to, Covered Persons that are no less favorable to the Covered Persons than the provisions contained (i)&nbsp;in the Organizational Documents of the Company, in each case as in effect on the date hereof
and (ii)&nbsp;in any indemnification agreement between such Covered Person and the Company that is listed in <U>Section</U><U></U><U>&nbsp;5.7</U> of the Company Disclosure Letter and has been Made Available to Parent prior to the date hereof, as in
effect on the date hereof (without giving effect to any amendments or modifications thereto, unless such amendments or modifications are specifically referenced). For purposes of this <U>Section</U><U></U><U>&nbsp;5.7</U>, &#147;<U>Covered
Person</U>&#148; shall mean any person who is serving (as of immediately prior to the Effective Time) or has previously served as a director, manager, managing director or officer of the Company listed on <U>Section</U><U></U><U>&nbsp;3.1(ii)</U> of
the Company Disclosure Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Following the Closing, Parent shall maintain the D&amp;O Tail Policy in full
force and effect for the entirety of its term and shall continue to honor all obligations thereunder. Notwithstanding anything to the contrary in this Agreement, for purposes of the calculation of the Closing Merger Consideration, the aggregate
amount of the premium paid to purchase the D&amp;O Tail Policy shall be the responsibility of the Company (and treated as Company Transaction Fees hereunder). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Preservation of Books and Records</U>. Each of Parent, Merger Sub 1 and Merger Sub 2 shall use
reasonable best efforts to preserve and keep, or cause to be preserved and kept, all original Books and Records in respect of the Business in the possession of Parent, the Surviving Company or their respective Affiliates for a period of seven
(7)&nbsp;years after the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9. <U>Public Announcement</U>. No Party or any of its respective Subsidiaries or
Affiliates will make any press release, public statement or public announcement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-92- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with respect to this Agreement or any of the transactions contemplated hereby or thereby without the prior written consent of Parent or the Company (prior to the Closing ) or the Securityholder
Representative (after the Closing), as the case may be; provided, that Parent may make any press release, public statement or public announcement which Parent determines is required by applicable Law, stock listing requirements or rating agency
arrangements, in which case Parent shall use reasonable best efforts to consult with the Company (prior to the Closing) or the Securityholder Representative (after the Closing) regarding the contents thereof prior to issuing any such press release
or making any such public statement or public announcement and shall consider in good faith any comments proposed by the Company or the Securityholder Representative, as applicable. Notwithstanding anything in this Agreement to the contrary, after
Closing and the public announcement of the Transactions, the Securityholder Representative shall be permitted to publicly announce that it has been engaged to serve as the Securityholder Representative in connection with the Transactions as long as
such announcement does not disclose any of the other terms of the Transactions or the other transactions contemplated herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial Statement Preparation</U>. Prior to Closing, the Company shall reasonably assist Parent
in causing to be prepared, as promptly as practicable, any financial statements that Parent is required to file pursuant to Form <FONT STYLE="white-space:nowrap">8-K,</FONT> Rule <FONT STYLE="white-space:nowrap">3-05</FONT> or Article 11 of
Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the 1934 Act, and shall use commercially reasonable efforts to obtain the consents of its auditor(s) with respect thereto as may be required by applicable SEC regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11. <U>Representations as to Tax Treatment</U>. Parent and the Company shall file all Tax Returns consistent with the Intended
Tax Treatment unless (i)&nbsp;there is a contrary assessment or determination made by a Taxing Authority upon audit or (ii)&nbsp;for Tax periods that do not end on or include the Closing Date, based on a change of law after the date of this
Agreement, Parent and the Securityholder Representative agree, acting reasonably and in good faith, that there is not substantial authority to support such a position. The Company acknowledges and agrees that it has, through competent advisors,
completed its own analysis as to the Tax treatment of the Mergers and, except with respect to <U>Section</U><U></U><U>&nbsp;4.14</U> and this <U>Section</U><U></U><U>&nbsp;5.11</U>, that Parent has not made any representations as to the Tax
treatment of the Mergers. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 6 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS TO CONSUMMATION OF THE TRANSACTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to Each Party&#146;s Obligation to Effect the Transactions</U>. The respective
obligations of each party hereto to consummate, or cause to be consummated, the Transactions are subject to the satisfaction at or prior to the Effective Time of the following condition: no Law or Order shall have been enacted, entered, promulgated
or enforced by any United States Governmental Authority having jurisdiction over the parties hereto which prohibits, restrains, enjoins, restricts or makes illegal the consummation of the Transactions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to the Obligation of the Company</U>. The obligation of the Company to consummate, or
cause to be consummated, the Transactions are subject to the satisfaction at or prior to the Effective Time of the following conditions: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-93- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall have delivered a certificate, duly executed by a
duly authorized officer of Parent, dated the Closing Date, certifying that the conditions specified in <U>Section</U><U></U><U>&nbsp;6.2(c)</U>, <U>Section</U><U></U><U>&nbsp;6.2(d)</U> and <U>Section</U><U></U><U>&nbsp;6.2(e)</U> have been
fulfilled; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall have delivered each of the deliverables required by
<U>Section</U><U></U><U>&nbsp;2.7(a)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;the representations and warranties of Parent, Merger Sub 1 and
Merger Sub 2 contained in <U>Article 4</U> of this Agreement, without giving effect to any &#147;material,&#148; &#147;materially&#148; or Parent Material Adverse Effect qualification contained in such representations and warranties, shall be true
and correct at and as of the Effective Time in all material respects (except to the extent such representations and warranties specifically related to an earlier date, in which case such representations and warranties shall be true and correct as of
such earlier date); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;each of the covenants and obligations of Parent, Merger Sub 1 and Merger Sub 2 to be
performed at or before the Effective Time pursuant to the terms of this Agreement shall have been duly performed in all material respects at or before the Effective Time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;since the date of this Agreement, there shall not have occurred any continuing Parent Material Adverse Effect; and
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall have delivered such other documents or instruments as the Company reasonably requests and are
reasonably necessary to consummate the Transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to the Obligations of Parent, Merger Sub 1 and Merger Sub 2</U>. The respective
obligations of Parent, Merger Sub 1 and Merger Sub 2 to consummate, or cause to be consummated, the Transactions, are subject to the satisfaction at or prior to the Effective Time of the following conditions (any or all of which may be waived by
Parent, in whole or in part, to the extent permitted by applicable Law): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;the Company shall have delivered a
certificate, duly executed by the Chief Executive Officer of the Company, dated the Closing Date, certifying that the conditions specified in <U>Section</U><U></U><U>&nbsp;6.3(h)</U>, <U>Section</U><U></U><U>&nbsp;6.3(i)</U> and
<U>Section</U><U></U><U>&nbsp;6.3(j)</U>, have been fulfilled; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;the Company shall have delivered each of the
deliverables required by in <U>Section</U><U></U><U>&nbsp;2.7(b)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;the Company shall have delivered
evidence of the conversion of the Bridge Notes, prior to or as of the Effective Time, in accordance with <U>Section</U><U></U><U>&nbsp;5.5</U> hereof, in form and substance reasonably satisfactory to Parent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;the aMAZE IDE Clinical Trial has not been suspended or ceased enrolling participants; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;if required pursuant to <U>Section</U><U></U><U>&nbsp;5.6</U> hereof, the Section&nbsp;280G Payments shall have
been submitted to the holders of Company Common Stock as required by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-94- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;280G(b)(5)(A)(ii) of the Code for approval or disapproval and such payments will have been approved or disapproved by the such securityholders and, if disapproved, such payments
shall have been waived by the recipients thereof and shall not have been made; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;the Company shall have
delivered letters of resignation and release, effective as of the Effective Time, in form and substance reasonably satisfactory to Parent, from each of the directors and officers of the Company and each person holding a comparable position with any
of the Company&#146;s Subsidiaries, in each case other than those officers, if any, designated in writing by Parent prior to the Closing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;the Company shall have delivered such other documents or instruments as Parent reasonably requests and are
reasonably necessary to consummate the Transactions contemplated by this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;the representations and
warranties of the Company contained in <U>Article 3</U> of this Agreement, without giving effect to any &#147;material,&#148; &#147;materially&#148; or Company Material Adverse Effect qualification contained in such representations and warranties,
shall be true and correct at and as of the Effective Time in all material respects (except to the extent such representations and warranties specifically related to an earlier date, in which case such representations and warranties shall be true and
correct as of such earlier date); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;each of the covenants and obligations of the Company to be performed at or
before the Effective Time shall have been duly performed, in all material respects, in each case at or before the Effective Time; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;since the date of this Agreement, there shall not have occurred any Company Material Adverse Effect. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 7 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION;
WAIVER </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. This Agreement may be terminated and the Mergers may be abandoned
at any time prior to the Effective Time: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;by mutual written consent of Parent and the Company authorized by
their respective boards of directors (or similar governing body) at any time prior to the Effective Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;by
Parent (by written notice to the Company) or by the Company (by written notice to Parent) if the Transactions have not been consummated by September&nbsp;11, 2019 (the &#147;<U>Outside Date</U>&#148;); <I>provided</I>, that no such party may
terminate this Agreement pursuant to this clause if such party&#146;s failure to fulfill any of its obligations under this Agreement shall have been the reason that the Closing shall not have occurred on or before the Outside Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;by the Company (by written notice to Parent) if (i)&nbsp;there shall have been a breach of any representation or
warranty on the part of Parent, Merger Sub 1 or Merger Sub 2 set forth in this Agreement such that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.2(c)</U> would be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-95- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
incapable of being satisfied by the Outside Date or (ii)&nbsp;there shall have been a breach by Parent, Merger Sub 1 or Merger Sub 2 of any of its covenants or agreements hereunder such that the
condition set forth in <U>Section</U><U></U><U>&nbsp;6.2(d)</U> would be incapable of being satisfied by the Outside Date, and Parent, Merger Sub 1 or Merger Sub 2, as the case may be, has not cured such breach within the earlier of twenty
(20)&nbsp;Business Days after receipt of written notice from the Company thereof or the Outside Date; <I>provided</I>, that the Company has not materially breached any of its material obligations hereunder; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;by Parent (by written notice to the Company) if (i)&nbsp;there shall have been a breach of any representation or
warranty on the part of the Company set forth in this Agreement, such that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.3(h)</U> would be incapable of being satisfied by the Outside Date, or (ii)&nbsp;there shall have been a breach by
the Company of its covenants or agreements hereunder such that the condition set forth in <U>Section</U><U></U><U>&nbsp;6.3(i)</U> would be incapable of being satisfied by the Outside Date, and the Company has not cured such breach within the
earlier of twenty (20)&nbsp;Business Days after receipt of written notice from Parent or Merger Sub 1 or Merger Sub 2 thereof or the Outside Date; <I>provided</I>, that neither Parent, Merger Sub 1 nor Merger Sub 2 has materially breached any of its
material obligations hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Termination</U><B>.</B> In the event of the
termination of this Agreement or the abandonment of the Transactions pursuant to <U>Section</U><U></U><U>&nbsp;7.1</U>, this Agreement shall forthwith become void and have no effect, without any liability on the part of any party hereto or its
Affiliates, directors, officers or members, other than liability of the Company, Parent, Merger Sub 1 or Merger Sub 2, as the case may be, for Fraud or Material Breach (as defined below) of any representation, warranty, covenant or agreement under
this Agreement occurring prior to such termination; <I>provided</I>, <I>however</I>, nothing herein shall be deemed to waive any rights of specific performance of this Agreement available to any party. The provisions of this
<U>Section</U><U></U><U>&nbsp;7.2</U>, <U>Section</U><U></U><U>&nbsp;8.3</U>, <U>Article 9</U> and all applicable definitions set forth in <U>Section</U><U></U><U>&nbsp;1.1</U> and <U>Section</U><U></U><U>&nbsp;1.2</U> and the interpretations
provisions of <U>Section</U><U></U><U>&nbsp;1.2</U> hereof shall survive any termination of this Agreement. No termination of this Agreement shall affect the obligations of the parties under the <FONT STYLE="white-space:nowrap">Non-Disclosure</FONT>
Agreement, all of which shall survive termination of this Agreement in accordance with the terms thereof. As used herein, the term &#147;<U>Material Breach</U>&#148; means a deliberate act or a deliberate failure to act, which act or failure to act
constitutes a material breach of this Agreement, regardless of whether breaching was the conscious object of the act or failure to act.<B> </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 8 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITYHOLDER REPRESENTATIVE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section 8.1. <U>Appointment; Duties</U>. By approving this Agreement and the Transactions contemplated hereby or by executing and delivering a
Letter of Transmittal, each Company Securityholder shall have irrevocably authorized and appointed the Securityholder Representative as such Person&#146;s representative, agent and attorney-in-fact for all purposes in connection with this Agreement
and all agreements ancillary hereto and to act on behalf of such Person with respect to this Agreement and to take any and all actions and make any decisions required or permitted to be taken by the Securityholder Representative pursuant to this
Agreement, including the exercise of the power to: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-96- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;give and receive notices and communications; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;agree to, negotiate, enter into settlements and compromises of, and comply with orders or otherwise handle any
other matters related to this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;execute and deliver all documents necessary or desirable to carry out
the intent of this Agreement and any Transaction Document; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;make all elections or decisions contemplated by
this Agreement and any Transaction Document; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;engage, employ or appoint any agents or representatives
(including attorneys, accountants and consultants) to assist the Securityholder Representative in complying with its duties and obligations; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;take all actions necessary or appropriate in the good faith judgment of the Securityholder Representative for the
accomplishment of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Parent shall be entitled to deal exclusively with the Securityholder Representative on all matters
relating to this Agreement and shall be entitled to rely conclusively (without further evidence of any kind whatsoever) on any document executed or purported to be executed on behalf of any Company Securityholder by the Securityholder
Representative, and on any other action taken or purported to be taken on behalf of any Company Securityholder by the Securityholder Representative, as being fully binding upon such Person. Notices or communications to or from the Securityholder
Representative (after Closing) shall constitute notice to or from each of the Company Securityholders. Any decision or action by the Securityholder Representative hereunder, including any agreement between the Securityholder Representative and
Parent relating to the defense, payment or settlement of any claims for indemnification hereunder, shall constitute a decision or action of all Company Securityholders and shall be final, binding and conclusive upon each such Person. No Company
Securityholder shall have the right to object to, dissent from, protest or otherwise contest the same. The provisions of this <U>Section</U><U></U><U>&nbsp;8.1</U>, including the power of attorney granted hereby, are independent and severable, are
irrevocable and coupled with an interest and shall not be terminated by any act of any one or more Company Securityholders or by operation of Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section 8.2. <U>Resignation</U>. The Securityholder Representative may resign at any time, and may be removed for any reason or no reason by
the vote or written consent of a majority in interest of the Company Securityholders (the &#147;<U>Majority Holders</U>&#148;) according to each such Company Securityholder&#146;s Pro Rata Share in the Company. In the event of the death, incapacity,
resignation or removal of the Securityholder Representative, a new Securityholder Representative shall be appointed by the vote or written consent of the Majority Holders. Notice of such vote or a copy of the written consent appointing such new
Securityholder Representative shall be sent to Parent, such appointment to be effective upon the later of the date indicated in such consent or the date such notice is received by Parent; <I>provided</I>, that until such notice is received, Parent,
Merger Sub 1, Merger Sub 2 and the Surviving Company shall be entitled to rely on the decisions and actions of the prior Securityholder Representative as described in <U>Section 8.1</U> above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-97- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section 8.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Liability</U>. The Securityholder Representative
shall incur no liability of any kind to the Company Securityholders with respect to any actions or omissions taken by the Securityholder Representative in connection with the Securityholder Representative&#146;s services pursuant to this Agreement
and any agreements ancillary hereto, except to the extent such actions shall have been determined by a court of competent jurisdiction to have constituted gross negligence, fraud, willful misconduct or bad faith (it being understood that any act
done or omitted pursuant to the advice of counsel, accountants and other professionals and experts retained by the Securityholder Representative shall be conclusive evidence of good faith). The Company Securityholders shall severally and not jointly
(in accordance with their Pro Rata Share in the Company), indemnify, defend and hold harmless the Securityholder Representative from and against, compensate it for, reimburse it for and pay any and all losses, liabilities, claims, penalties, fines,
forfeitures, actions, damages, costs and expenses, including the reasonable fees and expenses of counsel and experts and their staffs, all expenses of document location, duplication and shipment and disbursements, arising out of or in connection
with the Securityholder Representative&#146;s execution and performance of this Agreement and any agreements ancillary hereto (collectively, &#147;<U>Representative Losses</U>&#148;), in each case as such Representative Loss is suffered or incurred;
<I>provided</I>, that in the event any such Representative Loss or any portion thereof is finally adjudicated to have been primarily caused by the gross negligence, fraud, willful misconduct or bad faith of the Securityholder Representative, the
Securityholder Representative shall reimburse the Company Securityholders the amount of such indemnified Representative Loss to the extent attributable to such gross negligence, fraud, willful misconduct or bad faith. If not paid directly to the
Securityholder Representative by the Company Securityholders, any such Representative Loss may be recovered from: (i) the funds in the Representative Reserve, (ii) the funds in the Escrow Account at such time as remaining amounts would otherwise be
distributable to the Company Securityholders and (iii) the Milestone Consideration at such time as remaining amounts would otherwise be distributable to the Company Securityholders; <I>provided</I>, that while this section allows the Securityholder
Representative to be paid from the aforementioned sources of funds, this does not relieve the Company Securityholders from their obligation to promptly pay such Representative Losses as they are suffered or incurred, nor does it prevent the
Securityholder Representative from seeking any remedies available to it at law or otherwise. Notwithstanding anything in this Agreement to the contrary, any restrictions or limitations on liability or indemnification obligations of, or provisions
limiting the recourse against non-parties otherwise applicable to, the Company Securityholders set forth elsewhere in this Agreement are not intended to be applicable to the indemnities provided to the Securityholder Representative under this
section. The foregoing indemnities will survive the Closing, the resignation or removal of the Securityholder Representative or the termination of this Agreement. The Company Securityholders will not receive any interest or earnings on the
Representative Reserve and irrevocably transfer and assign to the Securityholder Representative any ownership right that they may otherwise have had in any such interest or earnings. The Securityholder Representative will not be liable for any loss
of principal of the Representative Reserve other than as a result of its gross negligence, fraud, willful misconduct or bad faith. The Securityholder Representative will hold these funds separate from its corporate funds, will not use these funds
for its operating expenses or any other corporate purposes and will not voluntarily make these funds available to its creditors in the event of bankruptcy. As soon as practicable after the date on which the final obligation of the Securityholder
Representative </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-98- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under this Agreement has been discharged or such other date as the Securityholder Representative deems appropriate, the Securityholder Representative shall deliver any amounts remaining in
Representative Reserve to the Exchange Agent, for further distribution to the Company Securityholders in accordance with their Pro Rata Share in the Company. For tax purposes, the Representative Reserve will be treated as having been received and
voluntarily set aside by the Company Securityholders at the time of Closing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 9 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1.&nbsp;&nbsp;&nbsp;&nbsp;<U><FONT STYLE="white-space:nowrap">Non-Survival</FONT></U><U>; Recourse</U>. The Parties hereto,
intending to modify any applicable statute of limitations, agree that (a)&nbsp;all representations and warranties of the Company contained in <U>Article 3</U> of this Agreement and in any certificate delivered with respect thereto shall terminate
effective as of the Closing and shall not survive the Closing for any purpose, and thereafter, except in the case of Fraud, there shall be no liability on the part of, nor shall any claim under any Legal Proceeding that may be based upon, in respect
of, arise under, out of or by reason of, be connected with, or relate in any manner to this Agreement, or the negotiation, execution, performance or breach (whether willful, intentional, unintentional or otherwise) of this Agreement (each of such
above-described legal, equitable or other theories or sources of liability, a &#147;<U>Recourse Theory</U>&#148;) be made by, any party hereto or any of their respective Affiliates in respect thereof, and (b)&nbsp;none of the covenants of any party
required to be performed by such party before the Closing shall survive the Closing, and after the Closing, there shall be no liability on the part of, nor shall any claim under any Recourse Theory be made by, any party hereto or any of their
respective Affiliates in respect of any covenant or agreement to be performed prior to the Closing. The representations and warranties of Parent contained in <U>Section</U><U></U><U>&nbsp;4.1</U> (Due Organization; Good Standing; Corporate Power),
<U>Section</U><U></U><U>&nbsp;4.2</U> (Capitalization), <U>Section</U><U></U><U>&nbsp;4.3</U> (Authority and Enforceability), <U>Section</U><U></U><U>&nbsp;4.6</U> (Brokers), <U>Section</U><U></U><U>&nbsp;4.7</U> (Issuance of Parent Common Stock),
<U>Section</U><U></U><U>&nbsp;4.8</U> (Merger Sub 1 and Merger Sub 2), <U>Section</U><U></U><U>&nbsp;4.10</U> (SEC Filings; Securities Law and Other Matters; Absence of Changes or Events) and <U>Section</U><U></U><U>&nbsp;5.11</U> (Representations
as to Tax Treatment) of this Agreement and in any certificate delivered with respect thereto shall survive until the later of <FONT STYLE="white-space:nowrap">(i)&nbsp;thirty-six</FONT> (36)&nbsp;months after the Closing or the date that is twelve
(12)&nbsp;months after the last payment made with respect to any Milestone has been paid in full by Parent, and all other representations and warranties of Parent contained in <U>Article 4</U> and in any certificate delivered with respect thereto
shall survive for a period of <FONT STYLE="white-space:nowrap">thirty-six</FONT> (36)&nbsp;months following the Closing. Unless otherwise indicated, the covenants and agreements set forth in this Agreement which by their terms are required to be
performed after the Closing shall survive the Closing until they have been performed or satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section
9.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement; Assignment</U>. This Agreement (including the Company Disclosure Letter and the Transaction Agreements) and the Shareholder Representative Services LLC engagement letter (a) constitute the final and
entire agreement between the parties hereto with respect to the subject matter hereof and supersede all other prior and contemporaneous agreements and understandings, both written and oral, between the parties with respect to the subject matter
hereof and (b) shall not be assigned by operation of law or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-99- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Validity</U>. If any provision of this Agreement
or the application thereof to any Person or circumstance is held invalid or unenforceable, the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected thereby and, to such end, the
provisions of this Agreement are agreed to be severable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment</U>. This Agreement may be
amended by action taken in writing by the Company, Parent, Merger Sub 1, Merger Sub 2 and the Securityholder Representative at any time before or after the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Extension; Waiver</U>. At any time prior to the Effective Time, each party hereto may
(a)&nbsp;extend the time for the performance of any of the obligations or other acts of the other party, (b)&nbsp;waive any inaccuracies in the representations and warranties of the other party contained herein or in any document, certificate or
writing delivered pursuant hereto or (c)&nbsp;waive compliance by the other party with any of the agreements or conditions contained herein. Any agreement on the part of any party hereto to any such extension or waiver shall be valid only if set
forth in an instrument, in writing, signed on behalf of such party. The failure of any party hereto to assert any of its rights hereunder shall not constitute a waiver of such rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All notices, requests, claims, demands and other communications hereunder shall be in
writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by facsimile, by <FONT STYLE="white-space:nowrap">nationally-recognized</FONT> overnight courier, by electronic mail (with confirmation of
receipt) or by registered or certified mail (postage prepaid, return receipt requested) to each other party as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;if to Parent, Merger Sub 1 or Merger Sub 2: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">AtriCure, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">7555 Innovation
Way </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Mason, OH 45040 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: President and Chief Executive Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Phone: (513) <FONT STYLE="white-space:nowrap">755-4567</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: mcarrel@atricure.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">with a copy to (which shall not constitute notice): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Pepper Hamilton LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Two Logan
Square </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Eighteenth and Arch Streets </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Philadelphia, PA 19103 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Rachael M. Bushey, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Phone: (215) <FONT STYLE="white-space:nowrap">981-4331</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: busheyr@pepperlaw.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;if to the Company (prior to the Closing): </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-100- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">SentreHEART, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">300 Saginaw Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Redwood
City, CA 94603 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Chris Lowe, Chief Financial Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Phone: (650) <FONT STYLE="white-space:nowrap">241-6018</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: Clowe@sentreheart.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">with a copy to (which shall not constitute notice): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Goodwin Procter LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">601
Marshall Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Redwood City, CA 94063 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Anthony McCusker; Scott Joachim </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Phone: (650) <FONT STYLE="white-space:nowrap">752-3267;</FONT> (650) <FONT STYLE="white-space:nowrap">752-3149</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: AMcCusker@goodwinlaw.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">SJoachim@goodwinlaw.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;if to the Securityholder Representative, or after Closing, to the Company Securityholders: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Shareholder Representative Services LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">950 17<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Street, Suite 1400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Denver, CO 80202 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention:
Managing Director </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Phone: (303) <FONT STYLE="white-space:nowrap">648-4085</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: deals@srsacquiom.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Facsimile: (303) <FONT STYLE="white-space:nowrap">623-0294</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address as the Person to whom notice is given may have previously furnished to the others in writing in the manner set forth above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section 9.7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law; Jurisdiction; Service of Process</U>. This Agreement, and all claims or causes of action
(whether at law, in contract or in tort or otherwise) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance hereof, shall be governed by and construed in accordance with the internal laws of
the State of Delaware applicable to agreements made and to be performed entirely within the State of Delaware, without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that
would cause the application of the laws of any jurisdiction other than the State of Delaware. With respect to any action or claim arising out of or relating to the Transactions contemplated hereby or any document or instrument delivered in
connection therewith, the parties hereto hereby expressly and irrevocably (a) agree and consent to be subject to the exclusive jurisdiction of the United States District Court located in the State of Delaware (and in the absence of federal
jurisdiction, the parties consent to be subject to the exclusive jurisdiction of the state courts located in the State of Delaware), (b) agree not to bring any action related to any transaction contemplated hereby or any document or instrument
delivered in connection therewith in any other court (except to enforce the judgment of such courts), (c) agree not to object to venue in such courts or to claim that such forum is inconvenient </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-101- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and (d)&nbsp;agree that notice or the service of process in any proceeding shall be properly served or delivered if delivered in the manner contemplated by <U>Section</U><U></U><U>&nbsp;9.6</U>.
Final judgment by such courts shall be conclusive and may be enforced in any manner permitted by applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver of Jury Trial</U>. EACH OF THE PARTIES WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING
ARISING OUT OF OR RELATING TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Parties in Interest</U>. None of the provisions of this Agreement is intended to provide any
rights or remedies to any employee, creditor or other Person other than Parent, Merger Sub 1, Merger Sub 2, the Company, the Securityholder Representative and their respective successors and assigns (if any). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>. Except as set forth in this Agreement, each of the parties hereto will bear its own
costs and Expenses incurred in connection with this Agreement and the Transactions herein contemplated, including all legal, accounting, investment banking and other Expenses incurred by it or on its behalf, whether or not such transactions are
consummated. Parent shall be responsible for all transfer, sales, use, real property transfer, recording, documentary, stamp, registration, share transfer and other similar Taxes and fees imposed in connection with the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Specific Performance</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise breached, and that any breach of this Agreement would not be adequately compensated by monetary damages. The parties acknowledge and agree that in the event of any breach
or threatened breach by the Company, on the one hand, or Parent, Merger Sub 1 or Merger Sub 2, on the other hand, of any of their respective covenants or obligations set forth in this Agreement, the Company, on the one hand, and the Parent, Merger
Sub 1 and Merger Sub 2, on the other hand, shall be entitled to an injunction or injunctions to prevent or restrain breaches or threatened breaches of this Agreement by the other (as applicable), and to specifically enforce the terms and provisions
of this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants and obligations of the other under this Agreement, without proof of actual damages or inadequacy of legal remedy and without bond or other
security being required. The pursuit of specific enforcement by any party hereto will not be deemed an election of remedies or waiver of the right to pursue any other right or remedy (whether at law or in equity) to which such party may be entitled
at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Any and all remedies herein expressly conferred upon a party will be deemed cumulative with and
not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise at any time of any other remedy. The Company, on the one hand, and Parent, Merger
Sub 1 and Merger Sub 2, on the other hand, hereby agree not to raise any objections to the availability of the equitable remedy of specific performance to prevent or restrain breaches or threatened breaches of this Agreement by the Company, Parent,
Merger Sub 1 and Merger Sub 2, as applicable, and to specifically enforce the terms and provisions of this Agreement to prevent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-102- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
breaches or threatened breaches of, or to enforce compliance with, the covenants and obligations of the Company or Parent, Merger Sub 1 and Merger Sub 2, as applicable, under this Agreement. The
parties hereto further agree that by seeking the remedies provided for in this <U>Section</U><U></U><U>&nbsp;9.11</U>, a party shall not in any respect waive its right to seek at any time any other form of relief that may be available to a party
under this Agreement (including monetary damages) in the event that this Agreement has been terminated or in the event that the remedies provided for in this <U>Section</U><U></U><U>&nbsp;9.11</U> are not available or otherwise are not granted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver of Conflicts</U>. Recognizing that Goodwin Procter LLP (&#147;<U>Goodwin</U>&#148;) has
acted as legal counsel to certain of the Company Securityholders and the Company and its Affiliates prior to the Closing, and that Goodwin intends to act as legal counsel to certain of the Company Securityholders after the Closing, each of the
Parent and the Surviving Company hereby waives, on its own behalf and agrees to cause its Affiliates to waive, any conflicts that may arise in connection with Goodwin representing any of the Company Securityholders, the Securityholder Representative
and/or their Affiliates after the Closing as such representation may relate to the Parent or the Transactions. In addition, all communications involving attorney-client confidences between any Company Securityholders and its Affiliates in the course
of the negotiation, documentation and consummation of the Transactions shall be deemed to be attorney-client confidences that belong solely to such Company Securityholders and their Affiliates (and not the Parent or the Surviving Company).
Accordingly, the Parent and the Surviving Company shall not have access to any such communications, or to the files of Goodwin relating to engagement, whether or not the Closing shall have occurred. Without limiting the generality of the foregoing,
upon and after the Closing, (i)&nbsp;the applicable Company Securityholders and their Affiliates (and not the Parent or the Surviving Company) shall be the sole holders of the attorney-client privilege with respect to such engagement, and none of
the Parent or the Surviving Company shall be a holder thereof, (ii)&nbsp;to the extent that files of Goodwin in respect of such engagement constitute property of the client, only the applicable Company Securityholders and their Affiliates (and not
the Parent or the Surviving Company) shall hold such property rights and (iii)&nbsp;Goodwin shall have no duty whatsoever to reveal or disclose any such attorney-client communications or files to the Parent or the Surviving Company by reason of any
attorney-client relationship between Goodwin and the Parent or Surviving Company or otherwise. Notwithstanding the foregoing, in the event that a dispute arises between the Parent or the Surviving Company and a third party (other than a party to
this Agreement or any of their respective Affiliates) after the Closing, the Surviving Company (including on behalf of the Parent) may assert the attorney-client privilege to prevent disclosure of confidential communications by Goodwin to such third
party; <I>provided, however</I>, that neither the Surviving Company nor the Parent may waive such privilege without the prior written consent of the Securityholder Representative, on behalf of the Company Securityholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts; Effectiveness</U>. This Agreement may be executed by facsimile in two (2)&nbsp;or
more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same agreement. This Agreement shall become effective when each party hereto shall have received counterparts thereof signed and
delivered (by facsimile, &#147;<U>portable document format</U>&#148; (PDF), electronic transmission or otherwise) by all of the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of Page Intentionally Left Blank] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-103- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The parties hereto have caused this Agreement and Plan of Merger to be duly executed as of
the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-size:10pt"><B>SENTREHEART, INC.</B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Russell Seiber</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Russell Seiber</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>STETSON MERGER SUB, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ M. Andrew Wade</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">M. Andrew Wade</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SECOND STETSON MERGER SUB, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ M. Andrew Wade</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">M. Andrew Wade</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ATRICURE, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ M. Andrew Wade</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">M. Andrew Wade</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SHAREHOLDER REPRESENTATIVE SERVICES LLC, solely in its capacity as the Securityholder Representative</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sam Riffe</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Sam Riffe</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Agreement and Plan of Merger] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
